[
    {
        "page_number": 1,
        "section_number": 1,
        "content": "J Clin Lab Anal.  2022;36:e24427.\t \t\t \t | 1 of 16",
        "metadata": {
            "section_title": "J Clin Lab Anal.  2022;36:e24427.\t \t\t \t | 1 of 16"
        }
    },
    {
        "page_number": 1,
        "section_number": 2,
        "content": "https://doi.org/10.1002/jcla.24427",
        "metadata": {
            "section_title": "https://doi.org/10.1002/jcla.24427"
        }
    },
    {
        "page_number": 1,
        "section_number": 3,
        "content": "wileyonlinelibrary.com/journal/jcla1 | INTRODUCTION",
        "metadata": {
            "section_title": "wileyonlinelibrary.com/journal/jcla1 | INTRODUCTION"
        }
    },
    {
        "page_number": 1,
        "section_number": 4,
        "content": "The macrolide antibiotic AZM was developed by a group of Croatian",
        "metadata": {
            "section_title": "The macrolide antibiotic AZM was developed by a group of Croatian "
        }
    },
    {
        "page_number": 1,
        "section_number": 5,
        "content": "pharmacists at PLIVA and called Sumamed, taking into account",
        "metadata": {
            "section_title": "pharmacists at PLIVA and called Sumamed, taking into account "
        }
    },
    {
        "page_number": 1,
        "section_number": 6,
        "content": "one of the great achievements in Croatia.1 This antibiotic was also developed under the name of Zithromax in the Pharmaceutical",
        "metadata": {
            "section_title": "one of the great achievements in Croatia.1 This antibiotic was also developed under the name of Zithromax in the Pharmaceutical "
        }
    },
    {
        "page_number": 1,
        "section_number": 7,
        "content": "Chemistry Laboratories at Pfizer Central Research2 AZM is annually",
        "metadata": {
            "section_title": "Chemistry Laboratories at Pfizer Central Research2 AZM is annually "
        }
    },
    {
        "page_number": 1,
        "section_number": 8,
        "content": "prescribed to more than 40 million patients owing to its antibacterial",
        "metadata": {
            "section_title": "prescribed to more than 40 million patients owing to its antibacterial "
        }
    },
    {
        "page_number": 1,
        "section_number": 9,
        "content": "activity.3 This well-  known azalide antibiotic is structurally related to",
        "metadata": {
            "section_title": "activity.3 This well-  known azalide antibiotic is structurally related to "
        }
    },
    {
        "page_number": 1,
        "section_number": 10,
        "content": "the macrolide family and can be distributed in a variety of tissues Received:\t15\tFebruary\t2022  | Revised:\t20\tMarch\t2022  | Accepted:\t24\tMarch\t2022",
        "metadata": {
            "section_title": "the macrolide family and can be distributed in a variety of tissues Received:\t15\tFebruary\t2022  | Revised:\t20\tMarch\t2022  | Accepted:\t24\tMarch\t2022"
        }
    },
    {
        "page_number": 1,
        "section_number": 11,
        "content": "DOI: 10.1002/jcla.24427",
        "metadata": {
            "section_title": "DOI: 10.1002/jcla.24427  "
        }
    },
    {
        "page_number": 1,
        "section_number": 12,
        "content": "REVIEW ARTICLE",
        "metadata": {
            "section_title": "REVIEW ARTICLE"
        }
    },
    {
        "page_number": 1,
        "section_number": 13,
        "content": "Mechanism of action, resistance, synergism, and clinical",
        "metadata": {
            "section_title": "Mechanism of action, resistance, synergism, and clinical "
        }
    },
    {
        "page_number": 1,
        "section_number": 14,
        "content": "implications of azithromycin",
        "metadata": {
            "section_title": "implications of azithromycin"
        }
    },
    {
        "page_number": 1,
        "section_number": 15,
        "content": "Mohsen Heidary1,2 |   Ahmad  Ebrahimi Samangani3 |   Abolfazl Kargari3 |",
        "metadata": {
            "section_title": "Mohsen Heidary1,2 |   Ahmad  Ebrahimi Samangani3 |   Abolfazl Kargari3 |    "
        }
    },
    {
        "page_number": 1,
        "section_number": 16,
        "content": "Aliakbar  Kiani Nejad3 |   Ilya Yashmi3 |   Moloudsadat Motahar4 |",
        "metadata": {
            "section_title": "Aliakbar  Kiani Nejad3 |   Ilya Yashmi3 |   Moloudsadat Motahar4 |    "
        }
    },
    {
        "page_number": 1,
        "section_number": 17,
        "content": "Elahe Taki5 |   Saeed Khoshnood6",
        "metadata": {
            "section_title": "Elahe Taki5 |   Saeed Khoshnood6"
        }
    },
    {
        "page_number": 1,
        "section_number": 18,
        "content": "This is an open access article under the terms of the Creative Commons Attribution  License, which permits use, distribution and reproduction in any medium,",
        "metadata": {
            "section_title": "This is an open access article under the terms of the Creative Commons Attribution  License, which permits use, distribution and reproduction in any medium, "
        }
    },
    {
        "page_number": 1,
        "section_number": 19,
        "content": "provided the original work is properly cited.",
        "metadata": {
            "section_title": "provided the original work is properly cited."
        }
    },
    {
        "page_number": 1,
        "section_number": 20,
        "content": "© 2022 The Authors. Journal of Clinical Laboratory Analysis  published by Wiley Periodicals LLCAhmad Ebrahimi Samangani, Abolfazl Kargari, Aliakbar Kiani Nejad, Ilya Yashmi and Moloudsadat Motahar co-  second authorship who contributed equally to this work.  1Department of Laboratory Sciences,",
        "metadata": {
            "section_title": "© 2022 The Authors. Journal of Clinical Laboratory Analysis  published by Wiley Periodicals LLCAhmad Ebrahimi Samangani, Abolfazl Kargari, Aliakbar Kiani Nejad, Ilya Yashmi and Moloudsadat Motahar co-  second authorship who contributed equally to this work.  1Department of Laboratory Sciences, "
        }
    },
    {
        "page_number": 1,
        "section_number": 21,
        "content": "School of Paramedical Sciences, Sabzevar",
        "metadata": {
            "section_title": "School of Paramedical Sciences, Sabzevar "
        }
    },
    {
        "page_number": 1,
        "section_number": 22,
        "content": "University of Medical Sciences, Sabzevar,",
        "metadata": {
            "section_title": "University of Medical Sciences, Sabzevar, "
        }
    },
    {
        "page_number": 1,
        "section_number": 23,
        "content": "Iran",
        "metadata": {
            "section_title": "Iran"
        }
    },
    {
        "page_number": 1,
        "section_number": 24,
        "content": "2Cellular and Molecular Research Center,",
        "metadata": {
            "section_title": "2Cellular and Molecular Research Center, "
        }
    },
    {
        "page_number": 1,
        "section_number": 25,
        "content": "Sabzevar University of Medical Sciences,",
        "metadata": {
            "section_title": "Sabzevar University of Medical Sciences, "
        }
    },
    {
        "page_number": 1,
        "section_number": 26,
        "content": "Sabzevar, Iran",
        "metadata": {
            "section_title": "Sabzevar, Iran"
        }
    },
    {
        "page_number": 1,
        "section_number": 27,
        "content": "3Student Research Committee, Sabzevar",
        "metadata": {
            "section_title": "3Student Research Committee, Sabzevar "
        }
    },
    {
        "page_number": 1,
        "section_number": 28,
        "content": "University of Medical Sciences, Sabzevar,",
        "metadata": {
            "section_title": "University of Medical Sciences, Sabzevar, "
        }
    },
    {
        "page_number": 1,
        "section_number": 29,
        "content": "Iran",
        "metadata": {
            "section_title": "Iran"
        }
    },
    {
        "page_number": 1,
        "section_number": 30,
        "content": "4Department of Microbiology, School of",
        "metadata": {
            "section_title": "4Department of Microbiology, School of "
        }
    },
    {
        "page_number": 1,
        "section_number": 31,
        "content": "Medicine, Ahvaz Jundishapur University",
        "metadata": {
            "section_title": "Medicine, Ahvaz Jundishapur University "
        }
    },
    {
        "page_number": 1,
        "section_number": 32,
        "content": "of Medical Sciences, Ahvaz, Iran",
        "metadata": {
            "section_title": "of Medical Sciences, Ahvaz, Iran"
        }
    },
    {
        "page_number": 1,
        "section_number": 33,
        "content": "5Department of Microbiology, School of",
        "metadata": {
            "section_title": "5Department of Microbiology, School of "
        }
    },
    {
        "page_number": 1,
        "section_number": 34,
        "content": "Medicine, Tehran University of Medical",
        "metadata": {
            "section_title": "Medicine, Tehran University of Medical "
        }
    },
    {
        "page_number": 1,
        "section_number": 35,
        "content": "Sciences, Tehran, Iran",
        "metadata": {
            "section_title": "Sciences, Tehran, Iran"
        }
    },
    {
        "page_number": 1,
        "section_number": 36,
        "content": "6Clinical Microbiology Research Center,",
        "metadata": {
            "section_title": "6Clinical Microbiology Research Center, "
        }
    },
    {
        "page_number": 1,
        "section_number": 37,
        "content": "Ilam University of Medical Sciences, Ilam,",
        "metadata": {
            "section_title": "Ilam University of Medical Sciences, Ilam, "
        }
    },
    {
        "page_number": 1,
        "section_number": 38,
        "content": "Iran",
        "metadata": {
            "section_title": "Iran"
        }
    },
    {
        "page_number": 1,
        "section_number": 39,
        "content": "Correspondence",
        "metadata": {
            "section_title": "Correspondence"
        }
    },
    {
        "page_number": 1,
        "section_number": 40,
        "content": "Elahe Taki, Department of Microbiology,",
        "metadata": {
            "section_title": "Elahe Taki, Department of Microbiology, "
        }
    },
    {
        "page_number": 1,
        "section_number": 41,
        "content": "School of Medicine, Tehran University of",
        "metadata": {
            "section_title": "School of Medicine, Tehran University of "
        }
    },
    {
        "page_number": 1,
        "section_number": 42,
        "content": "Medical Sciences, Tehran, Iran.",
        "metadata": {
            "section_title": "Medical Sciences, Tehran, Iran."
        }
    },
    {
        "page_number": 1,
        "section_number": 43,
        "content": "Email: elahe.taki.mm@gmail.com",
        "metadata": {
            "section_title": "Email: elahe.taki.mm@gmail.com"
        }
    },
    {
        "page_number": 1,
        "section_number": 44,
        "content": "Saeed Khoshnood, Clinical Microbiology",
        "metadata": {
            "section_title": "Saeed Khoshnood, Clinical Microbiology "
        }
    },
    {
        "page_number": 1,
        "section_number": 45,
        "content": "Research Center, Ilam University of",
        "metadata": {
            "section_title": "Research Center, Ilam University of "
        }
    },
    {
        "page_number": 1,
        "section_number": 46,
        "content": "Medical Sciences, Ilam, Iran.",
        "metadata": {
            "section_title": "Medical Sciences, Ilam, Iran."
        }
    },
    {
        "page_number": 1,
        "section_number": 47,
        "content": "Email: saeed.khoshnood22@gmail.comAbstract",
        "metadata": {
            "section_title": "Email: saeed.khoshnood22@gmail.comAbstract"
        }
    },
    {
        "page_number": 1,
        "section_number": 48,
        "content": "Background: Azithromycin (AZM), sold under the name Zithromax, is classified as a",
        "metadata": {
            "section_title": "Background: Azithromycin (AZM), sold under the name Zithromax, is classified as a "
        }
    },
    {
        "page_number": 1,
        "section_number": 49,
        "content": "macrolide. It has many benefits due to its immunomodulatory, anti-  inflammatory, and",
        "metadata": {
            "section_title": "macrolide. It has many benefits due to its immunomodulatory, anti-  inflammatory, and "
        }
    },
    {
        "page_number": 1,
        "section_number": 50,
        "content": "antibacterial effects. This review aims to study different clinical and biochemisterial",
        "metadata": {
            "section_title": "antibacterial effects. This review aims to study different clinical and biochemisterial "
        }
    },
    {
        "page_number": 1,
        "section_number": 51,
        "content": "aspects and properties of this drug which has a priority based on literature published",
        "metadata": {
            "section_title": "aspects and properties of this drug which has a priority based on literature published "
        }
    },
    {
        "page_number": 1,
        "section_number": 52,
        "content": "worldwide.",
        "metadata": {
            "section_title": "worldwide."
        }
    },
    {
        "page_number": 1,
        "section_number": 53,
        "content": "Methods: Several databases including Web of Science, Google Scholar, PubMed, and",
        "metadata": {
            "section_title": "Methods: Several databases including Web of Science, Google Scholar, PubMed, and "
        }
    },
    {
        "page_number": 1,
        "section_number": 54,
        "content": "Scopus were searched to obtain the relevant studies.",
        "metadata": {
            "section_title": "Scopus were searched to obtain the relevant studies."
        }
    },
    {
        "page_number": 1,
        "section_number": 55,
        "content": "Results: AZM mechanism of action including the inhibition of bacterial protein syn -",
        "metadata": {
            "section_title": "Results: AZM mechanism of action including the inhibition of bacterial protein syn -"
        }
    },
    {
        "page_number": 1,
        "section_number": 56,
        "content": "thesis, inhibition of proinflammatory cytokine production, inhibition of neutrophil in -",
        "metadata": {
            "section_title": "thesis, inhibition of proinflammatory cytokine production, inhibition of neutrophil in -"
        }
    },
    {
        "page_number": 1,
        "section_number": 57,
        "content": "festation, and macrophage polarization alteration, gives it the ability to act against",
        "metadata": {
            "section_title": "festation, and macrophage polarization alteration, gives it the ability to act against "
        }
    },
    {
        "page_number": 1,
        "section_number": 58,
        "content": "a wide range of microorganisms. Resistant organisms are spreading and being de -",
        "metadata": {
            "section_title": "a wide range of microorganisms. Resistant organisms are spreading and being de -"
        }
    },
    {
        "page_number": 1,
        "section_number": 59,
        "content": "veloped because of the irrational use of the drug in the case of dose and duration.",
        "metadata": {
            "section_title": "veloped because of the irrational use of the drug in the case of dose and duration. "
        }
    },
    {
        "page_number": 1,
        "section_number": 60,
        "content": "AZM shows synergistic effects with other drugs against a variety of organisms. This",
        "metadata": {
            "section_title": "AZM shows synergistic effects with other drugs against a variety of organisms. This "
        }
    },
    {
        "page_number": 1,
        "section_number": 61,
        "content": "macrolide is considered a valuable antimicrobial agent because of its use as a treat -",
        "metadata": {
            "section_title": "macrolide is considered a valuable antimicrobial agent because of its use as a treat -"
        }
    },
    {
        "page_number": 1,
        "section_number": 62,
        "content": "ment for a vast range of diseases such as asthma, bronchiolitis, COPD, cystic fibrosis,",
        "metadata": {
            "section_title": "ment for a vast range of diseases such as asthma, bronchiolitis, COPD, cystic fibrosis, "
        }
    },
    {
        "page_number": 1,
        "section_number": 63,
        "content": "enteric infections, STIs, and periodontal infections.",
        "metadata": {
            "section_title": "enteric infections, STIs, and periodontal infections."
        }
    },
    {
        "page_number": 1,
        "section_number": 64,
        "content": "Conclusions: Our study shows an increasing global prevalence of AZM resistance.",
        "metadata": {
            "section_title": "Conclusions: Our study shows an increasing global prevalence of AZM resistance. "
        }
    },
    {
        "page_number": 1,
        "section_number": 65,
        "content": "Thus, synergistic combinations are recommended to treat different pathogens.",
        "metadata": {
            "section_title": "Thus, synergistic combinations are recommended to treat different pathogens. "
        }
    },
    {
        "page_number": 1,
        "section_number": 66,
        "content": "Moreover, continuous monitoring of AZM resistance by registry centers and the de -",
        "metadata": {
            "section_title": "Moreover, continuous monitoring of AZM resistance by registry centers and the de -"
        }
    },
    {
        "page_number": 1,
        "section_number": 67,
        "content": "velopment of more rapid diagnostic assays are urgently needed.",
        "metadata": {
            "section_title": "velopment of more rapid diagnostic assays are urgently needed."
        }
    },
    {
        "page_number": 1,
        "section_number": 68,
        "content": "KEYWORDS",
        "metadata": {
            "section_title": "KEYWORDS"
        }
    },
    {
        "page_number": 1,
        "section_number": 69,
        "content": "azithromycin, pharmacology, resistance, synergism, Zithromax",
        "metadata": {
            "section_title": "azithromycin, pharmacology, resistance, synergism, Zithromax"
        }
    },
    {
        "page_number": 2,
        "section_number": 1,
        "content": "2 of 16  |",
        "metadata": {
            "section_title": "2 of 16  |    "
        }
    },
    {
        "page_number": 2,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 2,
        "section_number": 3,
        "content": "and body fluids.4 Due to the reversible cutting of the 50S bacterial",
        "metadata": {
            "section_title": "and body fluids.4 Due to the reversible cutting of the 50S bacterial "
        }
    },
    {
        "page_number": 2,
        "section_number": 4,
        "content": "ribosomal subunit, AZM inhibits protein synthesis and hinders the",
        "metadata": {
            "section_title": "ribosomal subunit, AZM inhibits protein synthesis and hinders the "
        }
    },
    {
        "page_number": 2,
        "section_number": 5,
        "content": "growth of bacteria.5,6 Moreover, it can penetrate into bacterial ex -",
        "metadata": {
            "section_title": "growth of bacteria.5,6 Moreover, it can penetrate into bacterial ex -"
        }
    },
    {
        "page_number": 2,
        "section_number": 6,
        "content": "tracellular vesicles, a kind of secretory defense system.5",
        "metadata": {
            "section_title": "tracellular vesicles, a kind of secretory defense system.5"
        }
    },
    {
        "page_number": 2,
        "section_number": 7,
        "content": "2 | PHARMACOLOGY",
        "metadata": {
            "section_title": "2 | PHARMACOLOGY"
        }
    },
    {
        "page_number": 2,
        "section_number": 8,
        "content": "2.1 | Pharmacodynamic of AZM",
        "metadata": {
            "section_title": "2.1 | Pharmacodynamic of AZM"
        }
    },
    {
        "page_number": 2,
        "section_number": 9,
        "content": "Azithromycin is classified as a macrolide antibiotic because of its",
        "metadata": {
            "section_title": "Azithromycin is classified as a macrolide antibiotic because of its "
        }
    },
    {
        "page_number": 2,
        "section_number": 10,
        "content": "unique ability.5 In virtue of its dual-  base structure, AZM is actively",
        "metadata": {
            "section_title": "unique ability.5 In virtue of its dual-  base structure, AZM is actively "
        }
    },
    {
        "page_number": 2,
        "section_number": 11,
        "content": "absorbed by a variety of cells, including fibroblasts and white blood",
        "metadata": {
            "section_title": "absorbed by a variety of cells, including fibroblasts and white blood "
        }
    },
    {
        "page_number": 2,
        "section_number": 12,
        "content": "cells.7 This antibiotic agent works in vitro against many pyogenic",
        "metadata": {
            "section_title": "cells.7 This antibiotic agent works in vitro against many pyogenic "
        }
    },
    {
        "page_number": 2,
        "section_number": 13,
        "content": "bacteria (e.g., Neisseria gonorrhoeae  [N. gonorrhoeae ] and Moraxella",
        "metadata": {
            "section_title": "bacteria (e.g., Neisseria gonorrhoeae  [N. gonorrhoeae ] and Moraxella "
        }
    },
    {
        "page_number": 2,
        "section_number": 14,
        "content": "catarrhalis  [M. catarrhalis ]) and beta-  lactam-  resistant bacteria (e.g.,",
        "metadata": {
            "section_title": "catarrhalis  [M. catarrhalis ]) and beta-  lactam-  resistant bacteria (e.g., "
        }
    },
    {
        "page_number": 2,
        "section_number": 15,
        "content": "Legionella  and Chlamydia  spp.).8 AZM has immunomodulatory,",
        "metadata": {
            "section_title": "Legionella  and Chlamydia  spp.).8 AZM has immunomodulatory, "
        }
    },
    {
        "page_number": 2,
        "section_number": 16,
        "content": "anti-  inflammatory, and antibacterial modulatory effects; thus, it is",
        "metadata": {
            "section_title": "anti-  inflammatory, and antibacterial modulatory effects; thus, it is "
        }
    },
    {
        "page_number": 2,
        "section_number": 17,
        "content": "beneficial for patients with varying inflammatory diseases of the res -",
        "metadata": {
            "section_title": "beneficial for patients with varying inflammatory diseases of the res -"
        }
    },
    {
        "page_number": 2,
        "section_number": 18,
        "content": "piratory tract.9 AZM is also effective in patients with COVID-  19 and",
        "metadata": {
            "section_title": "piratory tract.9 AZM is also effective in patients with COVID-  19 and "
        }
    },
    {
        "page_number": 2,
        "section_number": 19,
        "content": "has been used in clinical trials for the prevention of bacterial infec -",
        "metadata": {
            "section_title": "has been used in clinical trials for the prevention of bacterial infec -"
        }
    },
    {
        "page_number": 2,
        "section_number": 20,
        "content": "tion in these patients. It has been reported that AZM in combination",
        "metadata": {
            "section_title": "tion in these patients. It has been reported that AZM in combination "
        }
    },
    {
        "page_number": 2,
        "section_number": 21,
        "content": "with hydroxychloroquine (HCQ) can mitigate the viral load of SARS-",
        "metadata": {
            "section_title": "with hydroxychloroquine (HCQ) can mitigate the viral load of SARS- "
        }
    },
    {
        "page_number": 2,
        "section_number": 22,
        "content": "CoV- 2.10 Moreover, AZM can modulate the features of the immune",
        "metadata": {
            "section_title": "CoV- 2.10 Moreover, AZM can modulate the features of the immune "
        }
    },
    {
        "page_number": 2,
        "section_number": 23,
        "content": "system, that is, reducing cytokine production, maintaining epithelial",
        "metadata": {
            "section_title": "system, that is, reducing cytokine production, maintaining epithelial "
        }
    },
    {
        "page_number": 2,
        "section_number": 24,
        "content": "cell integrity, and preventing lung fibrosis.11 Treatment with AZM",
        "metadata": {
            "section_title": "cell integrity, and preventing lung fibrosis.11 Treatment with AZM "
        }
    },
    {
        "page_number": 2,
        "section_number": 25,
        "content": "involves a short period of time. The method of its administration in",
        "metadata": {
            "section_title": "involves a short period of time. The method of its administration in "
        }
    },
    {
        "page_number": 2,
        "section_number": 26,
        "content": "adults is 1500 mg immediate-  release (IR) AZM, that is, 500 mg once",
        "metadata": {
            "section_title": "adults is 1500 mg immediate-  release (IR) AZM, that is, 500 mg once "
        }
    },
    {
        "page_number": 2,
        "section_number": 27,
        "content": "daily for 3 days or 500 mg on the first day and 250 mg on Day two",
        "metadata": {
            "section_title": "daily for 3 days or 500 mg on the first day and 250 mg on Day two "
        }
    },
    {
        "page_number": 2,
        "section_number": 28,
        "content": "up to Day five.12 The highest oral dose approved for the treatment",
        "metadata": {
            "section_title": "up to Day five.12 The highest oral dose approved for the treatment "
        }
    },
    {
        "page_number": 2,
        "section_number": 29,
        "content": "of gonococcal urethritis is 2.0 g of IR AZM.12",
        "metadata": {
            "section_title": "of gonococcal urethritis is 2.0 g of IR AZM.12"
        }
    },
    {
        "page_number": 2,
        "section_number": 30,
        "content": "2.2 | Structure of drug",
        "metadata": {
            "section_title": "2.2 | Structure of drug"
        }
    },
    {
        "page_number": 2,
        "section_number": 31,
        "content": "AZM (9-  deoxo-  9a- methyl-  9a- aza- 9a- homo erythromycin A) with the",
        "metadata": {
            "section_title": "AZM (9-  deoxo-  9a- methyl-  9a- aza- 9a- homo erythromycin A) with the "
        }
    },
    {
        "page_number": 2,
        "section_number": 32,
        "content": "chemical formula C38H72N2O12 is produced by replacing carbonyl",
        "metadata": {
            "section_title": "chemical formula C38H72N2O12 is produced by replacing carbonyl "
        }
    },
    {
        "page_number": 2,
        "section_number": 33,
        "content": "(9a) in the aglycone ring with methyl nitrogen. Unlike erythromycin",
        "metadata": {
            "section_title": "(9a) in the aglycone ring with methyl nitrogen. Unlike erythromycin "
        }
    },
    {
        "page_number": 2,
        "section_number": 34,
        "content": "(ERY), AZM improves the durability and strength, blocks the internal",
        "metadata": {
            "section_title": "(ERY), AZM improves the durability and strength, blocks the internal "
        }
    },
    {
        "page_number": 2,
        "section_number": 35,
        "content": "reaction for hemiketal formation, and leaves the acid hydrolysis of",
        "metadata": {
            "section_title": "reaction for hemiketal formation, and leaves the acid hydrolysis of "
        }
    },
    {
        "page_number": 2,
        "section_number": 36,
        "content": "the ether bond to the neutral sugar of L-  cladinosis, as the main de -",
        "metadata": {
            "section_title": "the ether bond to the neutral sugar of L-  cladinosis, as the main de -"
        }
    },
    {
        "page_number": 2,
        "section_number": 37,
        "content": "composition pathway ( Figure  1).13",
        "metadata": {
            "section_title": "composition pathway ( Figure  1).13"
        }
    },
    {
        "page_number": 2,
        "section_number": 38,
        "content": "2.3 | Mechanism of action",
        "metadata": {
            "section_title": "2.3 | Mechanism of action"
        }
    },
    {
        "page_number": 2,
        "section_number": 39,
        "content": "Similar to other macrolide antibiotics, the main objective of AZM is",
        "metadata": {
            "section_title": "Similar to other macrolide antibiotics, the main objective of AZM is "
        }
    },
    {
        "page_number": 2,
        "section_number": 40,
        "content": "inhibiting bacterial protein synthesis by targeting the 50S subunit of",
        "metadata": {
            "section_title": "inhibiting bacterial protein synthesis by targeting the 50S subunit of "
        }
    },
    {
        "page_number": 2,
        "section_number": 41,
        "content": "the sensitive bacterial ribosome ( Figure  2). The reduction in protein",
        "metadata": {
            "section_title": "the sensitive bacterial ribosome ( Figure  2). The reduction in protein "
        }
    },
    {
        "page_number": 2,
        "section_number": 42,
        "content": "synthesis is correlated with the increase in macrolide concentra -",
        "metadata": {
            "section_title": "synthesis is correlated with the increase in macrolide concentra -"
        }
    },
    {
        "page_number": 2,
        "section_number": 43,
        "content": "tion.14 The unionized form of AZM membrane passage rate is higher,",
        "metadata": {
            "section_title": "tion.14 The unionized form of AZM membrane passage rate is higher, "
        }
    },
    {
        "page_number": 2,
        "section_number": 44,
        "content": "and this could be the reason behind the increased antimicrobial ac -",
        "metadata": {
            "section_title": "and this could be the reason behind the increased antimicrobial ac -"
        }
    },
    {
        "page_number": 2,
        "section_number": 45,
        "content": "tivity of AZM at alkaline pH.15 AZM binds at a site near peptidyl transferase center on 23S rRNA called nascent peptide exit tunnel",
        "metadata": {
            "section_title": "tivity of AZM at alkaline pH.15 AZM binds at a site near peptidyl transferase center on 23S rRNA called nascent peptide exit tunnel "
        }
    },
    {
        "page_number": 2,
        "section_number": 46,
        "content": "(which is approximately 100 Å long and 10–  20 Å wide) and partially",
        "metadata": {
            "section_title": "(which is approximately 100 Å long and 10–  20 Å wide) and partially "
        }
    },
    {
        "page_number": 2,
        "section_number": 47,
        "content": "occludes it.16,17 The binding process of AZM is almost similar to",
        "metadata": {
            "section_title": "occludes it.16,17 The binding process of AZM is almost similar to "
        }
    },
    {
        "page_number": 2,
        "section_number": 48,
        "content": "erythromycin. Resting of erythromycin on a surface formed by three",
        "metadata": {
            "section_title": "erythromycin. Resting of erythromycin on a surface formed by three "
        }
    },
    {
        "page_number": 2,
        "section_number": 49,
        "content": "bases (U2611, A2058, and A2059), utilizing three axial methyl groups",
        "metadata": {
            "section_title": "bases (U2611, A2058, and A2059), utilizing three axial methyl groups "
        }
    },
    {
        "page_number": 2,
        "section_number": 50,
        "content": "belonging to the lactone ring of the drug is the key to this process",
        "metadata": {
            "section_title": "belonging to the lactone ring of the drug is the key to this process "
        }
    },
    {
        "page_number": 2,
        "section_number": 51,
        "content": "based on research on H.  marismortui . There is also a hydrogen bond",
        "metadata": {
            "section_title": "based on research on H.  marismortui . There is also a hydrogen bond "
        }
    },
    {
        "page_number": 2,
        "section_number": 52,
        "content": "between\t the\t2′\tOH\tgroup\tof\tthe\tdesosamine\t sugar\tof\terythromy -",
        "metadata": {
            "section_title": "between\t the\t2′\tOH\tgroup\tof\tthe\tdesosamine\t sugar\tof\terythromy -"
        }
    },
    {
        "page_number": 2,
        "section_number": 53,
        "content": "cin and the N1 atom of A2058, which stabilizes erythromycin in its",
        "metadata": {
            "section_title": "cin and the N1 atom of A2058, which stabilizes erythromycin in its "
        }
    },
    {
        "page_number": 2,
        "section_number": 54,
        "content": "position. These interactions result in base movement and nascent",
        "metadata": {
            "section_title": "position. These interactions result in base movement and nascent "
        }
    },
    {
        "page_number": 2,
        "section_number": 55,
        "content": "peptide exit tunnel occlusion due to the placement of bases within",
        "metadata": {
            "section_title": "peptide exit tunnel occlusion due to the placement of bases within "
        }
    },
    {
        "page_number": 2,
        "section_number": 56,
        "content": "van der Waals contact of the amino group of P-  site tRNA.18 Novel",
        "metadata": {
            "section_title": "van der Waals contact of the amino group of P-  site tRNA.18 Novel "
        }
    },
    {
        "page_number": 2,
        "section_number": 57,
        "content": "findings show that the context of the nascent peptide has an impor -",
        "metadata": {
            "section_title": "findings show that the context of the nascent peptide has an impor -"
        }
    },
    {
        "page_number": 2,
        "section_number": 58,
        "content": "tant role in changing the possibility of being allowed to pass from",
        "metadata": {
            "section_title": "tant role in changing the possibility of being allowed to pass from "
        }
    },
    {
        "page_number": 2,
        "section_number": 59,
        "content": "the peptide exit tunnel, namely AZM does not completely occlude",
        "metadata": {
            "section_title": "the peptide exit tunnel, namely AZM does not completely occlude "
        }
    },
    {
        "page_number": 2,
        "section_number": 60,
        "content": "the passage (although the nascent peptide exit tunnel has various",
        "metadata": {
            "section_title": "the passage (although the nascent peptide exit tunnel has various "
        }
    },
    {
        "page_number": 2,
        "section_number": 61,
        "content": "responsibilities rather than being a normal passage to the cytoplasm",
        "metadata": {
            "section_title": "responsibilities rather than being a normal passage to the cytoplasm "
        }
    },
    {
        "page_number": 2,
        "section_number": 62,
        "content": "such as modulating the ribosome functions in response to sequences",
        "metadata": {
            "section_title": "such as modulating the ribosome functions in response to sequences "
        }
    },
    {
        "page_number": 2,
        "section_number": 63,
        "content": "of the novel peptide and environment).16 These events result in",
        "metadata": {
            "section_title": "of the novel peptide and environment).16 These events result in "
        }
    },
    {
        "page_number": 2,
        "section_number": 64,
        "content": "faster penetration of the outer membranes; hence, it has effects",
        "metadata": {
            "section_title": "faster penetration of the outer membranes; hence, it has effects "
        }
    },
    {
        "page_number": 2,
        "section_number": 65,
        "content": "on the entrance into the bacteria and increases the activity against",
        "metadata": {
            "section_title": "on the entrance into the bacteria and increases the activity against "
        }
    },
    {
        "page_number": 2,
        "section_number": 66,
        "content": "Gram-  negative bacteria.17 AZM also showed anti-  inflammatory ef -",
        "metadata": {
            "section_title": "Gram-  negative bacteria.17 AZM also showed anti-  inflammatory ef -"
        }
    },
    {
        "page_number": 2,
        "section_number": 67,
        "content": "fects on various studies; for instance, Cigana et al. demonstrated",
        "metadata": {
            "section_title": "fects on various studies; for instance, Cigana et al. demonstrated "
        }
    },
    {
        "page_number": 2,
        "section_number": 68,
        "content": "that AZM reduces TNF-  α mRNA expression, TNF-  α protein levels,",
        "metadata": {
            "section_title": "that AZM reduces TNF-  α mRNA expression, TNF-  α protein levels, "
        }
    },
    {
        "page_number": 2,
        "section_number": 69,
        "content": "and NF-  κB DNA-  binding activity in human cystic fibrosis (CF) cell",
        "metadata": {
            "section_title": "and NF-  κB DNA-  binding activity in human cystic fibrosis (CF) cell "
        }
    },
    {
        "page_number": 2,
        "section_number": 70,
        "content": "lines subsequent to the confirmation of a higher rate of TNF-  α mRNA",
        "metadata": {
            "section_title": "lines subsequent to the confirmation of a higher rate of TNF-  α mRNA "
        }
    },
    {
        "page_number": 2,
        "section_number": 71,
        "content": "expression, TNF-  α protein levels, and NF-  κB DNA-  binding activity in",
        "metadata": {
            "section_title": "expression, TNF-  α protein levels, and NF-  κB DNA-  binding activity in "
        }
    },
    {
        "page_number": 2,
        "section_number": 72,
        "content": "CF cell lines compared with isogenic non-  CF cell lines.19 The reduc -",
        "metadata": {
            "section_title": "CF cell lines compared with isogenic non-  CF cell lines.19 The reduc -"
        }
    },
    {
        "page_number": 2,
        "section_number": 73,
        "content": "tion in NF-  κB DNA-  binding activity is associated with the inhibition",
        "metadata": {
            "section_title": "tion in NF-  κB DNA-  binding activity is associated with the inhibition "
        }
    },
    {
        "page_number": 2,
        "section_number": 74,
        "content": "of the degradation of I κBα, the protein that prohibits the transloca -",
        "metadata": {
            "section_title": "of the degradation of I κBα, the protein that prohibits the transloca -"
        }
    },
    {
        "page_number": 2,
        "section_number": 75,
        "content": "tion of NF-  κB active subunits into the nucleus.20 Inflammatory cell FIGURE 1  Chemical\tstructure\tof\tazithromycin\t( https://go.drugb",
        "metadata": {
            "section_title": "tion of NF-  κB active subunits into the nucleus.20 Inflammatory cell FIGURE 1  Chemical\tstructure\tof\tazithromycin\t( https://go.drugb  "
        }
    },
    {
        "page_number": 2,
        "section_number": 76,
        "content": "ank.com/drugs/  DB00207 , accessed on December 18, 2021)",
        "metadata": {
            "section_title": "ank.com/drugs/  DB00207 , accessed on December 18, 2021)"
        }
    },
    {
        "page_number": 3,
        "section_number": 1,
        "content": "|  3 of 16",
        "metadata": {
            "section_title": "|  3 of 16"
        }
    },
    {
        "page_number": 3,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 3,
        "section_number": 3,
        "content": "signaling is affected by AZM, and these impacts include a decrease",
        "metadata": {
            "section_title": "signaling is affected by AZM, and these impacts include a decrease "
        }
    },
    {
        "page_number": 3,
        "section_number": 4,
        "content": "in NF-  κB (and subsequent IL-  6 and IL-  8 production), which is men -",
        "metadata": {
            "section_title": "in NF-  κB (and subsequent IL-  6 and IL-  8 production), which is men -"
        }
    },
    {
        "page_number": 3,
        "section_number": 5,
        "content": "tioned above, inhibition of LPS-  induced expression of PLA2, which",
        "metadata": {
            "section_title": "tioned above, inhibition of LPS-  induced expression of PLA2, which "
        }
    },
    {
        "page_number": 3,
        "section_number": 6,
        "content": "is involved in cytokine and chemokine production in macrophages,",
        "metadata": {
            "section_title": "is involved in cytokine and chemokine production in macrophages, "
        }
    },
    {
        "page_number": 3,
        "section_number": 7,
        "content": "neutrophils, and endothelial cells and cell signaling pathways, which",
        "metadata": {
            "section_title": "neutrophils, and endothelial cells and cell signaling pathways, which "
        }
    },
    {
        "page_number": 3,
        "section_number": 8,
        "content": "result in arachidonic acid and eicosanoids production, and inhibi -",
        "metadata": {
            "section_title": "result in arachidonic acid and eicosanoids production, and inhibi -"
        }
    },
    {
        "page_number": 3,
        "section_number": 9,
        "content": "tion of AP-  1 signaling in neutrophils isolated from the lungs of mice",
        "metadata": {
            "section_title": "tion of AP-  1 signaling in neutrophils isolated from the lungs of mice "
        }
    },
    {
        "page_number": 3,
        "section_number": 10,
        "content": "induced by LPS administration, which consequently reduce IL-  1b",
        "metadata": {
            "section_title": "induced by LPS administration, which consequently reduce IL-  1b "
        }
    },
    {
        "page_number": 3,
        "section_number": 11,
        "content": "concentrations.21 AZM affects neutrophils directly and indirectly.21",
        "metadata": {
            "section_title": "concentrations.21 AZM affects neutrophils directly and indirectly.21 "
        }
    },
    {
        "page_number": 3,
        "section_number": 12,
        "content": "The anti-  inflammatory properties of AZM are the reason behind the",
        "metadata": {
            "section_title": "The anti-  inflammatory properties of AZM are the reason behind the "
        }
    },
    {
        "page_number": 3,
        "section_number": 13,
        "content": "indirect effects of AZM on neutrophils. Direct effects include re -",
        "metadata": {
            "section_title": "indirect effects of AZM on neutrophils. Direct effects include re -"
        }
    },
    {
        "page_number": 3,
        "section_number": 14,
        "content": "duction in IL-  8 release and neutrophil airway infiltration, degranu -",
        "metadata": {
            "section_title": "duction in IL-  8 release and neutrophil airway infiltration, degranu -"
        }
    },
    {
        "page_number": 3,
        "section_number": 15,
        "content": "lation and degradation of extracellular myeloperoxidase, reduction",
        "metadata": {
            "section_title": "lation and degradation of extracellular myeloperoxidase, reduction "
        }
    },
    {
        "page_number": 3,
        "section_number": 16,
        "content": "in neutrophil oxidative burst,22,23 and decrease in the production",
        "metadata": {
            "section_title": "in neutrophil oxidative burst,22,23 and decrease in the production "
        }
    },
    {
        "page_number": 3,
        "section_number": 17,
        "content": "of leukotriene B4 (LTB4; a potent neutrophil chemoattractant that",
        "metadata": {
            "section_title": "of leukotriene B4 (LTB4; a potent neutrophil chemoattractant that "
        }
    },
    {
        "page_number": 3,
        "section_number": 18,
        "content": "stimulates neutrophil IL-  8 release).24 AZM also helps macrophages",
        "metadata": {
            "section_title": "stimulates neutrophil IL-  8 release).24 AZM also helps macrophages "
        }
    },
    {
        "page_number": 3,
        "section_number": 19,
        "content": "shift from M1 type to M2 alternative-  like phenotype in vitro by in -",
        "metadata": {
            "section_title": "shift from M1 type to M2 alternative-  like phenotype in vitro by in -"
        }
    },
    {
        "page_number": 3,
        "section_number": 20,
        "content": "hibiting pro-  inflammatory cytokine expression (including IL-  12 and",
        "metadata": {
            "section_title": "hibiting pro-  inflammatory cytokine expression (including IL-  12 and "
        }
    },
    {
        "page_number": 3,
        "section_number": 21,
        "content": "IL- 6) and shifting surface receptor expression.25",
        "metadata": {
            "section_title": "IL- 6) and shifting surface receptor expression.25"
        }
    },
    {
        "page_number": 3,
        "section_number": 22,
        "content": "2.4 | Pharmacokinetic parameters",
        "metadata": {
            "section_title": "2.4 | Pharmacokinetic parameters"
        }
    },
    {
        "page_number": 3,
        "section_number": 23,
        "content": "Demethylation is the major route of metabolism, and the metabolites",
        "metadata": {
            "section_title": "Demethylation is the major route of metabolism, and the metabolites "
        }
    },
    {
        "page_number": 3,
        "section_number": 24,
        "content": "are not considered to have any significant antimicrobial activity.26 As",
        "metadata": {
            "section_title": "are not considered to have any significant antimicrobial activity.26 As "
        }
    },
    {
        "page_number": 3,
        "section_number": 25,
        "content": "a result of oral administration, the bioavailability of AZM reached",
        "metadata": {
            "section_title": "a result of oral administration, the bioavailability of AZM reached "
        }
    },
    {
        "page_number": 3,
        "section_number": 26,
        "content": "37%. AZM absorption may be dropped by up to 50% when adminis -",
        "metadata": {
            "section_title": "37%. AZM absorption may be dropped by up to 50% when adminis -"
        }
    },
    {
        "page_number": 3,
        "section_number": 27,
        "content": "tered with a large meal.27 AZM coadministration with aluminum-   and",
        "metadata": {
            "section_title": "tered with a large meal.27 AZM coadministration with aluminum-   and "
        }
    },
    {
        "page_number": 3,
        "section_number": 28,
        "content": "magnesium-  containing antacids may reduce peak plasma concentra -",
        "metadata": {
            "section_title": "magnesium-  containing antacids may reduce peak plasma concentra -"
        }
    },
    {
        "page_number": 3,
        "section_number": 29,
        "content": "tions by 24%, but the overall extent of absorption is not altered.28",
        "metadata": {
            "section_title": "tions by 24%, but the overall extent of absorption is not altered.28"
        }
    },
    {
        "page_number": 3,
        "section_number": 30,
        "content": "The mean plasma clearance of AZM following a single 500 mg",
        "metadata": {
            "section_title": "The mean plasma clearance of AZM following a single 500 mg "
        }
    },
    {
        "page_number": 3,
        "section_number": 31,
        "content": "oral and intravenous dose is 630 ml/min. The primary route of AZM",
        "metadata": {
            "section_title": "oral and intravenous dose is 630 ml/min. The primary route of AZM "
        }
    },
    {
        "page_number": 3,
        "section_number": 32,
        "content": "elimination, particularly as an unchanged drug, is through biliary",
        "metadata": {
            "section_title": "elimination, particularly as an unchanged drug, is through biliary "
        }
    },
    {
        "page_number": 3,
        "section_number": 33,
        "content": "excretion, and the feces are a prominent route of elimination.26",
        "metadata": {
            "section_title": "excretion, and the feces are a prominent route of elimination.26 "
        }
    },
    {
        "page_number": 3,
        "section_number": 34,
        "content": "Moreover, over a period of 1 week, approximately 6% of the ad -",
        "metadata": {
            "section_title": "Moreover, over a period of 1 week, approximately 6% of the ad -"
        }
    },
    {
        "page_number": 3,
        "section_number": 35,
        "content": "ministered dose is discharged as an unchanged drug in urine; there -",
        "metadata": {
            "section_title": "ministered dose is discharged as an unchanged drug in urine; there -"
        }
    },
    {
        "page_number": 3,
        "section_number": 36,
        "content": "fore, urinary excretion of AZM appears to be a minor elimination",
        "metadata": {
            "section_title": "fore, urinary excretion of AZM appears to be a minor elimination "
        }
    },
    {
        "page_number": 3,
        "section_number": 37,
        "content": "route.26 AZM has a half-  life of about 35–  40 h in humans after a dose of 500 mg.4 The terminal half-  life is computed as the time required",
        "metadata": {
            "section_title": "route.26 AZM has a half-  life of about 35–  40 h in humans after a dose of 500 mg.4 The terminal half-  life is computed as the time required "
        }
    },
    {
        "page_number": 3,
        "section_number": 38,
        "content": "for plasma/blood concentration to decline by 50% after pseudo-",
        "metadata": {
            "section_title": "for plasma/blood concentration to decline by 50% after pseudo- "
        }
    },
    {
        "page_number": 3,
        "section_number": 39,
        "content": "equilibrium of distribution has been accomplished. The elimination",
        "metadata": {
            "section_title": "equilibrium of distribution has been accomplished. The elimination "
        }
    },
    {
        "page_number": 3,
        "section_number": 40,
        "content": "half-  life of AZM (the time for drug plasma concentration decreasing",
        "metadata": {
            "section_title": "half-  life of AZM (the time for drug plasma concentration decreasing "
        }
    },
    {
        "page_number": 3,
        "section_number": 41,
        "content": "due only to drug elimination) is nearly 68 h.29",
        "metadata": {
            "section_title": "due only to drug elimination) is nearly 68 h.29"
        }
    },
    {
        "page_number": 3,
        "section_number": 42,
        "content": "The long-  term studies have demonstrated AZM has no carcino -",
        "metadata": {
            "section_title": "The long-  term studies have demonstrated AZM has no carcino -"
        }
    },
    {
        "page_number": 3,
        "section_number": 43,
        "content": "genic and mutagenic potential in standard laboratory animals and",
        "metadata": {
            "section_title": "genic and mutagenic potential in standard laboratory animals and "
        }
    },
    {
        "page_number": 3,
        "section_number": 44,
        "content": "tests.28 The main possible adverse effects related to AZM include",
        "metadata": {
            "section_title": "tests.28 The main possible adverse effects related to AZM include "
        }
    },
    {
        "page_number": 3,
        "section_number": 45,
        "content": "gastrointestinal upset, headache, dizziness, hearing loss, and car -",
        "metadata": {
            "section_title": "gastrointestinal upset, headache, dizziness, hearing loss, and car -"
        }
    },
    {
        "page_number": 3,
        "section_number": 46,
        "content": "diovascular arrhythmias. In rare cases, hepatotoxicity has been re -",
        "metadata": {
            "section_title": "diovascular arrhythmias. In rare cases, hepatotoxicity has been re -"
        }
    },
    {
        "page_number": 3,
        "section_number": 47,
        "content": "ported. In patients with a prolonged QT interval, disturbed hepatic",
        "metadata": {
            "section_title": "ported. In patients with a prolonged QT interval, disturbed hepatic "
        }
    },
    {
        "page_number": 3,
        "section_number": 48,
        "content": "function, and renal GFR < 10 ml/min, caution should be taken when",
        "metadata": {
            "section_title": "function, and renal GFR < 10 ml/min, caution should be taken when "
        }
    },
    {
        "page_number": 3,
        "section_number": 49,
        "content": "administrating AZM.28,30",
        "metadata": {
            "section_title": "administrating AZM.28,30"
        }
    },
    {
        "page_number": 3,
        "section_number": 50,
        "content": "2.5 | New formulation of AZM",
        "metadata": {
            "section_title": "2.5 | New formulation of AZM"
        }
    },
    {
        "page_number": 3,
        "section_number": 51,
        "content": "A new formulation of AZM, designed as a microsphere with long-",
        "metadata": {
            "section_title": "A new formulation of AZM, designed as a microsphere with long- "
        }
    },
    {
        "page_number": 3,
        "section_number": 52,
        "content": "term release (ER) to delay the release of AZM, is released slowly",
        "metadata": {
            "section_title": "term release (ER) to delay the release of AZM, is released slowly "
        }
    },
    {
        "page_number": 3,
        "section_number": 53,
        "content": "through bypassing the upper gastrointestinal tract after reaching",
        "metadata": {
            "section_title": "through bypassing the upper gastrointestinal tract after reaching "
        }
    },
    {
        "page_number": 3,
        "section_number": 54,
        "content": "its lower part. In this method, by alkalizing the formulation, eleva -",
        "metadata": {
            "section_title": "its lower part. In this method, by alkalizing the formulation, eleva -"
        }
    },
    {
        "page_number": 3,
        "section_number": 55,
        "content": "tion in the pH of the suspension minimizes the release of the drug",
        "metadata": {
            "section_title": "tion in the pH of the suspension minimizes the release of the drug "
        }
    },
    {
        "page_number": 3,
        "section_number": 56,
        "content": "from the microspheres in the mouth and stomach and the micro -",
        "metadata": {
            "section_title": "from the microspheres in the mouth and stomach and the micro -"
        }
    },
    {
        "page_number": 3,
        "section_number": 57,
        "content": "sphere matrix. AZM is soluble, and this feature helps control the",
        "metadata": {
            "section_title": "sphere matrix. AZM is soluble, and this feature helps control the "
        }
    },
    {
        "page_number": 3,
        "section_number": 58,
        "content": "drug release. It spreads through the pores formed at the site of the",
        "metadata": {
            "section_title": "drug release. It spreads through the pores formed at the site of the "
        }
    },
    {
        "page_number": 3,
        "section_number": 59,
        "content": "microspheres. This ER formulation does not significantly compro-",
        "metadata": {
            "section_title": "microspheres. This ER formulation does not significantly compro-"
        }
    },
    {
        "page_number": 3,
        "section_number": 60,
        "content": "mise the oral bioavailability of AZM, although it bypasses a small",
        "metadata": {
            "section_title": "mise the oral bioavailability of AZM, although it bypasses a small "
        }
    },
    {
        "page_number": 3,
        "section_number": 61,
        "content": "portion of the uptake site in the upper gastrointestinal system. It",
        "metadata": {
            "section_title": "portion of the uptake site in the upper gastrointestinal system. It "
        }
    },
    {
        "page_number": 3,
        "section_number": 62,
        "content": "achieved approximately 83% bioavailability over the IR formulation,",
        "metadata": {
            "section_title": "achieved approximately 83% bioavailability over the IR formulation, "
        }
    },
    {
        "page_number": 3,
        "section_number": 63,
        "content": "the released microsphere formulation of AZM, allowing patients to",
        "metadata": {
            "section_title": "the released microsphere formulation of AZM, allowing patients to "
        }
    },
    {
        "page_number": 3,
        "section_number": 64,
        "content": "well tolerate a full course of AZM at a dose of 2.0 g. This formu -",
        "metadata": {
            "section_title": "well tolerate a full course of AZM at a dose of 2.0 g. This formu -"
        }
    },
    {
        "page_number": 3,
        "section_number": 65,
        "content": "lation should be taken on an empty stomach together with antac -",
        "metadata": {
            "section_title": "lation should be taken on an empty stomach together with antac -"
        }
    },
    {
        "page_number": 3,
        "section_number": 66,
        "content": "ids.31 A new oral-  free release microsphere formulation of AZM is the",
        "metadata": {
            "section_title": "ids.31 A new oral-  free release microsphere formulation of AZM is the "
        }
    },
    {
        "page_number": 3,
        "section_number": 67,
        "content": "first antibacterial drug approved in the USA for adult patients with",
        "metadata": {
            "section_title": "first antibacterial drug approved in the USA for adult patients with "
        }
    },
    {
        "page_number": 3,
        "section_number": 68,
        "content": "mild-  to- moderate acute bacterial sinusitis or community-  acquired",
        "metadata": {
            "section_title": "mild-  to- moderate acute bacterial sinusitis or community-  acquired "
        }
    },
    {
        "page_number": 3,
        "section_number": 69,
        "content": "pneumonia.32 The mentioned formulation of AZM is an oral pow -",
        "metadata": {
            "section_title": "pneumonia.32 The mentioned formulation of AZM is an oral pow -"
        }
    },
    {
        "page_number": 3,
        "section_number": 70,
        "content": "der that should be reconstituted with water and given in a single",
        "metadata": {
            "section_title": "der that should be reconstituted with water and given in a single "
        }
    },
    {
        "page_number": 3,
        "section_number": 71,
        "content": "dose of 2.0 g. Continuous release of the drug is achieved through FIGURE 2  Schematic\tview\tof\tAZM",
        "metadata": {
            "section_title": "dose of 2.0 g. Continuous release of the drug is achieved through FIGURE 2  Schematic\tview\tof\tAZM\t"
        }
    },
    {
        "page_number": 3,
        "section_number": 72,
        "content": "mechanism inhibiting translation of mRNA",
        "metadata": {
            "section_title": "mechanism inhibiting translation of mRNA"
        }
    },
    {
        "page_number": 4,
        "section_number": 1,
        "content": "4 of 16  |",
        "metadata": {
            "section_title": "4 of 16  |    "
        }
    },
    {
        "page_number": 4,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 4,
        "section_number": 3,
        "content": "diffusion from the microspheres; the time to reach a peak serum",
        "metadata": {
            "section_title": "diffusion from the microspheres; the time to reach a peak serum "
        }
    },
    {
        "page_number": 4,
        "section_number": 4,
        "content": "concentration is 5 h. AZM is well absorbed by free release. The mean",
        "metadata": {
            "section_title": "concentration is 5 h. AZM is well absorbed by free release. The mean "
        }
    },
    {
        "page_number": 4,
        "section_number": 5,
        "content": "maximum serum concentration is 0.82 μ g/ml, and AUC24 is about",
        "metadata": {
            "section_title": "maximum serum concentration is 0.82 μ g/ml, and AUC24 is about "
        }
    },
    {
        "page_number": 4,
        "section_number": 6,
        "content": "8.62  μg/ml. Free-  release AZM should be taken on an empty stomach",
        "metadata": {
            "section_title": "8.62  μg/ml. Free-  release AZM should be taken on an empty stomach "
        }
    },
    {
        "page_number": 4,
        "section_number": 7,
        "content": "to ensure slower absorption. AZM is mainly excreted unchanged in",
        "metadata": {
            "section_title": "to ensure slower absorption. AZM is mainly excreted unchanged in "
        }
    },
    {
        "page_number": 4,
        "section_number": 8,
        "content": "feces. The final half-  life of AZM secretion is 59 h.33 Drug delivery to",
        "metadata": {
            "section_title": "feces. The final half-  life of AZM secretion is 59 h.33 Drug delivery to "
        }
    },
    {
        "page_number": 4,
        "section_number": 9,
        "content": "the site of infection by phagocytes and fibroblasts is characterized",
        "metadata": {
            "section_title": "the site of infection by phagocytes and fibroblasts is characterized "
        }
    },
    {
        "page_number": 4,
        "section_number": 10,
        "content": "by tissue- directed AZM, which provides 5- day once- daily diets for",
        "metadata": {
            "section_title": "by tissue- directed AZM, which provides 5- day once- daily diets for "
        }
    },
    {
        "page_number": 4,
        "section_number": 11,
        "content": "most infections that respond to oral therapy and 7–  10 days for more",
        "metadata": {
            "section_title": "most infections that respond to oral therapy and 7–  10 days for more "
        }
    },
    {
        "page_number": 4,
        "section_number": 12,
        "content": "serious intravenous infections. Metabolism occurs through hepatic",
        "metadata": {
            "section_title": "serious intravenous infections. Metabolism occurs through hepatic "
        }
    },
    {
        "page_number": 4,
        "section_number": 13,
        "content": "pathways other than cytochrome P450, thus minimizing the risk of",
        "metadata": {
            "section_title": "pathways other than cytochrome P450, thus minimizing the risk of "
        }
    },
    {
        "page_number": 4,
        "section_number": 14,
        "content": "drug interactions.8",
        "metadata": {
            "section_title": "drug interactions.8"
        }
    },
    {
        "page_number": 4,
        "section_number": 15,
        "content": "2.6 | Activity in biofilms",
        "metadata": {
            "section_title": "2.6 | Activity in biofilms"
        }
    },
    {
        "page_number": 4,
        "section_number": 16,
        "content": "The potential role of AZM as an antibiofilm has been studied and",
        "metadata": {
            "section_title": "The potential role of AZM as an antibiofilm has been studied and "
        }
    },
    {
        "page_number": 4,
        "section_number": 17,
        "content": "shown to have a planktonic state when used in aerobic conditions. It",
        "metadata": {
            "section_title": "shown to have a planktonic state when used in aerobic conditions. It "
        }
    },
    {
        "page_number": 4,
        "section_number": 18,
        "content": "has been observed that AZM can significantly inhibit the formation",
        "metadata": {
            "section_title": "has been observed that AZM can significantly inhibit the formation "
        }
    },
    {
        "page_number": 4,
        "section_number": 19,
        "content": "and motility of biofilm in Pseudomonas aeruginosa  (P. aeruginosa ).34",
        "metadata": {
            "section_title": "and motility of biofilm in Pseudomonas aeruginosa  (P. aeruginosa ).34 "
        }
    },
    {
        "page_number": 4,
        "section_number": 20,
        "content": "Inhibition of biofilm mass in Porphyromonas gingivalis  has also been",
        "metadata": {
            "section_title": "Inhibition of biofilm mass in Porphyromonas gingivalis  has also been "
        }
    },
    {
        "page_number": 4,
        "section_number": 21,
        "content": "reported among the AZM-  treated isolates.35 AZM in combination",
        "metadata": {
            "section_title": "reported among the AZM-  treated isolates.35 AZM in combination "
        }
    },
    {
        "page_number": 4,
        "section_number": 22,
        "content": "with Dapsone can decline the glycosaminoglycan and durability of",
        "metadata": {
            "section_title": "with Dapsone can decline the glycosaminoglycan and durability of "
        }
    },
    {
        "page_number": 4,
        "section_number": 23,
        "content": "biofilms produced by Borrelia burgdorferi  isolates.36 Additionally,",
        "metadata": {
            "section_title": "biofilms produced by Borrelia burgdorferi  isolates.36 Additionally, "
        }
    },
    {
        "page_number": 4,
        "section_number": 24,
        "content": "when combined with ciprofloxacin (CIP) or rifampin, AZM is able to",
        "metadata": {
            "section_title": "when combined with ciprofloxacin (CIP) or rifampin, AZM is able to "
        }
    },
    {
        "page_number": 4,
        "section_number": 25,
        "content": "completely kill the biofilm of Bartonella henselae  within 6 days.37 The",
        "metadata": {
            "section_title": "completely kill the biofilm of Bartonella henselae  within 6 days.37 The "
        }
    },
    {
        "page_number": 4,
        "section_number": 26,
        "content": "antibiofilm activity of the AZM pattern has also been studied among",
        "metadata": {
            "section_title": "antibiofilm activity of the AZM pattern has also been studied among "
        }
    },
    {
        "page_number": 4,
        "section_number": 27,
        "content": "Stenotrophomonas maltophilia  isolates and demonstrated that AZM/",
        "metadata": {
            "section_title": "Stenotrophomonas maltophilia  isolates and demonstrated that AZM/"
        }
    },
    {
        "page_number": 4,
        "section_number": 28,
        "content": "tigecycline combination can hamper the formation of biofilms.38",
        "metadata": {
            "section_title": "tigecycline combination can hamper the formation of biofilms.38"
        }
    },
    {
        "page_number": 4,
        "section_number": 29,
        "content": "3 | AZITHROMYCIN RESISTANCE",
        "metadata": {
            "section_title": "3 | AZITHROMYCIN RESISTANCE"
        }
    },
    {
        "page_number": 4,
        "section_number": 30,
        "content": "3.1 | Mechanisms of resistance",
        "metadata": {
            "section_title": "3.1 | Mechanisms of resistance"
        }
    },
    {
        "page_number": 4,
        "section_number": 31,
        "content": "Like other drugs, the suboptimal use of AZM has been assumed the",
        "metadata": {
            "section_title": "Like other drugs, the suboptimal use of AZM has been assumed the "
        }
    },
    {
        "page_number": 4,
        "section_number": 32,
        "content": "most important cause of the development of resistant bacteria. The",
        "metadata": {
            "section_title": "most important cause of the development of resistant bacteria. The "
        }
    },
    {
        "page_number": 4,
        "section_number": 33,
        "content": "administration of an improper dose or duration of treatment results",
        "metadata": {
            "section_title": "administration of an improper dose or duration of treatment results "
        }
    },
    {
        "page_number": 4,
        "section_number": 34,
        "content": "in the emergence and spread of resistant organisms ( Table  1).39 Two",
        "metadata": {
            "section_title": "in the emergence and spread of resistant organisms ( Table  1).39 Two "
        }
    },
    {
        "page_number": 4,
        "section_number": 35,
        "content": "strategies have been generally involved in gonococcal resistance",
        "metadata": {
            "section_title": "strategies have been generally involved in gonococcal resistance "
        }
    },
    {
        "page_number": 4,
        "section_number": 36,
        "content": "against AZM: The mutations in the mtrR  coding region resulted in",
        "metadata": {
            "section_title": "against AZM: The mutations in the mtrR  coding region resulted in "
        }
    },
    {
        "page_number": 4,
        "section_number": 37,
        "content": "overexpression of the MtrCDE efflux pump. Moreover, the affinity",
        "metadata": {
            "section_title": "overexpression of the MtrCDE efflux pump. Moreover, the affinity "
        }
    },
    {
        "page_number": 4,
        "section_number": 38,
        "content": "of N. gonorrhoeae  to AZM decreases due to mutations in genes en -",
        "metadata": {
            "section_title": "of N. gonorrhoeae  to AZM decreases due to mutations in genes en -"
        }
    },
    {
        "page_number": 4,
        "section_number": 39,
        "content": "coding the 23S rRNA subunit.39 The modification of the drug target",
        "metadata": {
            "section_title": "coding the 23S rRNA subunit.39 The modification of the drug target "
        }
    },
    {
        "page_number": 4,
        "section_number": 40,
        "content": "is associated with methylation of the 23S ribosomal subunit (related",
        "metadata": {
            "section_title": "is associated with methylation of the 23S ribosomal subunit (related "
        }
    },
    {
        "page_number": 4,
        "section_number": 41,
        "content": "to the presence of erm  genes) or by mutations in rrl  alleles of the 23S",
        "metadata": {
            "section_title": "to the presence of erm  genes) or by mutations in rrl  alleles of the 23S "
        }
    },
    {
        "page_number": 4,
        "section_number": 42,
        "content": "rRNA gene, which blocks macrolide binding to this subunit.40",
        "metadata": {
            "section_title": "rRNA gene, which blocks macrolide binding to this subunit.40"
        }
    },
    {
        "page_number": 4,
        "section_number": 43,
        "content": "The molecular basis of the AZM resistance mechanism in P.  aeru -",
        "metadata": {
            "section_title": "The molecular basis of the AZM resistance mechanism in P.  aeru -"
        }
    },
    {
        "page_number": 4,
        "section_number": 44,
        "content": "ginosa  showed that the overexpression of efflux pumps particularly",
        "metadata": {
            "section_title": "ginosa  showed that the overexpression of efflux pumps particularly "
        }
    },
    {
        "page_number": 4,
        "section_number": 45,
        "content": "mexAB-  oprM and mexCD-  oprJ41 and mutations in the ribosomal",
        "metadata": {
            "section_title": "mexAB-  oprM and mexCD-  oprJ41 and mutations in the ribosomal "
        }
    },
    {
        "page_number": 4,
        "section_number": 46,
        "content": "target of drugs in the 23S rRNA gene can cause the development",
        "metadata": {
            "section_title": "target of drugs in the 23S rRNA gene can cause the development "
        }
    },
    {
        "page_number": 4,
        "section_number": 47,
        "content": "of resistant strains in the biofilm community of cystic fibrosis pa -",
        "metadata": {
            "section_title": "of resistant strains in the biofilm community of cystic fibrosis pa -"
        }
    },
    {
        "page_number": 4,
        "section_number": 48,
        "content": "tients.42 Although the better permeability and higher intracellular uptake of AZM resulted in the better activity of this antibiotic, the",
        "metadata": {
            "section_title": "tients.42 Although the better permeability and higher intracellular uptake of AZM resulted in the better activity of this antibiotic, the "
        }
    },
    {
        "page_number": 4,
        "section_number": 49,
        "content": "majority of macrolides are ineffective against Enterobacteriaceae",
        "metadata": {
            "section_title": "majority of macrolides are ineffective against Enterobacteriaceae "
        }
    },
    {
        "page_number": 4,
        "section_number": 50,
        "content": "due to intrinsic low macrolide permeability. In Enterobacteriaceae,",
        "metadata": {
            "section_title": "due to intrinsic low macrolide permeability. In Enterobacteriaceae, "
        }
    },
    {
        "page_number": 4,
        "section_number": 51,
        "content": "the relevance of 23S rRNA alterations as being responsible for mac -",
        "metadata": {
            "section_title": "the relevance of 23S rRNA alterations as being responsible for mac -"
        }
    },
    {
        "page_number": 4,
        "section_number": 52,
        "content": "rolide resistance is low since E. coli , Salmonella  spp., Shigella  spp., and",
        "metadata": {
            "section_title": "rolide resistance is low since E. coli , Salmonella  spp., Shigella  spp., and "
        }
    },
    {
        "page_number": 4,
        "section_number": 53,
        "content": "Klebsiella  spp. possess up to one or more rrn  loci.43",
        "metadata": {
            "section_title": "Klebsiella  spp. possess up to one or more rrn  loci.43"
        }
    },
    {
        "page_number": 4,
        "section_number": 54,
        "content": "The methylation of 23S rRNA mediated by methylases encoded",
        "metadata": {
            "section_title": "The methylation of 23S rRNA mediated by methylases encoded "
        }
    },
    {
        "page_number": 4,
        "section_number": 55,
        "content": "in erm genes is the most relevant mechanism of macrolide resistance.",
        "metadata": {
            "section_title": "in erm genes is the most relevant mechanism of macrolide resistance. "
        }
    },
    {
        "page_number": 4,
        "section_number": 56,
        "content": "These genes have been located in mobile elements such as plasmids",
        "metadata": {
            "section_title": "These genes have been located in mobile elements such as plasmids "
        }
    },
    {
        "page_number": 4,
        "section_number": 57,
        "content": "carrying more than one erm  gene.43,44 Another type of modification",
        "metadata": {
            "section_title": "carrying more than one erm  gene.43,44 Another type of modification "
        }
    },
    {
        "page_number": 4,
        "section_number": 58,
        "content": "related to macrolide resistance is pseudouridylation of 23S rRNA.",
        "metadata": {
            "section_title": "related to macrolide resistance is pseudouridylation of 23S rRNA. "
        }
    },
    {
        "page_number": 4,
        "section_number": 59,
        "content": "This post-  translational modification was observed in domain V of",
        "metadata": {
            "section_title": "This post-  translational modification was observed in domain V of "
        }
    },
    {
        "page_number": 4,
        "section_number": 60,
        "content": "the E. coli 23S rRNA. Moreover, mutations in other ribosomal pro -",
        "metadata": {
            "section_title": "the E. coli 23S rRNA. Moreover, mutations in other ribosomal pro -"
        }
    },
    {
        "page_number": 4,
        "section_number": 61,
        "content": "teins including L4 (encoded in the rplD  gene) and L22 (encoded in",
        "metadata": {
            "section_title": "teins including L4 (encoded in the rplD  gene) and L22 (encoded in "
        }
    },
    {
        "page_number": 4,
        "section_number": 62,
        "content": "the rplV gene) involved in the development of macrolide resistance",
        "metadata": {
            "section_title": "the rplV gene) involved in the development of macrolide resistance "
        }
    },
    {
        "page_number": 4,
        "section_number": 63,
        "content": "in Enterobacteriaceae.43",
        "metadata": {
            "section_title": "in Enterobacteriaceae.43"
        }
    },
    {
        "page_number": 4,
        "section_number": 64,
        "content": "It is important to note that the hydrophobic nature of macrolides",
        "metadata": {
            "section_title": "It is important to note that the hydrophobic nature of macrolides "
        }
    },
    {
        "page_number": 4,
        "section_number": 65,
        "content": "has been assumed the underlying cause of intrinsic resistance to",
        "metadata": {
            "section_title": "has been assumed the underlying cause of intrinsic resistance to "
        }
    },
    {
        "page_number": 4,
        "section_number": 66,
        "content": "most of these antimicrobial agents. Additionally, the overexpression",
        "metadata": {
            "section_title": "most of these antimicrobial agents. Additionally, the overexpression "
        }
    },
    {
        "page_number": 4,
        "section_number": 67,
        "content": "of chromosomal efflux pumps (AcrAB-  TolC) and outer membrane",
        "metadata": {
            "section_title": "of chromosomal efflux pumps (AcrAB-  TolC) and outer membrane "
        }
    },
    {
        "page_number": 4,
        "section_number": 68,
        "content": "protein (OmpW) has been observed in E. coli AZM-  resistant mutants",
        "metadata": {
            "section_title": "protein (OmpW) has been observed in E. coli AZM-  resistant mutants "
        }
    },
    {
        "page_number": 4,
        "section_number": 69,
        "content": "in vitro. In addition to mentioned mechanisms, bacterial macrolide",
        "metadata": {
            "section_title": "in vitro. In addition to mentioned mechanisms, bacterial macrolide "
        }
    },
    {
        "page_number": 4,
        "section_number": 70,
        "content": "modifications commonly lead to the decline of direct antibacterial",
        "metadata": {
            "section_title": "modifications commonly lead to the decline of direct antibacterial "
        }
    },
    {
        "page_number": 4,
        "section_number": 71,
        "content": "activity.43 In Enterobacteriaceae, two esterases encoded by ere  (A,B)",
        "metadata": {
            "section_title": "activity.43 In Enterobacteriaceae, two esterases encoded by ere  (A,B) "
        }
    },
    {
        "page_number": 4,
        "section_number": 72,
        "content": "genes and four different phosphotransferases encoded by mph  (A,",
        "metadata": {
            "section_title": "genes and four different phosphotransferases encoded by mph  (A, "
        }
    },
    {
        "page_number": 4,
        "section_number": 73,
        "content": "B, D, and E) hydrolyze and modify the macrolide structure.43,44 Short",
        "metadata": {
            "section_title": "B, D, and E) hydrolyze and modify the macrolide structure.43,44 Short "
        }
    },
    {
        "page_number": 4,
        "section_number": 74,
        "content": "peptides as 23S rRNA fragments are able to confer macrolide resis -",
        "metadata": {
            "section_title": "peptides as 23S rRNA fragments are able to confer macrolide resis -"
        }
    },
    {
        "page_number": 4,
        "section_number": 75,
        "content": "tance. These resistance peptides interact with the macrolide and re -",
        "metadata": {
            "section_title": "tance. These resistance peptides interact with the macrolide and re -"
        }
    },
    {
        "page_number": 4,
        "section_number": 76,
        "content": "move it from the ribosome and establish a new protein translation.43",
        "metadata": {
            "section_title": "move it from the ribosome and establish a new protein translation.43"
        }
    },
    {
        "page_number": 4,
        "section_number": 77,
        "content": "Studies showed that mutations of the rplD  gene contributed to",
        "metadata": {
            "section_title": "Studies showed that mutations of the rplD  gene contributed to "
        }
    },
    {
        "page_number": 4,
        "section_number": 78,
        "content": "less sensitive C. trachomatis  serovar L2 isolates to AZM and ERY.",
        "metadata": {
            "section_title": "less sensitive C. trachomatis  serovar L2 isolates to AZM and ERY. "
        }
    },
    {
        "page_number": 4,
        "section_number": 79,
        "content": "It has been reported that the mutations in L4 protein conclude in",
        "metadata": {
            "section_title": "It has been reported that the mutations in L4 protein conclude in "
        }
    },
    {
        "page_number": 4,
        "section_number": 80,
        "content": "the conformational modification of the 23S rRNA in domains II, III,",
        "metadata": {
            "section_title": "the conformational modification of the 23S rRNA in domains II, III, "
        }
    },
    {
        "page_number": 4,
        "section_number": 81,
        "content": "and V resulting in disorder in the translational activity of ribosomes.",
        "metadata": {
            "section_title": "and V resulting in disorder in the translational activity of ribosomes. "
        }
    },
    {
        "page_number": 4,
        "section_number": 82,
        "content": "Moreover, mutations in the peptidyl transferase region of 23S rRNA",
        "metadata": {
            "section_title": "Moreover, mutations in the peptidyl transferase region of 23S rRNA "
        }
    },
    {
        "page_number": 4,
        "section_number": 83,
        "content": "genes and the non-  conserved region of the protein L22 have been",
        "metadata": {
            "section_title": "genes and the non-  conserved region of the protein L22 have been "
        }
    },
    {
        "page_number": 4,
        "section_number": 84,
        "content": "seen in clinical isolates resistant to C.  trachomatis .45 The dramatic",
        "metadata": {
            "section_title": "seen in clinical isolates resistant to C.  trachomatis .45 The dramatic "
        }
    },
    {
        "page_number": 4,
        "section_number": 85,
        "content": "increase in macrolide-  resistant Treponema pallidum (T.  pallidum)  spp.",
        "metadata": {
            "section_title": "increase in macrolide-  resistant Treponema pallidum (T.  pallidum)  spp. "
        }
    },
    {
        "page_number": 4,
        "section_number": 86,
        "content": "pallidum  has been reported since 2000. The emergence of macrolide",
        "metadata": {
            "section_title": "pallidum  has been reported since 2000. The emergence of macrolide "
        }
    },
    {
        "page_number": 4,
        "section_number": 87,
        "content": "resistance isolates evolves by a two-  step process including either",
        "metadata": {
            "section_title": "resistance isolates evolves by a two-  step process including either "
        }
    },
    {
        "page_number": 4,
        "section_number": 88,
        "content": "A2058G or A2059G mutation in one copy of the 23S rRNA that sub -",
        "metadata": {
            "section_title": "A2058G or A2059G mutation in one copy of the 23S rRNA that sub -"
        }
    },
    {
        "page_number": 4,
        "section_number": 89,
        "content": "sequently results in gene conversion of both rRNA genes.46",
        "metadata": {
            "section_title": "sequently results in gene conversion of both rRNA genes.46"
        }
    },
    {
        "page_number": 4,
        "section_number": 90,
        "content": "The resistance mechanism of S.  pneumoniae is  associated with",
        "metadata": {
            "section_title": "The resistance mechanism of S.  pneumoniae is  associated with "
        }
    },
    {
        "page_number": 4,
        "section_number": 91,
        "content": "horizontal gene transfer of efflux pump Mef  (E) genes. Moreover,",
        "metadata": {
            "section_title": "horizontal gene transfer of efflux pump Mef  (E) genes. Moreover, "
        }
    },
    {
        "page_number": 4,
        "section_number": 92,
        "content": "streptococcal methylase ErmB can develop high-  level cross-",
        "metadata": {
            "section_title": "streptococcal methylase ErmB can develop high-  level cross- "
        }
    },
    {
        "page_number": 4,
        "section_number": 93,
        "content": "resistance to macrolides through methylation of A2058 nucleotide",
        "metadata": {
            "section_title": "resistance to macrolides through methylation of A2058 nucleotide "
        }
    },
    {
        "page_number": 4,
        "section_number": 94,
        "content": "of 23S rRNA. Other mechanisms, including mutations in domain V of",
        "metadata": {
            "section_title": "of 23S rRNA. Other mechanisms, including mutations in domain V of "
        }
    },
    {
        "page_number": 4,
        "section_number": 95,
        "content": "23S rRNA and in ribosomal proteins L4 or L22, can also appear more",
        "metadata": {
            "section_title": "23S rRNA and in ribosomal proteins L4 or L22, can also appear more "
        }
    },
    {
        "page_number": 4,
        "section_number": 96,
        "content": "rarely in macrolide resistance isolates of S.  pneumoniae .47 The ge -",
        "metadata": {
            "section_title": "rarely in macrolide resistance isolates of S.  pneumoniae .47 The ge -"
        }
    },
    {
        "page_number": 4,
        "section_number": 97,
        "content": "netic mechanism of macrolide resistance of S . aureus  strains isolated",
        "metadata": {
            "section_title": "netic mechanism of macrolide resistance of S . aureus  strains isolated "
        }
    },
    {
        "page_number": 4,
        "section_number": 98,
        "content": "from cystic fibrosis patients has been well documented by mutations",
        "metadata": {
            "section_title": "from cystic fibrosis patients has been well documented by mutations "
        }
    },
    {
        "page_number": 4,
        "section_number": 99,
        "content": "in genes of 23S rRNA domain II, V ( rrl), and ribosomal protein L4",
        "metadata": {
            "section_title": "in genes of 23S rRNA domain II, V ( rrl), and ribosomal protein L4 "
        }
    },
    {
        "page_number": 4,
        "section_number": 100,
        "content": "(rplD) and L22 ( rplV). In addition, acquired resistance genes such as",
        "metadata": {
            "section_title": "(rplD) and L22 ( rplV). In addition, acquired resistance genes such as"
        }
    },
    {
        "page_number": 5,
        "section_number": 1,
        "content": "|  5 of 16",
        "metadata": {
            "section_title": "|  5 of 16"
        }
    },
    {
        "page_number": 5,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 5,
        "section_number": 3,
        "content": "erm (encoding a ribosomal methylase) and msr (A) (encoding an efflux",
        "metadata": {
            "section_title": "erm (encoding a ribosomal methylase) and msr (A) (encoding an efflux "
        }
    },
    {
        "page_number": 5,
        "section_number": 4,
        "content": "protein) can lead to macrolide resistance in S.  aureus  strains.48",
        "metadata": {
            "section_title": "protein) can lead to macrolide resistance in S.  aureus  strains.48"
        }
    },
    {
        "page_number": 5,
        "section_number": 5,
        "content": "Although Salmonella  isolates have intrinsic resistance to ERY",
        "metadata": {
            "section_title": "Although Salmonella  isolates have intrinsic resistance to ERY "
        }
    },
    {
        "page_number": 5,
        "section_number": 6,
        "content": "which is associated with active efflux of drugs, these strains are",
        "metadata": {
            "section_title": "which is associated with active efflux of drugs, these strains are "
        }
    },
    {
        "page_number": 5,
        "section_number": 7,
        "content": "naturally susceptible to AZM. Resistance to macrolides is related to",
        "metadata": {
            "section_title": "naturally susceptible to AZM. Resistance to macrolides is related to "
        }
    },
    {
        "page_number": 5,
        "section_number": 8,
        "content": "mutations in nucleotides A2058 and A2059 of 23S rRNA domain V.",
        "metadata": {
            "section_title": "mutations in nucleotides A2058 and A2059 of 23S rRNA domain V. "
        }
    },
    {
        "page_number": 5,
        "section_number": 9,
        "content": "Additionally, the modification of the 50S ribosomal subunit proteins",
        "metadata": {
            "section_title": "Additionally, the modification of the 50S ribosomal subunit proteins "
        }
    },
    {
        "page_number": 5,
        "section_number": 10,
        "content": "L4 and L22 may contribute to macrolide resistance.49 Haemophiles",
        "metadata": {
            "section_title": "L4 and L22 may contribute to macrolide resistance.49 Haemophiles "
        }
    },
    {
        "page_number": 5,
        "section_number": 11,
        "content": "influenzae  strains are intrinsically resistant to macrolide due to the",
        "metadata": {
            "section_title": "influenzae  strains are intrinsically resistant to macrolide due to the "
        }
    },
    {
        "page_number": 5,
        "section_number": 12,
        "content": "presence of a homologous efflux pump to the acrAB efflux mecha -",
        "metadata": {
            "section_title": "presence of a homologous efflux pump to the acrAB efflux mecha -"
        }
    },
    {
        "page_number": 5,
        "section_number": 13,
        "content": "nism in E. coli or other efflux pumps. In a few strains, higher MICs re -",
        "metadata": {
            "section_title": "nism in E. coli or other efflux pumps. In a few strains, higher MICs re -"
        }
    },
    {
        "page_number": 5,
        "section_number": 14,
        "content": "lated to mutations in 23S rRNA and L4 and L22 ribosomal proteins.50",
        "metadata": {
            "section_title": "lated to mutations in 23S rRNA and L4 and L22 ribosomal proteins.50"
        }
    },
    {
        "page_number": 5,
        "section_number": 15,
        "content": "In Legionella pneumophila  strains, mutations in the upstream",
        "metadata": {
            "section_title": "In Legionella pneumophila  strains, mutations in the upstream "
        }
    },
    {
        "page_number": 5,
        "section_number": 16,
        "content": "sequence of lpeAB (lpp2879–  lpp2880) operon result in the overex -",
        "metadata": {
            "section_title": "sequence of lpeAB (lpp2879–  lpp2880) operon result in the overex -"
        }
    },
    {
        "page_number": 5,
        "section_number": 17,
        "content": "pression of protein products. Lpp2879–  Lpp2880 together with TolC",
        "metadata": {
            "section_title": "pression of protein products. Lpp2879–  Lpp2880 together with TolC "
        }
    },
    {
        "page_number": 5,
        "section_number": 18,
        "content": "forms a tripartite efflux pump of the resistance–  nodulation–  division (RND) family. Moreover, in AZM-  resistant isolates, mutations in 23S",
        "metadata": {
            "section_title": "forms a tripartite efflux pump of the resistance–  nodulation–  division (RND) family. Moreover, in AZM-  resistant isolates, mutations in 23S "
        }
    },
    {
        "page_number": 5,
        "section_number": 19,
        "content": "rRNA genes and L4/L22 ribosomal proteins have been identified.51",
        "metadata": {
            "section_title": "rRNA genes and L4/L22 ribosomal proteins have been identified.51 "
        }
    },
    {
        "page_number": 5,
        "section_number": 20,
        "content": "In Campylobacter  spp., the most common mechanism for high-  level",
        "metadata": {
            "section_title": "In Campylobacter  spp., the most common mechanism for high-  level "
        }
    },
    {
        "page_number": 5,
        "section_number": 21,
        "content": "resistance to macrolides is substitutions in the domain V of the 23S",
        "metadata": {
            "section_title": "resistance to macrolides is substitutions in the domain V of the 23S "
        }
    },
    {
        "page_number": 5,
        "section_number": 22,
        "content": "rRNA gene (A2075G, A2074C/G).52 The substitutions and insertions",
        "metadata": {
            "section_title": "rRNA gene (A2075G, A2074C/G).52 The substitutions and insertions "
        }
    },
    {
        "page_number": 5,
        "section_number": 23,
        "content": "in ribosomal proteins are another resistance mechanism in the ab -",
        "metadata": {
            "section_title": "in ribosomal proteins are another resistance mechanism in the ab -"
        }
    },
    {
        "page_number": 5,
        "section_number": 24,
        "content": "sence of mutations in 23S rRNA genes. Moreover, CmeABC efflux",
        "metadata": {
            "section_title": "sence of mutations in 23S rRNA genes. Moreover, CmeABC efflux "
        }
    },
    {
        "page_number": 5,
        "section_number": 25,
        "content": "pumps (a member of the RND transporter family) have an important",
        "metadata": {
            "section_title": "pumps (a member of the RND transporter family) have an important "
        }
    },
    {
        "page_number": 5,
        "section_number": 26,
        "content": "role in resistance to macrolides.52",
        "metadata": {
            "section_title": "role in resistance to macrolides.52"
        }
    },
    {
        "page_number": 5,
        "section_number": 27,
        "content": "These three mechanisms synergistically contribute to high-  level",
        "metadata": {
            "section_title": "These three mechanisms synergistically contribute to high-  level "
        }
    },
    {
        "page_number": 5,
        "section_number": 28,
        "content": "macrolide resistance.53 Another mechanism of macrolide resistance",
        "metadata": {
            "section_title": "macrolide resistance.53 Another mechanism of macrolide resistance "
        }
    },
    {
        "page_number": 5,
        "section_number": 29,
        "content": "in Campylobacter  spp. is antibiotic exclusion through the major outer",
        "metadata": {
            "section_title": "in Campylobacter  spp. is antibiotic exclusion through the major outer "
        }
    },
    {
        "page_number": 5,
        "section_number": 30,
        "content": "membrane porin (MOMP). Campylobacter  spp. can alter membrane",
        "metadata": {
            "section_title": "membrane porin (MOMP). Campylobacter  spp. can alter membrane "
        }
    },
    {
        "page_number": 5,
        "section_number": 31,
        "content": "permeability mediated by overexpression of MOMP, chromosom -",
        "metadata": {
            "section_title": "permeability mediated by overexpression of MOMP, chromosom -"
        }
    },
    {
        "page_number": 5,
        "section_number": 32,
        "content": "ally encoded by porA .53 A novel mechanism for resistance in E. coli",
        "metadata": {
            "section_title": "ally encoded by porA .53 A novel mechanism for resistance in E. coli "
        }
    },
    {
        "page_number": 5,
        "section_number": 33,
        "content": "isolates associated with erm  (B) transferred by multidrug resistance TABLE 1  Mechanisms\tof\tazithromycin\tresistance\tin\tdifferent\tbacteria",
        "metadata": {
            "section_title": "isolates associated with erm  (B) transferred by multidrug resistance TABLE 1  Mechanisms\tof\tazithromycin\tresistance\tin\tdifferent\tbacteria"
        }
    },
    {
        "page_number": 5,
        "section_number": 34,
        "content": "Bacteria Mechanisms of resistance References",
        "metadata": {
            "section_title": "Bacteria Mechanisms of resistance References"
        }
    },
    {
        "page_number": 5,
        "section_number": 35,
        "content": "Neisseria gonorrhoeae (1) Over expression of an efflux pump (due to mutations at mtrR  coding region)",
        "metadata": {
            "section_title": "Neisseria gonorrhoeae (1) Over expression of an efflux pump (due to mutations at mtrR  coding region)"
        }
    },
    {
        "page_number": 5,
        "section_number": 36,
        "content": "(2) Decreased antimicrobial affinity (due to mutations in genes encoding the 23S ribosomal",
        "metadata": {
            "section_title": "(2) Decreased antimicrobial affinity (due to mutations in genes encoding the 23S ribosomal "
        }
    },
    {
        "page_number": 5,
        "section_number": 37,
        "content": "subunit)39,40",
        "metadata": {
            "section_title": "subunit)39,40"
        }
    },
    {
        "page_number": 5,
        "section_number": 38,
        "content": "Pseudomonas aeruginosa (1) Efflux pump of P . aeruginosa  confers resistance to AZM during biofilm formation",
        "metadata": {
            "section_title": "Pseudomonas aeruginosa (1) Efflux pump of P . aeruginosa  confers resistance to AZM during biofilm formation"
        }
    },
    {
        "page_number": 5,
        "section_number": 39,
        "content": "(2) Mutations in the 23S rRNA gene41,42",
        "metadata": {
            "section_title": "(2) Mutations in the 23S rRNA gene41,42"
        }
    },
    {
        "page_number": 5,
        "section_number": 40,
        "content": "Enterobacteriaceae (1) Target mutations (23S rRNA mutations, ribosomal protein alterations)",
        "metadata": {
            "section_title": "Enterobacteriaceae (1) Target mutations (23S rRNA mutations, ribosomal protein alterations)"
        }
    },
    {
        "page_number": 5,
        "section_number": 41,
        "content": "(2) Methylation (Erm-  like, Cfr-  like, RlmA-  like)",
        "metadata": {
            "section_title": "(2) Methylation (Erm-  like, Cfr-  like, RlmA-  like)"
        }
    },
    {
        "page_number": 5,
        "section_number": 42,
        "content": "(3) Decreased uptake (efflux pumps, outer membrane alterations)",
        "metadata": {
            "section_title": "(3) Decreased uptake (efflux pumps, outer membrane alterations)"
        }
    },
    {
        "page_number": 5,
        "section_number": 43,
        "content": "(4) Macrolide modification (esterases, phosphotransferases)",
        "metadata": {
            "section_title": "(4) Macrolide modification (esterases, phosphotransferases)"
        }
    },
    {
        "page_number": 5,
        "section_number": 44,
        "content": "(5) Short peptides43",
        "metadata": {
            "section_title": "(5) Short peptides43"
        }
    },
    {
        "page_number": 5,
        "section_number": 45,
        "content": "Escherichia coli (1) Presence of chromosomal ( rplD, rplV , and 23S rRNA) mutations",
        "metadata": {
            "section_title": "Escherichia coli (1) Presence of chromosomal ( rplD, rplV , and 23S rRNA) mutations"
        }
    },
    {
        "page_number": 5,
        "section_number": 46,
        "content": "(2) Macrolide resistance genes (MRGs)",
        "metadata": {
            "section_title": "(2) Macrolide resistance genes (MRGs)"
        }
    },
    {
        "page_number": 5,
        "section_number": 47,
        "content": "(3) Efflux pump overexpression44",
        "metadata": {
            "section_title": "(3) Efflux pump overexpression44"
        }
    },
    {
        "page_number": 5,
        "section_number": 48,
        "content": "Chlamydia trachomatis (1) Mutations of rplD  gene, which codes for ribosomal protein L4",
        "metadata": {
            "section_title": "Chlamydia trachomatis (1) Mutations of rplD  gene, which codes for ribosomal protein L4"
        }
    },
    {
        "page_number": 5,
        "section_number": 49,
        "content": "(2) Mutations in the peptidyl transferase region of 23S rRNA genes",
        "metadata": {
            "section_title": "(2) Mutations in the peptidyl transferase region of 23S rRNA genes"
        }
    },
    {
        "page_number": 5,
        "section_number": 50,
        "content": "(3) A triple mutation in a non-  conserved region of the protein L2245",
        "metadata": {
            "section_title": "(3) A triple mutation in a non-  conserved region of the protein L2245"
        }
    },
    {
        "page_number": 5,
        "section_number": 51,
        "content": "Treponema pallidum Mutations in 23S rRNA gene (A2058G or A2059G mutations)46",
        "metadata": {
            "section_title": "Treponema pallidum Mutations in 23S rRNA gene (A2058G or A2059G mutations)46"
        }
    },
    {
        "page_number": 5,
        "section_number": 52,
        "content": "Streptococcus pneumoniae (1) Target modification from acquisition of the genes erm(B)  gene by horizontal transfer",
        "metadata": {
            "section_title": "Streptococcus pneumoniae (1) Target modification from acquisition of the genes erm(B)  gene by horizontal transfer "
        }
    },
    {
        "page_number": 5,
        "section_number": 53,
        "content": "(methylation by ErmB of 23S rRNA)",
        "metadata": {
            "section_title": "(methylation by ErmB of 23S rRNA)"
        }
    },
    {
        "page_number": 5,
        "section_number": 54,
        "content": "(2) Drug efflux from the acquisition of the mef(E)  gene by horizontal transfer",
        "metadata": {
            "section_title": "(2) Drug efflux from the acquisition of the mef(E)  gene by horizontal transfer"
        }
    },
    {
        "page_number": 5,
        "section_number": 55,
        "content": "(3) Chromosomal mutations in 23S rRNA genes",
        "metadata": {
            "section_title": "(3) Chromosomal mutations in 23S rRNA genes"
        }
    },
    {
        "page_number": 5,
        "section_number": 56,
        "content": "(4) Chromosomal mutations in the genes coding for ribosomal proteins L4 or L2247",
        "metadata": {
            "section_title": "(4) Chromosomal mutations in the genes coding for ribosomal proteins L4 or L2247"
        }
    },
    {
        "page_number": 5,
        "section_number": 57,
        "content": "Staphylococcus aureus (1) Mutations in sequence of ribosomal genes rrl  (23S rRNA)",
        "metadata": {
            "section_title": "Staphylococcus aureus (1) Mutations in sequence of ribosomal genes rrl  (23S rRNA)"
        }
    },
    {
        "page_number": 5,
        "section_number": 58,
        "content": "(3) Mutations in sequence of rplV  (L22 protein)10",
        "metadata": {
            "section_title": "(3) Mutations in sequence of rplV  (L22 protein)10"
        }
    },
    {
        "page_number": 5,
        "section_number": 59,
        "content": "Salmonella (1) Mutations in nucleotides A2058 and A2059 of the 23S rRNA",
        "metadata": {
            "section_title": "Salmonella (1) Mutations in nucleotides A2058 and A2059 of the 23S rRNA"
        }
    },
    {
        "page_number": 5,
        "section_number": 60,
        "content": "(2) Alteration of the 50S ribosomal subunit proteins L4 ( rlpD)",
        "metadata": {
            "section_title": "(2) Alteration of the 50S ribosomal subunit proteins L4 ( rlpD)"
        }
    },
    {
        "page_number": 5,
        "section_number": 61,
        "content": "(3) Alteration of the 50S ribosomal subunit proteins L22 ( rlpV)49",
        "metadata": {
            "section_title": "(3) Alteration of the 50S ribosomal subunit proteins L22 ( rlpV)49"
        }
    },
    {
        "page_number": 5,
        "section_number": 62,
        "content": "Haemophilus influenzae (1) Presence of an efflux pump homologous to the acrAB  efflux mechanism in E. coli or other",
        "metadata": {
            "section_title": "Haemophilus influenzae (1) Presence of an efflux pump homologous to the acrAB  efflux mechanism in E. coli or other "
        }
    },
    {
        "page_number": 5,
        "section_number": 63,
        "content": "efflux pumps",
        "metadata": {
            "section_title": "efflux pumps"
        }
    },
    {
        "page_number": 5,
        "section_number": 64,
        "content": "(2) L4 and L22 ribosomal protein and 23S rRNA mutations50",
        "metadata": {
            "section_title": "(2) L4 and L22 ribosomal protein and 23S rRNA mutations50"
        }
    },
    {
        "page_number": 5,
        "section_number": 65,
        "content": "Legionella pneumophila (1) Mutations of efflux pump gene lpeAB",
        "metadata": {
            "section_title": "Legionella pneumophila (1) Mutations of efflux pump gene lpeAB"
        }
    },
    {
        "page_number": 5,
        "section_number": 66,
        "content": "(2) Mutations in genes encoding 23S rRNA or L4 and L22 ribosomal proteins51",
        "metadata": {
            "section_title": "(2) Mutations in genes encoding 23S rRNA or L4 and L22 ribosomal proteins51"
        }
    },
    {
        "page_number": 5,
        "section_number": 67,
        "content": "Campylobacter (1) Target mutations in 23S rRNA genes",
        "metadata": {
            "section_title": "Campylobacter (1) Target mutations in 23S rRNA genes"
        }
    },
    {
        "page_number": 5,
        "section_number": 68,
        "content": "(2) Target mutations in L4 and L22 ribosomal proteins",
        "metadata": {
            "section_title": "(2) Target mutations in L4 and L22 ribosomal proteins"
        }
    },
    {
        "page_number": 5,
        "section_number": 69,
        "content": "(3) Ribosomal methylation encoded by erm(B)",
        "metadata": {
            "section_title": "(3) Ribosomal methylation encoded by erm(B)"
        }
    },
    {
        "page_number": 5,
        "section_number": 70,
        "content": "(4) Multidrug efflux pumps (CmeABC)",
        "metadata": {
            "section_title": "(4) Multidrug efflux pumps (CmeABC)"
        }
    },
    {
        "page_number": 5,
        "section_number": 71,
        "content": "(5) Decreased membrane permeability due to MOMP52,53",
        "metadata": {
            "section_title": "(5) Decreased membrane permeability due to MOMP52,53"
        }
    },
    {
        "page_number": 6,
        "section_number": 1,
        "content": "6 of 16  |",
        "metadata": {
            "section_title": "6 of 16  |    "
        }
    },
    {
        "page_number": 6,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 6,
        "section_number": 3,
        "content": "(MDR) genomic islands was reported in 2014.52 Erm(B) methylates",
        "metadata": {
            "section_title": "(MDR) genomic islands was reported in 2014.52 Erm(B) methylates "
        }
    },
    {
        "page_number": 6,
        "section_number": 4,
        "content": "the 23S rRNA gene and results in decreased binding of macrolides.52",
        "metadata": {
            "section_title": "the 23S rRNA gene and results in decreased binding of macrolides.52"
        }
    },
    {
        "page_number": 6,
        "section_number": 5,
        "content": "3.2 | Epidemiology of resistance",
        "metadata": {
            "section_title": "3.2 | Epidemiology of resistance"
        }
    },
    {
        "page_number": 6,
        "section_number": 6,
        "content": "3.2.1 | South\tAmerica\tand\tCaribbean",
        "metadata": {
            "section_title": "3.2.1 | South\tAmerica\tand\tCaribbean"
        }
    },
    {
        "page_number": 6,
        "section_number": 7,
        "content": "Most published studies from America have examined the rate of",
        "metadata": {
            "section_title": "Most published studies from America have examined the rate of "
        }
    },
    {
        "page_number": 6,
        "section_number": 8,
        "content": "AZM resistance and related mechanisms of Shigella  spp. isolates.",
        "metadata": {
            "section_title": "AZM resistance and related mechanisms of Shigella  spp. isolates. "
        }
    },
    {
        "page_number": 6,
        "section_number": 9,
        "content": "The resistance rate of AZM has been reported at 23.5–  100% among",
        "metadata": {
            "section_title": "The resistance rate of AZM has been reported at 23.5–  100% among "
        }
    },
    {
        "page_number": 6,
        "section_number": 10,
        "content": "Shigella  spp.54- 56 (Table  2). Although mostly mphA  plasmid-  encoded",
        "metadata": {
            "section_title": "Shigella  spp.54- 56 (Table  2). Although mostly mphA  plasmid-  encoded "
        }
    },
    {
        "page_number": 6,
        "section_number": 11,
        "content": "genes were reported as determinants of reduced susceptibility to",
        "metadata": {
            "section_title": "genes were reported as determinants of reduced susceptibility to "
        }
    },
    {
        "page_number": 6,
        "section_number": 12,
        "content": "AZM in these isolates, ermB  is identified in Shigella  spp. isolated from",
        "metadata": {
            "section_title": "AZM in these isolates, ermB  is identified in Shigella  spp. isolated from "
        }
    },
    {
        "page_number": 6,
        "section_number": 13,
        "content": "men who have sex with men in Canada.56",
        "metadata": {
            "section_title": "men who have sex with men in Canada.56"
        }
    },
    {
        "page_number": 6,
        "section_number": 14,
        "content": "The gonococcal AZM susceptibility in South America and the",
        "metadata": {
            "section_title": "The gonococcal AZM susceptibility in South America and the "
        }
    },
    {
        "page_number": 6,
        "section_number": 15,
        "content": "Caribbean determined in one study examined N . gonorrhoeae  iso-",
        "metadata": {
            "section_title": "Caribbean determined in one study examined N . gonorrhoeae  iso-"
        }
    },
    {
        "page_number": 6,
        "section_number": 16,
        "content": "lates from 1990 to 2011. The overall prevalence of N . gonorrhoeae",
        "metadata": {
            "section_title": "lates from 1990 to 2011. The overall prevalence of N . gonorrhoeae  "
        }
    },
    {
        "page_number": 6,
        "section_number": 17,
        "content": "isolates resistant to AZM was 10.0%. Moreover, the resistance rate",
        "metadata": {
            "section_title": "isolates resistant to AZM was 10.0%. Moreover, the resistance rate "
        }
    },
    {
        "page_number": 6,
        "section_number": 18,
        "content": "ranged from 25% in 2008 to 1% in 2010 in gonococcal isolates.57",
        "metadata": {
            "section_title": "ranged from 25% in 2008 to 1% in 2010 in gonococcal isolates.57 "
        }
    },
    {
        "page_number": 6,
        "section_number": 19,
        "content": "In a Gonococcal isolate surveillance project carried out from 2005",
        "metadata": {
            "section_title": "In a Gonococcal isolate surveillance project carried out from 2005 "
        }
    },
    {
        "page_number": 6,
        "section_number": 20,
        "content": "to 2013 in the USA, the overall percentage of AZM resistance in",
        "metadata": {
            "section_title": "to 2013 in the USA, the overall percentage of AZM resistance in "
        }
    },
    {
        "page_number": 6,
        "section_number": 21,
        "content": "N. gonorrhoeae  isolates was 0.4% with no overall temporal trends in",
        "metadata": {
            "section_title": "N. gonorrhoeae  isolates was 0.4% with no overall temporal trends in "
        }
    },
    {
        "page_number": 6,
        "section_number": 22,
        "content": "geometric means. These data support the continued administration",
        "metadata": {
            "section_title": "geometric means. These data support the continued administration "
        }
    },
    {
        "page_number": 6,
        "section_number": 23,
        "content": "of AZM in a combination therapy regimen for gonorrhea.58",
        "metadata": {
            "section_title": "of AZM in a combination therapy regimen for gonorrhea.58"
        }
    },
    {
        "page_number": 6,
        "section_number": 24,
        "content": "In an in vitro evaluation of AZM resistance of 10 Haemophilus",
        "metadata": {
            "section_title": "In an in vitro evaluation of AZM resistance of 10 Haemophilus "
        }
    },
    {
        "page_number": 6,
        "section_number": 25,
        "content": "influenzae  strains, minimum inhibitory concentrations (MICs) in -",
        "metadata": {
            "section_title": "influenzae  strains, minimum inhibitory concentrations (MICs) in -"
        }
    },
    {
        "page_number": 6,
        "section_number": 26,
        "content": "creased >fourfold for all strains. Mutants selected by AZM were",
        "metadata": {
            "section_title": "creased >fourfold for all strains. Mutants selected by AZM were "
        }
    },
    {
        "page_number": 6,
        "section_number": 27,
        "content": "related to alterations in 23S rRNA and ribosomal proteins L4 and",
        "metadata": {
            "section_title": "related to alterations in 23S rRNA and ribosomal proteins L4 and "
        }
    },
    {
        "page_number": 6,
        "section_number": 28,
        "content": "L22 sequences.59 The macrolide susceptibility assessment of 6382",
        "metadata": {
            "section_title": "L22 sequences.59 The macrolide susceptibility assessment of 6382 "
        }
    },
    {
        "page_number": 6,
        "section_number": 29,
        "content": "clinical H. influenzae  isolates was studied during a 4-  year period and",
        "metadata": {
            "section_title": "clinical H. influenzae  isolates was studied during a 4-  year period and "
        }
    },
    {
        "page_number": 6,
        "section_number": 30,
        "content": "showed in 1.3% of the isolates, the MICs were > 4 µg/ml. Among",
        "metadata": {
            "section_title": "showed in 1.3% of the isolates, the MICs were > 4 µg/ml. Among "
        }
    },
    {
        "page_number": 6,
        "section_number": 31,
        "content": "all strains that showed resistance to AZM, mutations in ribosomal",
        "metadata": {
            "section_title": "all strains that showed resistance to AZM, mutations in ribosomal "
        }
    },
    {
        "page_number": 6,
        "section_number": 32,
        "content": "proteins L4 and L22 were represented as the most common AZM",
        "metadata": {
            "section_title": "proteins L4 and L22 were represented as the most common AZM "
        }
    },
    {
        "page_number": 6,
        "section_number": 33,
        "content": "resistance mechanism.60",
        "metadata": {
            "section_title": "resistance mechanism.60"
        }
    },
    {
        "page_number": 6,
        "section_number": 34,
        "content": "A study of sequential sub-  cultures in sub- MICs of antibiotics",
        "metadata": {
            "section_title": "A study of sequential sub-  cultures in sub- MICs of antibiotics "
        }
    },
    {
        "page_number": 6,
        "section_number": 35,
        "content": "in 12 S.  pneumonia  strains was performed to identify resistant mu -",
        "metadata": {
            "section_title": "in 12 S.  pneumonia  strains was performed to identify resistant mu -"
        }
    },
    {
        "page_number": 6,
        "section_number": 36,
        "content": "tants. The overall prevalence of S.  pneumonia  isolates resistant to",
        "metadata": {
            "section_title": "tants. The overall prevalence of S.  pneumonia  isolates resistant to "
        }
    },
    {
        "page_number": 6,
        "section_number": 37,
        "content": "AZM was 50% and in all AZM-  resistant parents and derived mu -",
        "metadata": {
            "section_title": "AZM was 50% and in all AZM-  resistant parents and derived mu -"
        }
    },
    {
        "page_number": 6,
        "section_number": 38,
        "content": "tants, the presence of mefE  was reported.61 The molecular screen -",
        "metadata": {
            "section_title": "tants, the presence of mefE  was reported.61 The molecular screen -"
        }
    },
    {
        "page_number": 6,
        "section_number": 39,
        "content": "ing of 124 syphilis infections collected from 2000 to 2004 indicated",
        "metadata": {
            "section_title": "ing of 124 syphilis infections collected from 2000 to 2004 indicated "
        }
    },
    {
        "page_number": 6,
        "section_number": 40,
        "content": "37.1% of T.  pallidum  isolates were resistant to AZM and associated",
        "metadata": {
            "section_title": "37.1% of T.  pallidum  isolates were resistant to AZM and associated "
        }
    },
    {
        "page_number": 6,
        "section_number": 41,
        "content": "with mutations in the 23S rRNA gene.62 Moreover, the first report",
        "metadata": {
            "section_title": "with mutations in the 23S rRNA gene.62 Moreover, the first report "
        }
    },
    {
        "page_number": 6,
        "section_number": 42,
        "content": "of MDR-  resistant Chlamydia trachomatis  (C. trachomatis ) in the USA",
        "metadata": {
            "section_title": "of MDR-  resistant Chlamydia trachomatis  (C. trachomatis ) in the USA "
        }
    },
    {
        "page_number": 6,
        "section_number": 43,
        "content": "was reported in 2000. All three C.  trachomatis  isolates involved in",
        "metadata": {
            "section_title": "was reported in 2000. All three C.  trachomatis  isolates involved in "
        }
    },
    {
        "page_number": 6,
        "section_number": 44,
        "content": "this study represented a high resistance to doxycycline, AZM, and",
        "metadata": {
            "section_title": "this study represented a high resistance to doxycycline, AZM, and "
        }
    },
    {
        "page_number": 6,
        "section_number": 45,
        "content": "ofloxacin (OFL) ( >4 µg/ml).63",
        "metadata": {
            "section_title": "ofloxacin (OFL) ( >4 µg/ml).63"
        }
    },
    {
        "page_number": 6,
        "section_number": 46,
        "content": "3.2.2 | Asia",
        "metadata": {
            "section_title": "3.2.2 | Asia"
        }
    },
    {
        "page_number": 6,
        "section_number": 47,
        "content": "Several studies on the resistance of Neisseria  isolates to AZM",
        "metadata": {
            "section_title": "Several studies on the resistance of Neisseria  isolates to AZM "
        }
    },
    {
        "page_number": 6,
        "section_number": 48,
        "content": "have been reported from East Asia. These studies examined the susceptibility of N . gonorrhoeae  isolates between 2009 and 2016,",
        "metadata": {
            "section_title": "have been reported from East Asia. These studies examined the susceptibility of N . gonorrhoeae  isolates between 2009 and 2016, "
        }
    },
    {
        "page_number": 6,
        "section_number": 49,
        "content": "and the calculated AZM resistance ranged between a high of 28.6%",
        "metadata": {
            "section_title": "and the calculated AZM resistance ranged between a high of 28.6% "
        }
    },
    {
        "page_number": 6,
        "section_number": 50,
        "content": "and 3.6% of isolates tested in China.83- 86 Moreover, two studies",
        "metadata": {
            "section_title": "and 3.6% of isolates tested in China.83- 86 Moreover, two studies "
        }
    },
    {
        "page_number": 6,
        "section_number": 51,
        "content": "from India and Taiwan presented the overall percentage of AZM re -",
        "metadata": {
            "section_title": "from India and Taiwan presented the overall percentage of AZM re -"
        }
    },
    {
        "page_number": 6,
        "section_number": 52,
        "content": "sistance in N . gonorrhoeae  isolates—  5% and 14.6%, respectively.75,79",
        "metadata": {
            "section_title": "sistance in N . gonorrhoeae  isolates—  5% and 14.6%, respectively.75,79 "
        }
    },
    {
        "page_number": 6,
        "section_number": 53,
        "content": "The resistance mechanism mentioned in relation to these resistant",
        "metadata": {
            "section_title": "The resistance mechanism mentioned in relation to these resistant "
        }
    },
    {
        "page_number": 6,
        "section_number": 54,
        "content": "isolates was mutations in 23S rRNA, penA , and mtrA  genes.83,85 The",
        "metadata": {
            "section_title": "isolates was mutations in 23S rRNA, penA , and mtrA  genes.83,85 The "
        }
    },
    {
        "page_number": 6,
        "section_number": 55,
        "content": "susceptibility assessment of Campylobacter  spp. isolated from ani -",
        "metadata": {
            "section_title": "susceptibility assessment of Campylobacter  spp. isolated from ani -"
        }
    },
    {
        "page_number": 6,
        "section_number": 56,
        "content": "mals and human samples carried out in South Korea, China, Russia,",
        "metadata": {
            "section_title": "mals and human samples carried out in South Korea, China, Russia, "
        }
    },
    {
        "page_number": 6,
        "section_number": 57,
        "content": "and Thailand.71,93,94,95,96",
        "metadata": {
            "section_title": "and Thailand.71,93,94,95,96"
        }
    },
    {
        "page_number": 6,
        "section_number": 58,
        "content": "The study period ranged from 1981 to 2016 and reported that",
        "metadata": {
            "section_title": "The study period ranged from 1981 to 2016 and reported that "
        }
    },
    {
        "page_number": 6,
        "section_number": 59,
        "content": "the overall percentage of AZM-  resistant Campylobacter  spp. iso -",
        "metadata": {
            "section_title": "the overall percentage of AZM-  resistant Campylobacter  spp. iso -"
        }
    },
    {
        "page_number": 6,
        "section_number": 60,
        "content": "lated from poultry samples differed between a high of 71.1% of",
        "metadata": {
            "section_title": "lated from poultry samples differed between a high of 71.1% of "
        }
    },
    {
        "page_number": 6,
        "section_number": 61,
        "content": "isolates tested in South Korea and 10% in Russia.93,95 Furthermore,",
        "metadata": {
            "section_title": "isolates tested in South Korea and 10% in Russia.93,95 Furthermore, "
        }
    },
    {
        "page_number": 6,
        "section_number": 62,
        "content": "AZM resistance among Campylobacter  species isolated from human",
        "metadata": {
            "section_title": "AZM resistance among Campylobacter  species isolated from human "
        }
    },
    {
        "page_number": 6,
        "section_number": 63,
        "content": "stool specimens was 11.2% and 31% in two studies performed in",
        "metadata": {
            "section_title": "stool specimens was 11.2% and 31% in two studies performed in "
        }
    },
    {
        "page_number": 6,
        "section_number": 64,
        "content": "Thailand.71,96 Frequent mutations in the 23S rRNA gene and the",
        "metadata": {
            "section_title": "Thailand.71,96 Frequent mutations in the 23S rRNA gene and the "
        }
    },
    {
        "page_number": 6,
        "section_number": 65,
        "content": "CmeABC efflux pump were reported as determinants of reduced",
        "metadata": {
            "section_title": "CmeABC efflux pump were reported as determinants of reduced "
        }
    },
    {
        "page_number": 6,
        "section_number": 66,
        "content": "susceptibility to AZM in these isolates.93- 95 Two studies from China",
        "metadata": {
            "section_title": "susceptibility to AZM in these isolates.93- 95 Two studies from China "
        }
    },
    {
        "page_number": 6,
        "section_number": 67,
        "content": "and Iran determined the prevalence of AZM resistance of Legionella",
        "metadata": {
            "section_title": "and Iran determined the prevalence of AZM resistance of Legionella "
        }
    },
    {
        "page_number": 6,
        "section_number": 68,
        "content": "pneumophila  isolates 16.8% and 29.9%, respectively.91,92 The AZM-",
        "metadata": {
            "section_title": "pneumophila  isolates 16.8% and 29.9%, respectively.91,92 The AZM- "
        }
    },
    {
        "page_number": 6,
        "section_number": 69,
        "content": "resistant strains were associated with overexpression levels of the",
        "metadata": {
            "section_title": "resistant strains were associated with overexpression levels of the "
        }
    },
    {
        "page_number": 6,
        "section_number": 70,
        "content": "efflux pump gene lpeAB .91 The AZM resistance of Haemophilus influ -",
        "metadata": {
            "section_title": "efflux pump gene lpeAB .91 The AZM resistance of Haemophilus influ -"
        }
    },
    {
        "page_number": 6,
        "section_number": 71,
        "content": "enzae  isolates ranged from 10% of isolates tested in 2014 increasing",
        "metadata": {
            "section_title": "enzae  isolates ranged from 10% of isolates tested in 2014 increasing "
        }
    },
    {
        "page_number": 6,
        "section_number": 72,
        "content": "to 17.4% in 2018 in two studies from Iran.89,90",
        "metadata": {
            "section_title": "to 17.4% in 2018 in two studies from Iran.89,90"
        }
    },
    {
        "page_number": 6,
        "section_number": 73,
        "content": "A study in Russia evaluated the alteration in the 23S rRNA gene",
        "metadata": {
            "section_title": "A study in Russia evaluated the alteration in the 23S rRNA gene "
        }
    },
    {
        "page_number": 6,
        "section_number": 74,
        "content": "of C. trachomatis  related to resistance to macrolides and reported",
        "metadata": {
            "section_title": "of C. trachomatis  related to resistance to macrolides and reported "
        }
    },
    {
        "page_number": 6,
        "section_number": 75,
        "content": "66.7% of C.  trachomatis  isolates were AZM-  resistant strains. The",
        "metadata": {
            "section_title": "66.7% of C.  trachomatis  isolates were AZM-  resistant strains. The "
        }
    },
    {
        "page_number": 6,
        "section_number": 76,
        "content": "macrolide-  resistant isolates had the mutations A2058C and T2611C",
        "metadata": {
            "section_title": "macrolide-  resistant isolates had the mutations A2058C and T2611C "
        }
    },
    {
        "page_number": 6,
        "section_number": 77,
        "content": "in the 23S rRNA gene.65 Moreover, in another study that examined",
        "metadata": {
            "section_title": "in the 23S rRNA gene.65 Moreover, in another study that examined "
        }
    },
    {
        "page_number": 6,
        "section_number": 78,
        "content": "C. trachomatis  isolates obtained from recurrently infected women",
        "metadata": {
            "section_title": "C. trachomatis  isolates obtained from recurrently infected women "
        }
    },
    {
        "page_number": 6,
        "section_number": 79,
        "content": "between 2006 and 2007, the prevalence of AZM resistance was re -",
        "metadata": {
            "section_title": "between 2006 and 2007, the prevalence of AZM resistance was re -"
        }
    },
    {
        "page_number": 6,
        "section_number": 80,
        "content": "ported at 9.5%.64 The antimicrobial susceptibility testing (AST) of 84",
        "metadata": {
            "section_title": "ported at 9.5%.64 The antimicrobial susceptibility testing (AST) of 84 "
        }
    },
    {
        "page_number": 6,
        "section_number": 81,
        "content": "Enterotoxigenic Escherichia coli  (ETEC) strains in China represented",
        "metadata": {
            "section_title": "Enterotoxigenic Escherichia coli  (ETEC) strains in China represented "
        }
    },
    {
        "page_number": 6,
        "section_number": 82,
        "content": "a high proportion of AZM resistance (86.7%) associated with a",
        "metadata": {
            "section_title": "a high proportion of AZM resistance (86.7%) associated with a "
        }
    },
    {
        "page_number": 6,
        "section_number": 83,
        "content": "novel IncFII plasmid harboring mphA  and blaTEM - 1 resistance genes.70",
        "metadata": {
            "section_title": "novel IncFII plasmid harboring mphA  and blaTEM - 1 resistance genes.70 "
        }
    },
    {
        "page_number": 6,
        "section_number": 84,
        "content": "However, an overview of antibiotic susceptibility of diarrheal patho -",
        "metadata": {
            "section_title": "However, an overview of antibiotic susceptibility of diarrheal patho -"
        }
    },
    {
        "page_number": 6,
        "section_number": 85,
        "content": "gens over a 15-  year period in Thailand demonstrated that AZM re -",
        "metadata": {
            "section_title": "gens over a 15-  year period in Thailand demonstrated that AZM re -"
        }
    },
    {
        "page_number": 6,
        "section_number": 86,
        "content": "sistance was found in 15% of ETEC.71 Moreover, the prevalence of",
        "metadata": {
            "section_title": "sistance was found in 15% of ETEC.71 Moreover, the prevalence of "
        }
    },
    {
        "page_number": 6,
        "section_number": 87,
        "content": "AZM resistance in Salmonella  bloodstream infections in Cambodia",
        "metadata": {
            "section_title": "AZM resistance in Salmonella  bloodstream infections in Cambodia "
        }
    },
    {
        "page_number": 6,
        "section_number": 88,
        "content": "and T. pallidum  isolated from different areas in China reported 33.9%",
        "metadata": {
            "section_title": "and T. pallidum  isolated from different areas in China reported 33.9% "
        }
    },
    {
        "page_number": 6,
        "section_number": 89,
        "content": "and 91.9, respectively.71,72,87",
        "metadata": {
            "section_title": "and 91.9, respectively.71,72,87"
        }
    },
    {
        "page_number": 6,
        "section_number": 90,
        "content": "3.2.3 | Europe",
        "metadata": {
            "section_title": "3.2.3 | Europe"
        }
    },
    {
        "page_number": 6,
        "section_number": 91,
        "content": "Most studies reported from Europe have examined the antibiotic",
        "metadata": {
            "section_title": "Most studies reported from Europe have examined the antibiotic "
        }
    },
    {
        "page_number": 6,
        "section_number": 92,
        "content": "susceptibility of Neisseria  isolates in different geographical areas. The",
        "metadata": {
            "section_title": "susceptibility of Neisseria  isolates in different geographical areas. The "
        }
    },
    {
        "page_number": 6,
        "section_number": 93,
        "content": "results of the European gonococcal antimicrobial surveillance pro-",
        "metadata": {
            "section_title": "results of the European gonococcal antimicrobial surveillance pro-"
        }
    },
    {
        "page_number": 6,
        "section_number": 94,
        "content": "gram published in 2011. Over a 2-  year period, 1902 N.  gonorrhoeae",
        "metadata": {
            "section_title": "gram published in 2011. Over a 2-  year period, 1902 N.  gonorrhoeae  "
        }
    },
    {
        "page_number": 6,
        "section_number": 95,
        "content": "isolates were collected from 21 participating countries and found that",
        "metadata": {
            "section_title": "isolates were collected from 21 participating countries and found that "
        }
    },
    {
        "page_number": 6,
        "section_number": 96,
        "content": "5.3% of the examined gonococcal isolates had in vitro resistance to",
        "metadata": {
            "section_title": "5.3% of the examined gonococcal isolates had in vitro resistance to "
        }
    },
    {
        "page_number": 6,
        "section_number": 97,
        "content": "AZM.76 Between 2012 and 2015, the percentage of AZM resistance",
        "metadata": {
            "section_title": "AZM.76 Between 2012 and 2015, the percentage of AZM resistance"
        }
    },
    {
        "page_number": 7,
        "section_number": 1,
        "content": "|  7 of 16",
        "metadata": {
            "section_title": "|  7 of 16"
        }
    },
    {
        "page_number": 7,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 7,
        "section_number": 3,
        "content": "TABLE 2  Epidemiology\tof\tazithromycin\tresistance",
        "metadata": {
            "section_title": "TABLE 2  Epidemiology\tof\tazithromycin\tresistance"
        }
    },
    {
        "page_number": 7,
        "section_number": 4,
        "content": "First author CountryEnrollment",
        "metadata": {
            "section_title": "First author CountryEnrollment "
        }
    },
    {
        "page_number": 7,
        "section_number": 5,
        "content": "timePublished",
        "metadata": {
            "section_title": "timePublished "
        }
    },
    {
        "page_number": 7,
        "section_number": 6,
        "content": "time BacteriaNo. of",
        "metadata": {
            "section_title": "time BacteriaNo. of "
        }
    },
    {
        "page_number": 7,
        "section_number": 7,
        "content": "resistant",
        "metadata": {
            "section_title": "resistant "
        }
    },
    {
        "page_number": 7,
        "section_number": 8,
        "content": "bacteria MIC ( μg/ml) Resistance mechanismResistance",
        "metadata": {
            "section_title": "bacteria MIC ( μg/ml) Resistance mechanismResistance "
        }
    },
    {
        "page_number": 7,
        "section_number": 9,
        "content": "rate",
        "metadata": {
            "section_title": "rate"
        }
    },
    {
        "page_number": 7,
        "section_number": 10,
        "content": "Somani63USA 1997–  1998 2000 Chlamydia trachomatis 3 >4 – –",
        "metadata": {
            "section_title": "Somani63USA 1997–  1998 2000 Chlamydia trachomatis 3 >4 – – "
        }
    },
    {
        "page_number": 7,
        "section_number": 11,
        "content": "Bhengraj64India 2006–  2007 2010 Chlamydia trachomatis 2 8 – 9.5%",
        "metadata": {
            "section_title": "Bhengraj64India 2006–  2007 2010 Chlamydia trachomatis 2 8 – 9.5%"
        }
    },
    {
        "page_number": 7,
        "section_number": 12,
        "content": "Misyurina65Russia 2000–  2002 2004 Chlamydia trachomatis 4 >5.12 Mutations in a 23S rRNA and L22 Genes 66.7%",
        "metadata": {
            "section_title": "Misyurina65Russia 2000–  2002 2004 Chlamydia trachomatis 4 >5.12 Mutations in a 23S rRNA and L22 Genes 66.7%"
        }
    },
    {
        "page_number": 7,
        "section_number": 13,
        "content": "Wolter66South Africa 2001–  2003 2005 Streptococcus pneumoniae 2 4 Mutations in ribosomal protein L4 –",
        "metadata": {
            "section_title": "Wolter66South Africa 2001–  2003 2005 Streptococcus pneumoniae 2 4 Mutations in ribosomal protein L4 – "
        }
    },
    {
        "page_number": 7,
        "section_number": 14,
        "content": "Nagai61USA 1998–  1999 2000 Streptococcus pneumoniae 6 16– 32 mef(E) 50%",
        "metadata": {
            "section_title": "Nagai61USA 1998–  1999 2000 Streptococcus pneumoniae 6 16– 32 mef(E) 50%"
        }
    },
    {
        "page_number": 7,
        "section_number": 15,
        "content": "Gür67Turkey 1996–  1997 2002 Streptococcus pneumoniae 6 – – 2.1%",
        "metadata": {
            "section_title": "Gür67Turkey 1996–  1997 2002 Streptococcus pneumoniae 6 – – 2.1%"
        }
    },
    {
        "page_number": 7,
        "section_number": 16,
        "content": "Gür67Turkey 1996–  1997 2002 Streptococcus pyogenes 5 – – 1.9%",
        "metadata": {
            "section_title": "Gür67Turkey 1996–  1997 2002 Streptococcus pyogenes 5 – – 1.9%"
        }
    },
    {
        "page_number": 7,
        "section_number": 17,
        "content": "Baker68U.K 1995– 2014 2015 Shigella flexneri – 6 4– >256 Acquired antimicrobial resistance genes",
        "metadata": {
            "section_title": "Baker68U.K 1995– 2014 2015 Shigella flexneri – 6 4– >256 Acquired antimicrobial resistance genes "
        }
    },
    {
        "page_number": 7,
        "section_number": 18,
        "content": "(pKSR100)–",
        "metadata": {
            "section_title": "(pKSR100)– "
        }
    },
    {
        "page_number": 7,
        "section_number": 19,
        "content": "Gaudreau54Canada 2012–  2013 2014 Shigella  spp. 10 ≥64 mph(A) gene 38.5%",
        "metadata": {
            "section_title": "Gaudreau54Canada 2012–  2013 2014 Shigella  spp. 10 ≥64 mph(A) gene 38.5%"
        }
    },
    {
        "page_number": 7,
        "section_number": 20,
        "content": "Sjolund Karlsson55USA 2011–  2012 2013 Shigella sonnei 4 >16 Presence of mph A –",
        "metadata": {
            "section_title": "Sjolund Karlsson55USA 2011–  2012 2013 Shigella sonnei 4 >16 Presence of mph A – "
        }
    },
    {
        "page_number": 7,
        "section_number": 21,
        "content": "Yousfi56Canada 2013–  2014 2019 Shigella  spp. 60 3 2–\t≥ 2 5 6 mphA  and ermB  genes 23.6%",
        "metadata": {
            "section_title": "Yousfi56Canada 2013–  2014 2019 Shigella  spp. 60 3 2–\t≥ 2 5 6 mphA  and ermB  genes 23.6%"
        }
    },
    {
        "page_number": 7,
        "section_number": 22,
        "content": "Benmessaoud69Morocco 2001–  2012 2016 Shigella  spp. 1 – – 11.1%",
        "metadata": {
            "section_title": "Benmessaoud69Morocco 2001–  2012 2016 Shigella  spp. 1 – – 11.1%"
        }
    },
    {
        "page_number": 7,
        "section_number": 23,
        "content": "Xiang70China 2016–  2018 2020 Escherichia coli 26 – mphA  gene 86.7%",
        "metadata": {
            "section_title": "Xiang70China 2016–  2018 2020 Escherichia coli 26 – mphA  gene 86.7%"
        }
    },
    {
        "page_number": 7,
        "section_number": 24,
        "content": "Benmessaoud69Morocco 2001–  2012 2016 Escherichia coli 11 – – 15.5%",
        "metadata": {
            "section_title": "Benmessaoud69Morocco 2001–  2012 2016 Escherichia coli 11 – – 15.5%"
        }
    },
    {
        "page_number": 7,
        "section_number": 25,
        "content": "Hoge71Thailand 1995–  1996 1998 Escherichia coli 6 >64 – 15%",
        "metadata": {
            "section_title": "Hoge71Thailand 1995–  1996 1998 Escherichia coli 6 >64 – 15%"
        }
    },
    {
        "page_number": 7,
        "section_number": 26,
        "content": "Vlieghe72Cambodia 2007–  2010 2012 Salmonella  spp. 20 >16 – 33.9%",
        "metadata": {
            "section_title": "Vlieghe72Cambodia 2007–  2010 2012 Salmonella  spp. 20 >16 – 33.9%"
        }
    },
    {
        "page_number": 7,
        "section_number": 27,
        "content": "Nair73U.K 2012–  2015 2016 Salmonella  spp. 15 6– >16 Macrolide resistance genes ( mphA , mphB",
        "metadata": {
            "section_title": "Nair73U.K 2012–  2015 2016 Salmonella  spp. 15 6– >16 Macrolide resistance genes ( mphA , mphB  "
        }
    },
    {
        "page_number": 7,
        "section_number": 28,
        "content": "or mefB )2.2%",
        "metadata": {
            "section_title": "or mefB )2.2%"
        }
    },
    {
        "page_number": 7,
        "section_number": 29,
        "content": "Benmessaoud69Morocco 2001–  2012 2016 Salmonella  spp. 1 – – 20%",
        "metadata": {
            "section_title": "Benmessaoud69Morocco 2001–  2012 2016 Salmonella  spp. 1 – – 20%"
        }
    },
    {
        "page_number": 7,
        "section_number": 30,
        "content": "Hoge71Thailand 1995–  1996 1998 Salmonella  spp. 2 >64 – 3%",
        "metadata": {
            "section_title": "Hoge71Thailand 1995–  1996 1998 Salmonella  spp. 2 >64 – 3%"
        }
    },
    {
        "page_number": 7,
        "section_number": 31,
        "content": "Brunner74Hungary 2014–  2015 2016 Neisseria gonorrhoeae 58 >0.5 – 30%",
        "metadata": {
            "section_title": "Brunner74Hungary 2014–  2015 2016 Neisseria gonorrhoeae 58 >0.5 – 30%"
        }
    },
    {
        "page_number": 7,
        "section_number": 32,
        "content": "Kulkarni75India 2013–  2016 2018 Neisseria gonorrhoeae 6 1– 8 – 5%",
        "metadata": {
            "section_title": "Kulkarni75India 2013–  2016 2018 Neisseria gonorrhoeae 6 1– 8 – 5%"
        }
    },
    {
        "page_number": 7,
        "section_number": 33,
        "content": "Cole76Europe 2011–  2012 2014 Neisseria gonorrhoeae 99 >0.5 – 5.3%",
        "metadata": {
            "section_title": "Cole76Europe 2011–  2012 2014 Neisseria gonorrhoeae 99 >0.5 – 5.3%"
        }
    },
    {
        "page_number": 7,
        "section_number": 34,
        "content": "Kirkcaldy58USA 2005–  2013 2017 Neisseria gonorrhoeae 175 ≥2 – 0.4%",
        "metadata": {
            "section_title": "Kirkcaldy58USA 2005–  2013 2017 Neisseria gonorrhoeae 175 ≥2 – 0.4%"
        }
    },
    {
        "page_number": 7,
        "section_number": 35,
        "content": "Buder77Germany 2014–  2015 2018 Neisseria gonorrhoeae 58 ≥0.5 – 10.8%",
        "metadata": {
            "section_title": "Buder77Germany 2014–  2015 2018 Neisseria gonorrhoeae 58 ≥0.5 – 10.8%"
        }
    },
    {
        "page_number": 7,
        "section_number": 36,
        "content": "Wind78Netherlands 2012–  2015 2017 Neisseria gonorrhoeae 38 >0.5 – 1.2%",
        "metadata": {
            "section_title": "Wind78Netherlands 2012–  2015 2017 Neisseria gonorrhoeae 38 >0.5 – 1.2%"
        }
    },
    {
        "page_number": 7,
        "section_number": 37,
        "content": "Liu79Taiwan 2001–  2013 2018 Neisseria gonorrhoeae 33 >0.5 – 14.6%",
        "metadata": {
            "section_title": "Liu79Taiwan 2001–  2013 2018 Neisseria gonorrhoeae 33 >0.5 – 14.6%"
        }
    },
    {
        "page_number": 7,
        "section_number": 38,
        "content": "Belkacem40France 2013–  2014 2016 Neisseria gonorrhoeae 9 >0.5 Mutation in rrl , mtrR , and rplD  genes 1%",
        "metadata": {
            "section_title": "Belkacem40France 2013–  2014 2016 Neisseria gonorrhoeae 9 >0.5 Mutation in rrl , mtrR , and rplD  genes 1%"
        }
    },
    {
        "page_number": 7,
        "section_number": 39,
        "content": "Latif80Zimbabwe 2015–  2016 2018 Neisseria gonorrhoeae 1 4 – 10%",
        "metadata": {
            "section_title": "Latif80Zimbabwe 2015–  2016 2018 Neisseria gonorrhoeae 1 4 – 10%"
        }
    },
    {
        "page_number": 7,
        "section_number": 40,
        "content": "Dillon57South America 1992– 2011 2013 Neisseria gonorrhoeae 1114 – – 10%",
        "metadata": {
            "section_title": "Dillon57South America 1992– 2011 2013 Neisseria gonorrhoeae 1114 – – 10%"
        }
    },
    {
        "page_number": 7,
        "section_number": 41,
        "content": "(Continues)",
        "metadata": {
            "section_title": "(Continues)"
        }
    },
    {
        "page_number": 8,
        "section_number": 1,
        "content": "8 of 16  |",
        "metadata": {
            "section_title": "8 of 16  |    "
        }
    },
    {
        "page_number": 8,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 8,
        "section_number": 3,
        "content": "First author CountryEnrollment",
        "metadata": {
            "section_title": "First author CountryEnrollment "
        }
    },
    {
        "page_number": 8,
        "section_number": 4,
        "content": "timePublished",
        "metadata": {
            "section_title": "timePublished "
        }
    },
    {
        "page_number": 8,
        "section_number": 5,
        "content": "time BacteriaNo. of",
        "metadata": {
            "section_title": "time BacteriaNo. of "
        }
    },
    {
        "page_number": 8,
        "section_number": 6,
        "content": "resistant",
        "metadata": {
            "section_title": "resistant "
        }
    },
    {
        "page_number": 8,
        "section_number": 7,
        "content": "bacteria MIC ( μg/ml) Resistance mechanismResistance",
        "metadata": {
            "section_title": "bacteria MIC ( μg/ml) Resistance mechanismResistance "
        }
    },
    {
        "page_number": 8,
        "section_number": 8,
        "content": "rate",
        "metadata": {
            "section_title": "rate"
        }
    },
    {
        "page_number": 8,
        "section_number": 9,
        "content": "Lahra81Australia 2015–  2016 2016 Neisseria gonorrhoeae 22 – – 1.7%",
        "metadata": {
            "section_title": "Lahra81Australia 2015–  2016 2016 Neisseria gonorrhoeae 22 – – 1.7%"
        }
    },
    {
        "page_number": 8,
        "section_number": 10,
        "content": "Vandepitte82Uganda 2008–  2009 2014 Neisseria gonorrhoeae 4 ≥0.75 – 2.7%",
        "metadata": {
            "section_title": "Vandepitte82Uganda 2008–  2009 2014 Neisseria gonorrhoeae 4 ≥0.75 – 2.7%"
        }
    },
    {
        "page_number": 8,
        "section_number": 11,
        "content": "Liang83China 2009–  2013 2016 Neisseria gonorrhoeae 77 ≥1 Mutations in 23S rRNA, mtrR  and penA",
        "metadata": {
            "section_title": "Liang83China 2009–  2013 2016 Neisseria gonorrhoeae 77 ≥1 Mutations in 23S rRNA, mtrR  and penA  "
        }
    },
    {
        "page_number": 8,
        "section_number": 12,
        "content": "genes15.9%",
        "metadata": {
            "section_title": "genes15.9%"
        }
    },
    {
        "page_number": 8,
        "section_number": 13,
        "content": "Li84China 2013–  2015 2018 Neisseria gonorrhoeae 11 >1 – 3.6%",
        "metadata": {
            "section_title": "Li84China 2013–  2015 2018 Neisseria gonorrhoeae 11 >1 – 3.6%"
        }
    },
    {
        "page_number": 8,
        "section_number": 14,
        "content": "Jiang85China 2014–  2015 2017 Neisseria gonorrhoeae 36 ≥1 Mutations in 23S rRNA and mtrR  genes 28.6%",
        "metadata": {
            "section_title": "Jiang85China 2014–  2015 2017 Neisseria gonorrhoeae 36 ≥1 Mutations in 23S rRNA and mtrR  genes 28.6%"
        }
    },
    {
        "page_number": 8,
        "section_number": 15,
        "content": "Yin86China 2013–  2016 2018 Neisseria gonorrhoeae 710 ≥1 – 18.6%",
        "metadata": {
            "section_title": "Yin86China 2013–  2016 2018 Neisseria gonorrhoeae 710 ≥1 – 18.6%"
        }
    },
    {
        "page_number": 8,
        "section_number": 16,
        "content": "Mitchell62USA 2000–  2004 2006 Treponema pallidum 46 – Mutations in 23S rRNA gene 37.1%",
        "metadata": {
            "section_title": "Mitchell62USA 2000–  2004 2006 Treponema pallidum 46 – Mutations in 23S rRNA gene 37.1%"
        }
    },
    {
        "page_number": 8,
        "section_number": 17,
        "content": "Chen87China 2008–  2011 2013 Treponema pallidum 194 – Mutations in 23S rRNA gene (A2058G",
        "metadata": {
            "section_title": "Chen87China 2008–  2011 2013 Treponema pallidum 194 – Mutations in 23S rRNA gene (A2058G "
        }
    },
    {
        "page_number": 8,
        "section_number": 18,
        "content": "mutations)91.9%",
        "metadata": {
            "section_title": "mutations)91.9%"
        }
    },
    {
        "page_number": 8,
        "section_number": 19,
        "content": "Muldoon88Ireland 2009–  2010 2012 Treponema pallidum 27 – A2058G mutations 93.1%",
        "metadata": {
            "section_title": "Muldoon88Ireland 2009–  2010 2012 Treponema pallidum 27 – A2058G mutations 93.1%"
        }
    },
    {
        "page_number": 8,
        "section_number": 20,
        "content": "Vaez89Iran 2018–  2019 2019 Haemophilus influenzae – – – 17.4%",
        "metadata": {
            "section_title": "Vaez89Iran 2018–  2019 2019 Haemophilus influenzae – – – 17.4%"
        }
    },
    {
        "page_number": 8,
        "section_number": 21,
        "content": "Clark59USA 2001–  2002 2002 Haemophilus influenzae 10 16– >128 Mutations in 23S rRNA and ribosomal",
        "metadata": {
            "section_title": "Clark59USA 2001–  2002 2002 Haemophilus influenzae 10 16– >128 Mutations in 23S rRNA and ribosomal "
        }
    },
    {
        "page_number": 8,
        "section_number": 22,
        "content": "proteins L4 and L22–",
        "metadata": {
            "section_title": "proteins L4 and L22– "
        }
    },
    {
        "page_number": 8,
        "section_number": 23,
        "content": "Boroumand90Iran 2014–  2015 2015 Haemophilus influenzae 2 – – 10%",
        "metadata": {
            "section_title": "Boroumand90Iran 2014–  2015 2015 Haemophilus influenzae 2 – – 10%"
        }
    },
    {
        "page_number": 8,
        "section_number": 24,
        "content": "Peric60USA 1997–  2000 2003 Haemophilus influenzae 82 >4 Ribosomal mutations 1.3%",
        "metadata": {
            "section_title": "Peric60USA 1997–  2000 2003 Haemophilus influenzae 82 >4 Ribosomal mutations 1.3%"
        }
    },
    {
        "page_number": 8,
        "section_number": 25,
        "content": "Jia91China 2002–  2016 2019 Legionella pneumophila 25 1.5– 2 Expression of efflux pump gene lpeAB 16.8%",
        "metadata": {
            "section_title": "Jia91China 2002–  2016 2019 Legionella pneumophila 25 1.5– 2 Expression of efflux pump gene lpeAB 16.8%"
        }
    },
    {
        "page_number": 8,
        "section_number": 26,
        "content": "Rahimi92Iran 2015–  2016 2017 Legionella pneumophila 7 – – 25.9%",
        "metadata": {
            "section_title": "Rahimi92Iran 2015–  2016 2017 Legionella pneumophila 7 – – 25.9%"
        }
    },
    {
        "page_number": 8,
        "section_number": 27,
        "content": "Wei93South Korea 2013–  2016 2018 Campylobacter  spp. 27 – Mutation in the 23S rRNA gene 71.1%",
        "metadata": {
            "section_title": "Wei93South Korea 2013–  2016 2018 Campylobacter  spp. 27 – Mutation in the 23S rRNA gene 71.1%"
        }
    },
    {
        "page_number": 8,
        "section_number": 28,
        "content": "Tang94China 2019–  2020 2020 Campylobacter  spp. 62 – Mutation in the 23S rRNA gene 66.7%",
        "metadata": {
            "section_title": "Tang94China 2019–  2020 2020 Campylobacter  spp. 62 – Mutation in the 23S rRNA gene 66.7%"
        }
    },
    {
        "page_number": 8,
        "section_number": 29,
        "content": "Efimochkina95Russia 2019–  2020 2020 Campylobacter jejuni 4 – Efflux pump CmeABC genes, mutations in",
        "metadata": {
            "section_title": "Efimochkina95Russia 2019–  2020 2020 Campylobacter jejuni 4 – Efflux pump CmeABC genes, mutations in "
        }
    },
    {
        "page_number": 8,
        "section_number": 30,
        "content": "23S rRNA sequence10%",
        "metadata": {
            "section_title": "23S rRNA sequence10%"
        }
    },
    {
        "page_number": 8,
        "section_number": 31,
        "content": "Hoge71Thailand 1981–  1995 1998 Campylobacter  spp. 13 – – 11.2%",
        "metadata": {
            "section_title": "Hoge71Thailand 1981–  1995 1998 Campylobacter  spp. 13 – – 11.2%"
        }
    },
    {
        "page_number": 8,
        "section_number": 32,
        "content": "Murphy96Thailand 1994–  1995 1996 Campylobacter  spp. 9 ≥8 – 31%TABLE 2  (Continued)",
        "metadata": {
            "section_title": "Murphy96Thailand 1994–  1995 1996 Campylobacter  spp. 9 ≥8 – 31%TABLE 2  (Continued)"
        }
    },
    {
        "page_number": 9,
        "section_number": 1,
        "content": "|  9 of 16",
        "metadata": {
            "section_title": "|  9 of 16"
        }
    },
    {
        "page_number": 9,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 9,
        "section_number": 3,
        "content": "in N. gonorrhoeae  isolated from STIs in the Netherlands reported 1.2%,",
        "metadata": {
            "section_title": "in N. gonorrhoeae  isolated from STIs in the Netherlands reported 1.2%, "
        }
    },
    {
        "page_number": 9,
        "section_number": 4,
        "content": "and the prevalence of isolates with intermediate MICs ( >0.25 and",
        "metadata": {
            "section_title": "and the prevalence of isolates with intermediate MICs ( >0.25 and "
        }
    },
    {
        "page_number": 9,
        "section_number": 5,
        "content": "≤0.5\tmg/L)\tincreased\tfrom\t3.7%\tin\t2012\tto\t8.6%\tin\t2015.78",
        "metadata": {
            "section_title": "≤0.5\tmg/L)\tincreased\tfrom\t3.7%\tin\t2012\tto\t8.6%\tin\t2015.78"
        }
    },
    {
        "page_number": 9,
        "section_number": 6,
        "content": "The epidemiology of AZM resistance in France during 2013–  2014",
        "metadata": {
            "section_title": "The epidemiology of AZM resistance in France during 2013–  2014 "
        }
    },
    {
        "page_number": 9,
        "section_number": 7,
        "content": "indicated, among the 970 N.  gonorrhoeae  isolates, the prevalence of",
        "metadata": {
            "section_title": "indicated, among the 970 N.  gonorrhoeae  isolates, the prevalence of "
        }
    },
    {
        "page_number": 9,
        "section_number": 8,
        "content": "AZM resistance and intermediate resistance was 1% and 4.6%, respec -",
        "metadata": {
            "section_title": "AZM resistance and intermediate resistance was 1% and 4.6%, respec -"
        }
    },
    {
        "page_number": 9,
        "section_number": 9,
        "content": "tively.40 The molecular analysis of isolates showed mutations in do -",
        "metadata": {
            "section_title": "tively.40 The molecular analysis of isolates showed mutations in do -"
        }
    },
    {
        "page_number": 9,
        "section_number": 10,
        "content": "main V of 23S rRNA, substitution and deletion in the mtrR  promoter,",
        "metadata": {
            "section_title": "main V of 23S rRNA, substitution and deletion in the mtrR  promoter, "
        }
    },
    {
        "page_number": 9,
        "section_number": 11,
        "content": "and mutations in the L4 ribosomal protein associated with AZM resis -",
        "metadata": {
            "section_title": "and mutations in the L4 ribosomal protein associated with AZM resis -"
        }
    },
    {
        "page_number": 9,
        "section_number": 12,
        "content": "tance.40 Moreover, the antibiotic assessment of N . gonorrhoeae  isolates",
        "metadata": {
            "section_title": "tance.40 Moreover, the antibiotic assessment of N . gonorrhoeae  isolates "
        }
    },
    {
        "page_number": 9,
        "section_number": 13,
        "content": "in two separates studies accomplished during 2014–  2015 reported",
        "metadata": {
            "section_title": "in two separates studies accomplished during 2014–  2015 reported "
        }
    },
    {
        "page_number": 9,
        "section_number": 14,
        "content": "30% of strains collected in Hungary and 10.8% of strains collected in",
        "metadata": {
            "section_title": "30% of strains collected in Hungary and 10.8% of strains collected in "
        }
    },
    {
        "page_number": 9,
        "section_number": 15,
        "content": "Germany were resistant to AZM.74,77 A cross-  sectional study on 331",
        "metadata": {
            "section_title": "Germany were resistant to AZM.74,77 A cross-  sectional study on 331 "
        }
    },
    {
        "page_number": 9,
        "section_number": 16,
        "content": "clinical isolates of S.  flexneri  serotype 3a was carried out between",
        "metadata": {
            "section_title": "clinical isolates of S.  flexneri  serotype 3a was carried out between "
        }
    },
    {
        "page_number": 9,
        "section_number": 17,
        "content": "December 1995 and June 2014 in the UK. The strains with high-  level",
        "metadata": {
            "section_title": "December 1995 and June 2014 in the UK. The strains with high-  level "
        }
    },
    {
        "page_number": 9,
        "section_number": 18,
        "content": "resistance to AZM (MIC 64 to > 256 mg/L) harbored the conjugative",
        "metadata": {
            "section_title": "resistance to AZM (MIC 64 to > 256 mg/L) harbored the conjugative "
        }
    },
    {
        "page_number": 9,
        "section_number": 19,
        "content": "R- plasmid pKSR100 that carried mphA  and ermB .68",
        "metadata": {
            "section_title": "R- plasmid pKSR100 that carried mphA  and ermB .68"
        }
    },
    {
        "page_number": 9,
        "section_number": 20,
        "content": "The detection of the prevalence and mechanism of resistance to",
        "metadata": {
            "section_title": "The detection of the prevalence and mechanism of resistance to "
        }
    },
    {
        "page_number": 9,
        "section_number": 21,
        "content": "AZM of 15 isolates of non-  typhoidal Salmonella enterica  in the UK",
        "metadata": {
            "section_title": "AZM of 15 isolates of non-  typhoidal Salmonella enterica  in the UK "
        }
    },
    {
        "page_number": 9,
        "section_number": 22,
        "content": "showed 2.2% of isolates had resistance or decreased susceptibility",
        "metadata": {
            "section_title": "showed 2.2% of isolates had resistance or decreased susceptibility "
        }
    },
    {
        "page_number": 9,
        "section_number": 23,
        "content": "to AZM (MIC 6 to > 16 mg/L) and the presence of plasmid or chromo -",
        "metadata": {
            "section_title": "to AZM (MIC 6 to > 16 mg/L) and the presence of plasmid or chromo -"
        }
    },
    {
        "page_number": 9,
        "section_number": 24,
        "content": "somally mediated genes including s mphA , mphB , and mefB  related",
        "metadata": {
            "section_title": "somally mediated genes including s mphA , mphB , and mefB  related "
        }
    },
    {
        "page_number": 9,
        "section_number": 25,
        "content": "to AZM resistance.73 The molecular analysis of T.  pallidum  AZM re -",
        "metadata": {
            "section_title": "to AZM resistance.73 The molecular analysis of T.  pallidum  AZM re -"
        }
    },
    {
        "page_number": 9,
        "section_number": 26,
        "content": "sistance in Ireland indicated 27 out of 29 strains had the A2058G",
        "metadata": {
            "section_title": "sistance in Ireland indicated 27 out of 29 strains had the A2058G "
        }
    },
    {
        "page_number": 9,
        "section_number": 27,
        "content": "mutation and mentioned that this antibiotic should not be suggested",
        "metadata": {
            "section_title": "mutation and mentioned that this antibiotic should not be suggested "
        }
    },
    {
        "page_number": 9,
        "section_number": 28,
        "content": "for the treatment of syphilis in Ireland.88",
        "metadata": {
            "section_title": "for the treatment of syphilis in Ireland.88"
        }
    },
    {
        "page_number": 9,
        "section_number": 29,
        "content": "3.2.4 | Africa",
        "metadata": {
            "section_title": "3.2.4 | Africa"
        }
    },
    {
        "page_number": 9,
        "section_number": 30,
        "content": "The assessment of antibiotic susceptibility of diarrhoeagenic bacteria",
        "metadata": {
            "section_title": "The assessment of antibiotic susceptibility of diarrhoeagenic bacteria "
        }
    },
    {
        "page_number": 9,
        "section_number": 31,
        "content": "collected from children in Morocco showed the prevalence of AZM re -",
        "metadata": {
            "section_title": "collected from children in Morocco showed the prevalence of AZM re -"
        }
    },
    {
        "page_number": 9,
        "section_number": 32,
        "content": "sistance of Shigella  spp., E. coli , and Salmonella  spp. was 11.1%, 15.5%,",
        "metadata": {
            "section_title": "sistance of Shigella  spp., E. coli , and Salmonella  spp. was 11.1%, 15.5%, "
        }
    },
    {
        "page_number": 9,
        "section_number": 33,
        "content": "and 20% respectively; however, the mechanisms involved in the antibi -",
        "metadata": {
            "section_title": "and 20% respectively; however, the mechanisms involved in the antibi -"
        }
    },
    {
        "page_number": 9,
        "section_number": 34,
        "content": "otic resistance of these isolates have not been identified.69 Moreover,",
        "metadata": {
            "section_title": "otic resistance of these isolates have not been identified.69 Moreover, "
        }
    },
    {
        "page_number": 9,
        "section_number": 35,
        "content": "the resistance rate of N. gonorrhoeae  isolates in two studies accom -",
        "metadata": {
            "section_title": "the resistance rate of N. gonorrhoeae  isolates in two studies accom -"
        }
    },
    {
        "page_number": 9,
        "section_number": 36,
        "content": "plished in Uganda and Zimbabwe ranged from 2.7% in 2008–  2009 to",
        "metadata": {
            "section_title": "plished in Uganda and Zimbabwe ranged from 2.7% in 2008–  2009 to "
        }
    },
    {
        "page_number": 9,
        "section_number": 37,
        "content": "20% in 2015–  2016 respectively.80,82 Few studies have been performed",
        "metadata": {
            "section_title": "20% in 2015–  2016 respectively.80,82 Few studies have been performed "
        }
    },
    {
        "page_number": 9,
        "section_number": 38,
        "content": "on the molecular mechanism of resistance in AZM-  resistant isolates. A",
        "metadata": {
            "section_title": "on the molecular mechanism of resistance in AZM-  resistant isolates. A "
        }
    },
    {
        "page_number": 9,
        "section_number": 39,
        "content": "study in South Africa assessed two macrolide resistance Streptococcus",
        "metadata": {
            "section_title": "study in South Africa assessed two macrolide resistance Streptococcus "
        }
    },
    {
        "page_number": 9,
        "section_number": 40,
        "content": "pneumoniae  isolates and found the novel mechanism of resistance due",
        "metadata": {
            "section_title": "pneumoniae  isolates and found the novel mechanism of resistance due "
        }
    },
    {
        "page_number": 9,
        "section_number": 41,
        "content": "to a 6 bp deletion in the gene encoding riboprotein L4.66",
        "metadata": {
            "section_title": "to a 6 bp deletion in the gene encoding riboprotein L4.66"
        }
    },
    {
        "page_number": 9,
        "section_number": 42,
        "content": "4 | SYNERGISM",
        "metadata": {
            "section_title": "4 | SYNERGISM"
        }
    },
    {
        "page_number": 9,
        "section_number": 43,
        "content": "4.1 | Synergism against Plasmodium falciparum",
        "metadata": {
            "section_title": "4.1 | Synergism against Plasmodium falciparum"
        }
    },
    {
        "page_number": 9,
        "section_number": 44,
        "content": "Chloroquine (CQ) is a drug that contains quinoline (a heterocyclic",
        "metadata": {
            "section_title": "Chloroquine (CQ) is a drug that contains quinoline (a heterocyclic "
        }
    },
    {
        "page_number": 9,
        "section_number": 45,
        "content": "aromatic organic compound with the chemical formula C9H7N)",
        "metadata": {
            "section_title": "aromatic organic compound with the chemical formula C9H7N) "
        }
    },
    {
        "page_number": 9,
        "section_number": 46,
        "content": "and has a successful history in malaria treatment.97 Ohrt et al.",
        "metadata": {
            "section_title": "and has a successful history in malaria treatment.97 Ohrt et al. "
        }
    },
    {
        "page_number": 9,
        "section_number": 47,
        "content": "demonstrated that CQ/AZM combination is efficacious against",
        "metadata": {
            "section_title": "demonstrated that CQ/AZM combination is efficacious against "
        }
    },
    {
        "page_number": 9,
        "section_number": 48,
        "content": "CQ- resistant Plasmodium falciparum (P.  falciparum)  and AZM has an additive to synergistic activity on CQ in vitro and this therapy",
        "metadata": {
            "section_title": "CQ- resistant Plasmodium falciparum (P.  falciparum)  and AZM has an additive to synergistic activity on CQ in vitro and this therapy "
        }
    },
    {
        "page_number": 9,
        "section_number": 49,
        "content": "should be evaluated for malaria prophylaxis.98 In an Indian study,",
        "metadata": {
            "section_title": "should be evaluated for malaria prophylaxis.98 In an Indian study, "
        }
    },
    {
        "page_number": 9,
        "section_number": 50,
        "content": "it was indicated that CQ/AZM combination is much more effec -",
        "metadata": {
            "section_title": "it was indicated that CQ/AZM combination is much more effec -"
        }
    },
    {
        "page_number": 9,
        "section_number": 51,
        "content": "tive than AZM or CQ alone as single-  drug therapy in P.  falciparum",
        "metadata": {
            "section_title": "tive than AZM or CQ alone as single-  drug therapy in P.  falciparum  "
        }
    },
    {
        "page_number": 9,
        "section_number": 52,
        "content": "treatment.99",
        "metadata": {
            "section_title": "treatment.99"
        }
    },
    {
        "page_number": 9,
        "section_number": 53,
        "content": "To discover the reason behind this synergy, Cook et al. performed",
        "metadata": {
            "section_title": "To discover the reason behind this synergy, Cook et al. performed "
        }
    },
    {
        "page_number": 9,
        "section_number": 54,
        "content": "a study, which revealed that synergism is not due to a systemic drug–",
        "metadata": {
            "section_title": "a study, which revealed that synergism is not due to a systemic drug– "
        }
    },
    {
        "page_number": 9,
        "section_number": 55,
        "content": "drug interaction or the following factors: (1) the enhancement of ex -",
        "metadata": {
            "section_title": "drug interaction or the following factors: (1) the enhancement of ex -"
        }
    },
    {
        "page_number": 9,
        "section_number": 56,
        "content": "posure to one or both drugs because of improved bioavailability; (2)",
        "metadata": {
            "section_title": "posure to one or both drugs because of improved bioavailability; (2) "
        }
    },
    {
        "page_number": 9,
        "section_number": 57,
        "content": "a decrease in clearance.100 Nakornchai et al. also support the fact",
        "metadata": {
            "section_title": "a decrease in clearance.100 Nakornchai et al. also support the fact "
        }
    },
    {
        "page_number": 9,
        "section_number": 58,
        "content": "that there is a range of additive to synergistic effects in CQ/AZM",
        "metadata": {
            "section_title": "that there is a range of additive to synergistic effects in CQ/AZM "
        }
    },
    {
        "page_number": 9,
        "section_number": 59,
        "content": "combination in vitro.101",
        "metadata": {
            "section_title": "combination in vitro.101"
        }
    },
    {
        "page_number": 9,
        "section_number": 60,
        "content": "A study was conducted by Pereira et al.102 which showed that",
        "metadata": {
            "section_title": "A study was conducted by Pereira et al.102 which showed that "
        }
    },
    {
        "page_number": 9,
        "section_number": 61,
        "content": "CQ- resistant isolates become more susceptible to CQ in high",
        "metadata": {
            "section_title": "CQ- resistant isolates become more susceptible to CQ in high "
        }
    },
    {
        "page_number": 9,
        "section_number": 62,
        "content": "concentrations of AZM. They also mentioned that to achieve a",
        "metadata": {
            "section_title": "concentrations of AZM. They also mentioned that to achieve a "
        }
    },
    {
        "page_number": 9,
        "section_number": 63,
        "content": "maximum degree of antimalarial activity, CQ and AZM should be",
        "metadata": {
            "section_title": "maximum degree of antimalarial activity, CQ and AZM should be "
        }
    },
    {
        "page_number": 9,
        "section_number": 64,
        "content": "administered in a dose such that their potency becomes equivalent",
        "metadata": {
            "section_title": "administered in a dose such that their potency becomes equivalent "
        }
    },
    {
        "page_number": 9,
        "section_number": 65,
        "content": "(1:1 ratio), although pediatric subjects should take a higher dose of",
        "metadata": {
            "section_title": "(1:1 ratio), although pediatric subjects should take a higher dose of "
        }
    },
    {
        "page_number": 9,
        "section_number": 66,
        "content": "this combination due to higher drug clearance in their body.103 In",
        "metadata": {
            "section_title": "this combination due to higher drug clearance in their body.103 In "
        }
    },
    {
        "page_number": 9,
        "section_number": 67,
        "content": "addition, Phiri et al. noted that CQ/AZM combination can still be",
        "metadata": {
            "section_title": "addition, Phiri et al. noted that CQ/AZM combination can still be "
        }
    },
    {
        "page_number": 9,
        "section_number": 68,
        "content": "a viable intermittent preventive treatment option in P.  falciparum -",
        "metadata": {
            "section_title": "a viable intermittent preventive treatment option in P.  falciparum - "
        }
    },
    {
        "page_number": 9,
        "section_number": 69,
        "content": "infected pregnant women in an open-  label, non-  comparative out-",
        "metadata": {
            "section_title": "infected pregnant women in an open-  label, non-  comparative out-  "
        }
    },
    {
        "page_number": 9,
        "section_number": 70,
        "content": "patient study.104",
        "metadata": {
            "section_title": "patient study.104"
        }
    },
    {
        "page_number": 9,
        "section_number": 71,
        "content": "A study conducted by Kshirsagar et al. in adults with acute un -",
        "metadata": {
            "section_title": "A study conducted by Kshirsagar et al. in adults with acute un -"
        }
    },
    {
        "page_number": 9,
        "section_number": 72,
        "content": "complicated P. falciparum  malaria showed that the efficacy of CQ/",
        "metadata": {
            "section_title": "complicated P. falciparum  malaria showed that the efficacy of CQ/"
        }
    },
    {
        "page_number": 9,
        "section_number": 73,
        "content": "AZM treatment is dependent on the dose. In other words, adminis -",
        "metadata": {
            "section_title": "AZM treatment is dependent on the dose. In other words, adminis -"
        }
    },
    {
        "page_number": 9,
        "section_number": 74,
        "content": "tration of 2 g AZM + 600 mg CQ had higher efficacy compared to",
        "metadata": {
            "section_title": "tration of 2 g AZM + 600 mg CQ had higher efficacy compared to "
        }
    },
    {
        "page_number": 9,
        "section_number": 75,
        "content": "1000 or 500 mg AZM + 600  mg CQ.105",
        "metadata": {
            "section_title": "1000 or 500 mg AZM + 600  mg CQ.105"
        }
    },
    {
        "page_number": 9,
        "section_number": 76,
        "content": "Quinine is also a quinoline-  containing drug that is effective",
        "metadata": {
            "section_title": "Quinine is also a quinoline-  containing drug that is effective "
        }
    },
    {
        "page_number": 9,
        "section_number": 77,
        "content": "against P. falciparum - induced malaria.97 It is claimed that Quinine/",
        "metadata": {
            "section_title": "against P. falciparum - induced malaria.97 It is claimed that Quinine/"
        }
    },
    {
        "page_number": 9,
        "section_number": 78,
        "content": "AZM drug therapy is the best way to counteract MDR-  resistant",
        "metadata": {
            "section_title": "AZM drug therapy is the best way to counteract MDR-  resistant "
        }
    },
    {
        "page_number": 9,
        "section_number": 79,
        "content": "P. falciparum  in vitro.101 A randomized, dose-  ranging study in",
        "metadata": {
            "section_title": "P. falciparum  in vitro.101 A randomized, dose-  ranging study in "
        }
    },
    {
        "page_number": 9,
        "section_number": 80,
        "content": "Thailand indicated that the combination of Quinine/AZM (qui -",
        "metadata": {
            "section_title": "Thailand indicated that the combination of Quinine/AZM (qui -"
        }
    },
    {
        "page_number": 9,
        "section_number": 81,
        "content": "nine:\t30\tmg\tsalt/kg\tdivided\t three\ttimes\ta\tday\tand\tAZM:\t≥1\tg/",
        "metadata": {
            "section_title": "nine:\t30\tmg\tsalt/kg\tdivided\t three\ttimes\ta\tday\tand\tAZM:\t≥1\tg/"
        }
    },
    {
        "page_number": 9,
        "section_number": 82,
        "content": "day for 3 days) was effective against MDR-  resistant P.  falciparum",
        "metadata": {
            "section_title": "day for 3 days) was effective against MDR-  resistant P.  falciparum  "
        }
    },
    {
        "page_number": 9,
        "section_number": 83,
        "content": "malaria.106",
        "metadata": {
            "section_title": "malaria.106"
        }
    },
    {
        "page_number": 9,
        "section_number": 84,
        "content": "In a case of uncomplicated P.  falciparum  malaria, a randomized,",
        "metadata": {
            "section_title": "In a case of uncomplicated P.  falciparum  malaria, a randomized, "
        }
    },
    {
        "page_number": 9,
        "section_number": 85,
        "content": "phase 2 clinical trial was conducted in Thailand, which showed",
        "metadata": {
            "section_title": "phase 2 clinical trial was conducted in Thailand, which showed "
        }
    },
    {
        "page_number": 9,
        "section_number": 86,
        "content": "high cure rates for Quinine/AZM combination plus quinine, for a",
        "metadata": {
            "section_title": "high cure rates for Quinine/AZM combination plus quinine, for a "
        }
    },
    {
        "page_number": 9,
        "section_number": 87,
        "content": "total dose of 4.5 g of AZM plus 60 mg/kg quinine or 3 days of AZM",
        "metadata": {
            "section_title": "total dose of 4.5 g of AZM plus 60 mg/kg quinine or 3 days of AZM "
        }
    },
    {
        "page_number": 9,
        "section_number": 88,
        "content": "plus quinine. This study also demonstrated that AZM, which is a",
        "metadata": {
            "section_title": "plus quinine. This study also demonstrated that AZM, which is a "
        }
    },
    {
        "page_number": 9,
        "section_number": 89,
        "content": "slow-  acting drug, should be combined with a fast-  acting drug to",
        "metadata": {
            "section_title": "slow-  acting drug, should be combined with a fast-  acting drug to "
        }
    },
    {
        "page_number": 9,
        "section_number": 90,
        "content": "reach a quicker initial parasite clearance.107 Noedl et al. mentioned",
        "metadata": {
            "section_title": "reach a quicker initial parasite clearance.107 Noedl et al. mentioned "
        }
    },
    {
        "page_number": 9,
        "section_number": 91,
        "content": "that quinine can be a promising partner for AZM. The strongest",
        "metadata": {
            "section_title": "that quinine can be a promising partner for AZM. The strongest "
        }
    },
    {
        "page_number": 9,
        "section_number": 92,
        "content": "propensity toward synergy was seen in a combination ratio of",
        "metadata": {
            "section_title": "propensity toward synergy was seen in a combination ratio of "
        }
    },
    {
        "page_number": 9,
        "section_number": 93,
        "content": "1:44.108",
        "metadata": {
            "section_title": "1:44.108"
        }
    },
    {
        "page_number": 9,
        "section_number": 94,
        "content": "Dihydroartemisinin (DHA), an artemisinin derivative, is a drug",
        "metadata": {
            "section_title": "Dihydroartemisinin (DHA), an artemisinin derivative, is a drug "
        }
    },
    {
        "page_number": 9,
        "section_number": 95,
        "content": "used to treat malaria. Results showed that a 3-  day combination of",
        "metadata": {
            "section_title": "used to treat malaria. Results showed that a 3-  day combination of "
        }
    },
    {
        "page_number": 9,
        "section_number": 96,
        "content": "dihydroartemisinin with AZM (dihydroartemisinin 80  mg or 4 tablets",
        "metadata": {
            "section_title": "dihydroartemisinin with AZM (dihydroartemisinin 80  mg or 4 tablets "
        }
    },
    {
        "page_number": 9,
        "section_number": 97,
        "content": "together with AZM 500 mg (2 capsules) for 3 days) yielded an ap -",
        "metadata": {
            "section_title": "together with AZM 500 mg (2 capsules) for 3 days) yielded an ap -"
        }
    },
    {
        "page_number": 9,
        "section_number": 98,
        "content": "proximately 70% cure rate, and this regimen can be a proper regimen",
        "metadata": {
            "section_title": "proximately 70% cure rate, and this regimen can be a proper regimen "
        }
    },
    {
        "page_number": 9,
        "section_number": 99,
        "content": "for children and pregnant women and areas where a parasitological",
        "metadata": {
            "section_title": "for children and pregnant women and areas where a parasitological "
        }
    },
    {
        "page_number": 9,
        "section_number": 100,
        "content": "diagnosis is not available.109",
        "metadata": {
            "section_title": "diagnosis is not available.109"
        }
    },
    {
        "page_number": 10,
        "section_number": 1,
        "content": "10 of 16  |",
        "metadata": {
            "section_title": "10 of 16  |    "
        }
    },
    {
        "page_number": 10,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 10,
        "section_number": 3,
        "content": "4.2 | Synergism against Pythium insidiosum",
        "metadata": {
            "section_title": "4.2 | Synergism against Pythium insidiosum"
        }
    },
    {
        "page_number": 10,
        "section_number": 4,
        "content": "Pythiosis is a zoonosis disease caused by a fungus-  like pathogen,",
        "metadata": {
            "section_title": "Pythiosis is a zoonosis disease caused by a fungus-  like pathogen, "
        }
    },
    {
        "page_number": 10,
        "section_number": 5,
        "content": "named Pythium insidiosum ( P. insidiosum ), which presents many",
        "metadata": {
            "section_title": "named Pythium insidiosum ( P. insidiosum ), which presents many "
        }
    },
    {
        "page_number": 10,
        "section_number": 6,
        "content": "clinical manifestations based on the type of infection.110 Jesus",
        "metadata": {
            "section_title": "clinical manifestations based on the type of infection.110 Jesus "
        }
    },
    {
        "page_number": 10,
        "section_number": 7,
        "content": "et al. demonstrated that AZM has synergistic effects with some",
        "metadata": {
            "section_title": "et al. demonstrated that AZM has synergistic effects with some "
        }
    },
    {
        "page_number": 10,
        "section_number": 8,
        "content": "antifungal agents such as terbinafine, amphotericin B, itraconazole,",
        "metadata": {
            "section_title": "antifungal agents such as terbinafine, amphotericin B, itraconazole, "
        }
    },
    {
        "page_number": 10,
        "section_number": 9,
        "content": "voriconazole, micafungin, caspofungin, and anidulafungin against",
        "metadata": {
            "section_title": "voriconazole, micafungin, caspofungin, and anidulafungin against "
        }
    },
    {
        "page_number": 10,
        "section_number": 10,
        "content": "P. insidiosum  in vitro.111 Furthermore, in another study, AZM showed",
        "metadata": {
            "section_title": "P. insidiosum  in vitro.111 Furthermore, in another study, AZM showed "
        }
    },
    {
        "page_number": 10,
        "section_number": 11,
        "content": "a synergistic effect with Carvacrol and Thymol against P.  insidiosum",
        "metadata": {
            "section_title": "a synergistic effect with Carvacrol and Thymol against P.  insidiosum  "
        }
    },
    {
        "page_number": 10,
        "section_number": 12,
        "content": "in vitro.112",
        "metadata": {
            "section_title": "in vitro.112"
        }
    },
    {
        "page_number": 10,
        "section_number": 13,
        "content": "A lack of antagonism between AZM and topical drugs such as",
        "metadata": {
            "section_title": "A lack of antagonism between AZM and topical drugs such as "
        }
    },
    {
        "page_number": 10,
        "section_number": 14,
        "content": "benzalkonium, cetrimide, cetylpyridinium, mupirocin, and triclosan",
        "metadata": {
            "section_title": "benzalkonium, cetrimide, cetylpyridinium, mupirocin, and triclosan "
        }
    },
    {
        "page_number": 10,
        "section_number": 15,
        "content": "in vitro and a lack of topical therapeutics against P. insidiosum  sug-",
        "metadata": {
            "section_title": "in vitro and a lack of topical therapeutics against P. insidiosum  sug-"
        }
    },
    {
        "page_number": 10,
        "section_number": 16,
        "content": "gests that these combinations may provide a potential therapy for",
        "metadata": {
            "section_title": "gests that these combinations may provide a potential therapy for "
        }
    },
    {
        "page_number": 10,
        "section_number": 17,
        "content": "pythiosis treatment.113 In vivo studies showed that AZM could be a",
        "metadata": {
            "section_title": "pythiosis treatment.113 In vivo studies showed that AZM could be a "
        }
    },
    {
        "page_number": 10,
        "section_number": 18,
        "content": "remarkable anti-  P. insidiosum  therapy in combination with minocy -",
        "metadata": {
            "section_title": "remarkable anti-  P. insidiosum  therapy in combination with minocy -"
        }
    },
    {
        "page_number": 10,
        "section_number": 19,
        "content": "cline or alone.114",
        "metadata": {
            "section_title": "cline or alone.114"
        }
    },
    {
        "page_number": 10,
        "section_number": 20,
        "content": "4.3 | Synergism against Naegleria fowleri",
        "metadata": {
            "section_title": "4.3 | Synergism against Naegleria fowleri"
        }
    },
    {
        "page_number": 10,
        "section_number": 21,
        "content": "Naegleria fowleri  is an ameba that causes a rapidly fatal infec -",
        "metadata": {
            "section_title": "Naegleria fowleri  is an ameba that causes a rapidly fatal infec -"
        }
    },
    {
        "page_number": 10,
        "section_number": 22,
        "content": "tion called primary amebic meningoencephalitis (PAM) in humans.",
        "metadata": {
            "section_title": "tion called primary amebic meningoencephalitis (PAM) in humans. "
        }
    },
    {
        "page_number": 10,
        "section_number": 23,
        "content": "Amphotericin B, a broad-  spectrum drug, acts against most human",
        "metadata": {
            "section_title": "Amphotericin B, a broad-  spectrum drug, acts against most human "
        }
    },
    {
        "page_number": 10,
        "section_number": 24,
        "content": "fungal pathogens and is used to treat PAM.115 Soltow et al. men -",
        "metadata": {
            "section_title": "fungal pathogens and is used to treat PAM.115 Soltow et al. men -"
        }
    },
    {
        "page_number": 10,
        "section_number": 25,
        "content": "tioned that AZM has synergistic effects with amphotericin B against",
        "metadata": {
            "section_title": "tioned that AZM has synergistic effects with amphotericin B against "
        }
    },
    {
        "page_number": 10,
        "section_number": 26,
        "content": "Naegleria fowleri ; each of these drugs had less than 50% efficacy",
        "metadata": {
            "section_title": "Naegleria fowleri ; each of these drugs had less than 50% efficacy "
        }
    },
    {
        "page_number": 10,
        "section_number": 27,
        "content": "while administrated alone; however, when they were utilized with",
        "metadata": {
            "section_title": "while administrated alone; however, when they were utilized with "
        }
    },
    {
        "page_number": 10,
        "section_number": 28,
        "content": "each other, the combination had 100% efficacy in vitro; therefore, it",
        "metadata": {
            "section_title": "each other, the combination had 100% efficacy in vitro; therefore, it "
        }
    },
    {
        "page_number": 10,
        "section_number": 29,
        "content": "might be an acceptable regimen to treat PAM.116",
        "metadata": {
            "section_title": "might be an acceptable regimen to treat PAM.116"
        }
    },
    {
        "page_number": 10,
        "section_number": 30,
        "content": "4.4 | Synergism against Pseudomonas aeruginosa",
        "metadata": {
            "section_title": "4.4 | Synergism against Pseudomonas aeruginosa"
        }
    },
    {
        "page_number": 10,
        "section_number": 31,
        "content": "Due to increasing CIP-  resistant P.  aeruginosa  isolates, new ap -",
        "metadata": {
            "section_title": "Due to increasing CIP-  resistant P.  aeruginosa  isolates, new ap -"
        }
    },
    {
        "page_number": 10,
        "section_number": 32,
        "content": "proaches should be further investigated to treat the caused infec -",
        "metadata": {
            "section_title": "proaches should be further investigated to treat the caused infec -"
        }
    },
    {
        "page_number": 10,
        "section_number": 33,
        "content": "tions.117 Combination therapy might be the key to this subject. After",
        "metadata": {
            "section_title": "tions.117 Combination therapy might be the key to this subject. After "
        }
    },
    {
        "page_number": 10,
        "section_number": 34,
        "content": "the synergism of CIP and AZM was confirmed in vitro, on the peak",
        "metadata": {
            "section_title": "the synergism of CIP and AZM was confirmed in vitro, on the peak "
        }
    },
    {
        "page_number": 10,
        "section_number": 35,
        "content": "infection day, the use of CIP/AZM combination improved clearance",
        "metadata": {
            "section_title": "infection day, the use of CIP/AZM combination improved clearance "
        }
    },
    {
        "page_number": 10,
        "section_number": 36,
        "content": "from the kidney and bladder and exhibited anti-  inflammatory and",
        "metadata": {
            "section_title": "from the kidney and bladder and exhibited anti-  inflammatory and "
        }
    },
    {
        "page_number": 10,
        "section_number": 37,
        "content": "immunomodulatory effects in P.  aeruginosa  biofilm induced acute",
        "metadata": {
            "section_title": "immunomodulatory effects in P.  aeruginosa  biofilm induced acute "
        }
    },
    {
        "page_number": 10,
        "section_number": 38,
        "content": "pyelonephritis.118 Saini et al. showed that this combination can also",
        "metadata": {
            "section_title": "pyelonephritis.118 Saini et al. showed that this combination can also "
        }
    },
    {
        "page_number": 10,
        "section_number": 39,
        "content": "be used as a material to construct a special catheter that prevents",
        "metadata": {
            "section_title": "be used as a material to construct a special catheter that prevents "
        }
    },
    {
        "page_number": 10,
        "section_number": 40,
        "content": "catheter-  associated urinary tract infections in vitro.119",
        "metadata": {
            "section_title": "catheter-  associated urinary tract infections in vitro.119"
        }
    },
    {
        "page_number": 10,
        "section_number": 41,
        "content": "The efficacy of a novel CIP/AZM sinus stent (CASS) was evalu -",
        "metadata": {
            "section_title": "The efficacy of a novel CIP/AZM sinus stent (CASS) was evalu -"
        }
    },
    {
        "page_number": 10,
        "section_number": 42,
        "content": "ated in a subsequent study, and results showed that CASS delivers a",
        "metadata": {
            "section_title": "ated in a subsequent study, and results showed that CASS delivers a "
        }
    },
    {
        "page_number": 10,
        "section_number": 43,
        "content": "sustainable amount of CIP and AZM which causes antibiofilm activ -",
        "metadata": {
            "section_title": "sustainable amount of CIP and AZM which causes antibiofilm activ -"
        }
    },
    {
        "page_number": 10,
        "section_number": 44,
        "content": "ity against P. aeruginosa  in vitro.120 Lim et al. also demonstrated that",
        "metadata": {
            "section_title": "ity against P. aeruginosa  in vitro.120 Lim et al. also demonstrated that "
        }
    },
    {
        "page_number": 10,
        "section_number": 45,
        "content": "the attainable dose of AZM released from CASS showed significant",
        "metadata": {
            "section_title": "the attainable dose of AZM released from CASS showed significant "
        }
    },
    {
        "page_number": 10,
        "section_number": 46,
        "content": "anti-  inflammatory activity by successfully reducing LPS-  stimulated",
        "metadata": {
            "section_title": "anti-  inflammatory activity by successfully reducing LPS-  stimulated "
        }
    },
    {
        "page_number": 10,
        "section_number": 47,
        "content": "IL- 8 secreted from P. aeruginosa  in human sinonasal epithelial cells",
        "metadata": {
            "section_title": "IL- 8 secreted from P. aeruginosa  in human sinonasal epithelial cells "
        }
    },
    {
        "page_number": 10,
        "section_number": 48,
        "content": "without compromising their integrity.121 In another study, Raouf et al. noted that CIP/AZM combination, either in free form or as",
        "metadata": {
            "section_title": "without compromising their integrity.121 In another study, Raouf et al. noted that CIP/AZM combination, either in free form or as "
        }
    },
    {
        "page_number": 10,
        "section_number": 49,
        "content": "nanoparticles on a chitosan nanocarrier, showed promising re -",
        "metadata": {
            "section_title": "nanoparticles on a chitosan nanocarrier, showed promising re -"
        }
    },
    {
        "page_number": 10,
        "section_number": 50,
        "content": "sults including improved survival, decreased bacteriological count,",
        "metadata": {
            "section_title": "sults including improved survival, decreased bacteriological count, "
        }
    },
    {
        "page_number": 10,
        "section_number": 51,
        "content": "and better wound healing against CIP-  resistant biofilm-  producing",
        "metadata": {
            "section_title": "and better wound healing against CIP-  resistant biofilm-  producing "
        }
    },
    {
        "page_number": 10,
        "section_number": 52,
        "content": "P. aeruginosa  strains.122",
        "metadata": {
            "section_title": "P. aeruginosa  strains.122"
        }
    },
    {
        "page_number": 10,
        "section_number": 53,
        "content": "4.5 | Synergism against Escherichia coli",
        "metadata": {
            "section_title": "4.5 | Synergism against Escherichia coli"
        }
    },
    {
        "page_number": 10,
        "section_number": 54,
        "content": "Colistin, also called polymyxin E, is a molecule that is often used",
        "metadata": {
            "section_title": "Colistin, also called polymyxin E, is a molecule that is often used "
        }
    },
    {
        "page_number": 10,
        "section_number": 55,
        "content": "as a last-  line therapy to treat MDR-  resistant Gram-  negative bacte -",
        "metadata": {
            "section_title": "as a last-  line therapy to treat MDR-  resistant Gram-  negative bacte -"
        }
    },
    {
        "page_number": 10,
        "section_number": 56,
        "content": "ria and can be administered either intravenously or in oral form.123",
        "metadata": {
            "section_title": "ria and can be administered either intravenously or in oral form.123 "
        }
    },
    {
        "page_number": 10,
        "section_number": 57,
        "content": "Li et al. demonstrated that synergistic effects were seen during a",
        "metadata": {
            "section_title": "Li et al. demonstrated that synergistic effects were seen during a "
        }
    },
    {
        "page_number": 10,
        "section_number": 58,
        "content": "high dose of AZM administration with colistin against colistin-",
        "metadata": {
            "section_title": "high dose of AZM administration with colistin against colistin- "
        }
    },
    {
        "page_number": 10,
        "section_number": 59,
        "content": "resistant Escherichia coli  isolates in vitro. Indeed, 1 or 2 mg/liter",
        "metadata": {
            "section_title": "resistant Escherichia coli  isolates in vitro. Indeed, 1 or 2 mg/liter "
        }
    },
    {
        "page_number": 10,
        "section_number": 60,
        "content": "colistin + 2.5 mg/L AZM showed an eradication effect by 48 h in",
        "metadata": {
            "section_title": "colistin + 2.5 mg/L AZM showed an eradication effect by 48 h in "
        }
    },
    {
        "page_number": 10,
        "section_number": 61,
        "content": "MZ1501R isolates in vivo.124",
        "metadata": {
            "section_title": "MZ1501R isolates in vivo.124"
        }
    },
    {
        "page_number": 10,
        "section_number": 62,
        "content": "4.6 | Synergism against Neisseria gonorrhoeae",
        "metadata": {
            "section_title": "4.6 | Synergism against Neisseria gonorrhoeae"
        }
    },
    {
        "page_number": 10,
        "section_number": 63,
        "content": "Ceftriaxone (CRO) 250 mg intramuscular (IM) as a single dose +AZM",
        "metadata": {
            "section_title": "Ceftriaxone (CRO) 250 mg intramuscular (IM) as a single dose +AZM "
        }
    },
    {
        "page_number": 10,
        "section_number": 64,
        "content": "1 g orally as a single dose or cefixime (CFIX) 400 mg orally as a sin -",
        "metadata": {
            "section_title": "1 g orally as a single dose or cefixime (CFIX) 400 mg orally as a sin -"
        }
    },
    {
        "page_number": 10,
        "section_number": 65,
        "content": "gle dose + AZM 1 g orally as a single dose are suggested as dual",
        "metadata": {
            "section_title": "gle dose + AZM 1 g orally as a single dose are suggested as dual "
        }
    },
    {
        "page_number": 10,
        "section_number": 66,
        "content": "therapies for N.  gonorrhoeae  genital or anorectal infections treat -",
        "metadata": {
            "section_title": "therapies for N.  gonorrhoeae  genital or anorectal infections treat -"
        }
    },
    {
        "page_number": 10,
        "section_number": 67,
        "content": "ment by WHO.125 Furuya et al. evaluated the synergy between",
        "metadata": {
            "section_title": "ment by WHO.125 Furuya et al. evaluated the synergy between "
        }
    },
    {
        "page_number": 10,
        "section_number": 68,
        "content": "CFIX, cefteram (CFTM), and amoxicillin (AMX) with AZM, and the",
        "metadata": {
            "section_title": "CFIX, cefteram (CFTM), and amoxicillin (AMX) with AZM, and the "
        }
    },
    {
        "page_number": 10,
        "section_number": 69,
        "content": "results demonstrated that CFIX/AZM combination showed a greater",
        "metadata": {
            "section_title": "results demonstrated that CFIX/AZM combination showed a greater "
        }
    },
    {
        "page_number": 10,
        "section_number": 70,
        "content": "synergy in comparison with CFTM/AZM or amoxicillin/AZM (32% in",
        "metadata": {
            "section_title": "synergy in comparison with CFTM/AZM or amoxicillin/AZM (32% in "
        }
    },
    {
        "page_number": 10,
        "section_number": 71,
        "content": "comparison with 12% and 4%) in vitro.126 Onodera et al. introduced",
        "metadata": {
            "section_title": "comparison with 12% and 4%) in vitro.126 Onodera et al. introduced "
        }
    },
    {
        "page_number": 10,
        "section_number": 72,
        "content": "clavulanic acid/amoxicillin (CVA/AMPC)  + AZM and CFTM/AZM",
        "metadata": {
            "section_title": "clavulanic acid/amoxicillin (CVA/AMPC)  + AZM and CFTM/AZM "
        }
    },
    {
        "page_number": 10,
        "section_number": 73,
        "content": "as alternative strategies to treat CFIX-  resistant N.  gonorrhoeae .127",
        "metadata": {
            "section_title": "as alternative strategies to treat CFIX-  resistant N.  gonorrhoeae .127 "
        }
    },
    {
        "page_number": 10,
        "section_number": 74,
        "content": "Singh et al. noted that synergistic or additive effects were displayed",
        "metadata": {
            "section_title": "Singh et al. noted that synergistic or additive effects were displayed "
        }
    },
    {
        "page_number": 10,
        "section_number": 75,
        "content": "in WHO-  recommended treatment without any antagonism in vitro.",
        "metadata": {
            "section_title": "in WHO-  recommended treatment without any antagonism in vitro. "
        }
    },
    {
        "page_number": 10,
        "section_number": 76,
        "content": "The absence of antagonism is the reason for the continuation of this",
        "metadata": {
            "section_title": "The absence of antagonism is the reason for the continuation of this "
        }
    },
    {
        "page_number": 10,
        "section_number": 77,
        "content": "therapy.128",
        "metadata": {
            "section_title": "therapy.128"
        }
    },
    {
        "page_number": 10,
        "section_number": 78,
        "content": "5 | CLINICAL TREATMENT",
        "metadata": {
            "section_title": "5 | CLINICAL TREATMENT"
        }
    },
    {
        "page_number": 10,
        "section_number": 79,
        "content": "5.1 | Asthma",
        "metadata": {
            "section_title": "5.1 | Asthma"
        }
    },
    {
        "page_number": 10,
        "section_number": 80,
        "content": "Azithromycin accumulates in the lysosomes of phagocytic cells. In",
        "metadata": {
            "section_title": "Azithromycin accumulates in the lysosomes of phagocytic cells. In "
        }
    },
    {
        "page_number": 10,
        "section_number": 81,
        "content": "the lungs, the concentration of macrolides in neutrophils and mac -",
        "metadata": {
            "section_title": "the lungs, the concentration of macrolides in neutrophils and mac -"
        }
    },
    {
        "page_number": 10,
        "section_number": 82,
        "content": "rophages is much higher than that measured in extracellular com -",
        "metadata": {
            "section_title": "rophages is much higher than that measured in extracellular com -"
        }
    },
    {
        "page_number": 10,
        "section_number": 83,
        "content": "partments. This information represents important cellular sites of",
        "metadata": {
            "section_title": "partments. This information represents important cellular sites of "
        }
    },
    {
        "page_number": 10,
        "section_number": 84,
        "content": "immunomodulatory function in asthma.129 Hiles et al. conducted a",
        "metadata": {
            "section_title": "immunomodulatory function in asthma.129 Hiles et al. conducted a "
        }
    },
    {
        "page_number": 10,
        "section_number": 85,
        "content": "randomized controlled trial on 420 patients to assess the effect of",
        "metadata": {
            "section_title": "randomized controlled trial on 420 patients to assess the effect of "
        }
    },
    {
        "page_number": 10,
        "section_number": 86,
        "content": "oral AZM in reducing the incidence of asthma. In that study, 213",
        "metadata": {
            "section_title": "oral AZM in reducing the incidence of asthma. In that study, 213 "
        }
    },
    {
        "page_number": 10,
        "section_number": 87,
        "content": "patients received 500 mg of AZM and 207 received placebo three",
        "metadata": {
            "section_title": "patients received 500 mg of AZM and 207 received placebo three "
        }
    },
    {
        "page_number": 10,
        "section_number": 88,
        "content": "times per week. Their results showed that AZM reduced asthma ex -",
        "metadata": {
            "section_title": "times per week. Their results showed that AZM reduced asthma ex -"
        }
    },
    {
        "page_number": 10,
        "section_number": 89,
        "content": "acerbations by 1.07 per patient/year, while this rate for placebo was",
        "metadata": {
            "section_title": "acerbations by 1.07 per patient/year, while this rate for placebo was "
        }
    },
    {
        "page_number": 10,
        "section_number": 90,
        "content": "1.86 per patient/year. Furthermore, low-  dose AZM was an effective",
        "metadata": {
            "section_title": "1.86 per patient/year. Furthermore, low-  dose AZM was an effective"
        }
    },
    {
        "page_number": 11,
        "section_number": 1,
        "content": "|  11 of 16",
        "metadata": {
            "section_title": "|  11 of 16"
        }
    },
    {
        "page_number": 11,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 11,
        "section_number": 3,
        "content": "therapy for persistent asthma. It reduced 40% of exacerbations in",
        "metadata": {
            "section_title": "therapy for persistent asthma. It reduced 40% of exacerbations in "
        }
    },
    {
        "page_number": 11,
        "section_number": 4,
        "content": "severe asthma and also respiratory tract infections.130 In another",
        "metadata": {
            "section_title": "severe asthma and also respiratory tract infections.130 In another "
        }
    },
    {
        "page_number": 11,
        "section_number": 5,
        "content": "retrospective cohort study, Douglas et al. evaluated AZM therapy",
        "metadata": {
            "section_title": "retrospective cohort study, Douglas et al. evaluated AZM therapy "
        }
    },
    {
        "page_number": 11,
        "section_number": 6,
        "content": "in 174 children hospitalized with asthma. The overall median length",
        "metadata": {
            "section_title": "in 174 children hospitalized with asthma. The overall median length "
        }
    },
    {
        "page_number": 11,
        "section_number": 7,
        "content": "of stay was 2.3 days, and 9% were readmitted for asthma within",
        "metadata": {
            "section_title": "of stay was 2.3 days, and 9% were readmitted for asthma within "
        }
    },
    {
        "page_number": 11,
        "section_number": 8,
        "content": "90 days of discharge compared with 20% who had a longer length of",
        "metadata": {
            "section_title": "90 days of discharge compared with 20% who had a longer length of "
        }
    },
    {
        "page_number": 11,
        "section_number": 9,
        "content": "stay after AZM treatment. Based on their results, AZM therapy was",
        "metadata": {
            "section_title": "stay after AZM treatment. Based on their results, AZM therapy was "
        }
    },
    {
        "page_number": 11,
        "section_number": 10,
        "content": "not associated with 90-  day readmission for asthma and showed no",
        "metadata": {
            "section_title": "not associated with 90-  day readmission for asthma and showed no "
        }
    },
    {
        "page_number": 11,
        "section_number": 11,
        "content": "statistically significant difference in the rate of readmission in chil -",
        "metadata": {
            "section_title": "statistically significant difference in the rate of readmission in chil -"
        }
    },
    {
        "page_number": 11,
        "section_number": 12,
        "content": "dren with asthma.131",
        "metadata": {
            "section_title": "dren with asthma.131"
        }
    },
    {
        "page_number": 11,
        "section_number": 13,
        "content": "5.2 | Bronchiolitis",
        "metadata": {
            "section_title": "5.2 | Bronchiolitis"
        }
    },
    {
        "page_number": 11,
        "section_number": 14,
        "content": "Azithromycin is mostly used to treat lung infection and viral bron -",
        "metadata": {
            "section_title": "Azithromycin is mostly used to treat lung infection and viral bron -"
        }
    },
    {
        "page_number": 11,
        "section_number": 15,
        "content": "chiolitis.132 In a secondary analysis of a randomized double-  blinded",
        "metadata": {
            "section_title": "chiolitis.132 In a secondary analysis of a randomized double-  blinded "
        }
    },
    {
        "page_number": 11,
        "section_number": 16,
        "content": "placebo-  controlled trial, 104 infants (50 in AZM group and 54 in",
        "metadata": {
            "section_title": "placebo-  controlled trial, 104 infants (50 in AZM group and 54 in "
        }
    },
    {
        "page_number": 11,
        "section_number": 17,
        "content": "placebo group) were studied. That study demonstrated that 10 mg/",
        "metadata": {
            "section_title": "placebo group) were studied. That study demonstrated that 10 mg/"
        }
    },
    {
        "page_number": 11,
        "section_number": 18,
        "content": "kg of AZM can reduce the rate of recurrent wheezing, which was",
        "metadata": {
            "section_title": "kg of AZM can reduce the rate of recurrent wheezing, which was "
        }
    },
    {
        "page_number": 11,
        "section_number": 19,
        "content": "significantly occurred less than 6 months after discharge.133 By ana -",
        "metadata": {
            "section_title": "significantly occurred less than 6 months after discharge.133 By ana -"
        }
    },
    {
        "page_number": 11,
        "section_number": 20,
        "content": "lyzing some double-  blinded placebo-  controlled studies, Che et al.",
        "metadata": {
            "section_title": "lyzing some double-  blinded placebo-  controlled studies, Che et al. "
        }
    },
    {
        "page_number": 11,
        "section_number": 21,
        "content": "evaluated the clinical efficacy of AZM adjuvant therapy in 1328",
        "metadata": {
            "section_title": "evaluated the clinical efficacy of AZM adjuvant therapy in 1328 "
        }
    },
    {
        "page_number": 11,
        "section_number": 22,
        "content": "children with bronchiolitis; 667 and 661 children received AZM and",
        "metadata": {
            "section_title": "children with bronchiolitis; 667 and 661 children received AZM and "
        }
    },
    {
        "page_number": 11,
        "section_number": 23,
        "content": "placebo, respectively. The results of their study revealed that AZM",
        "metadata": {
            "section_title": "placebo, respectively. The results of their study revealed that AZM "
        }
    },
    {
        "page_number": 11,
        "section_number": 24,
        "content": "could significantly diminish the time to the relief of wheezing and the",
        "metadata": {
            "section_title": "could significantly diminish the time to the relief of wheezing and the "
        }
    },
    {
        "page_number": 11,
        "section_number": 25,
        "content": "detection rates of Haemophilus influenza , Moraxella catarrhalis , and",
        "metadata": {
            "section_title": "detection rates of Haemophilus influenza , Moraxella catarrhalis , and "
        }
    },
    {
        "page_number": 11,
        "section_number": 26,
        "content": "Streptococcus pneumoniae  in the nasopharyngeal region. However,",
        "metadata": {
            "section_title": "Streptococcus pneumoniae  in the nasopharyngeal region. However, "
        }
    },
    {
        "page_number": 11,
        "section_number": 27,
        "content": "no improvement was observed in the length of hospitalization and",
        "metadata": {
            "section_title": "no improvement was observed in the length of hospitalization and "
        }
    },
    {
        "page_number": 11,
        "section_number": 28,
        "content": "oxygen supply time.134",
        "metadata": {
            "section_title": "oxygen supply time.134"
        }
    },
    {
        "page_number": 11,
        "section_number": 29,
        "content": "5.3 | Chronic obstructive pulmonary disease",
        "metadata": {
            "section_title": "5.3 | Chronic obstructive pulmonary disease "
        }
    },
    {
        "page_number": 11,
        "section_number": 30,
        "content": "(COPD)",
        "metadata": {
            "section_title": "(COPD)"
        }
    },
    {
        "page_number": 11,
        "section_number": 31,
        "content": "Azithromycin has been shown to have the greatest effect on sub -",
        "metadata": {
            "section_title": "Azithromycin has been shown to have the greatest effect on sub -"
        }
    },
    {
        "page_number": 11,
        "section_number": 32,
        "content": "jects with COPD.135 In a retrospective observational study, Naderi",
        "metadata": {
            "section_title": "jects with COPD.135 In a retrospective observational study, Naderi "
        }
    },
    {
        "page_number": 11,
        "section_number": 33,
        "content": "et al. randomized patients to receive AZM (250 mg, at least three",
        "metadata": {
            "section_title": "et al. randomized patients to receive AZM (250 mg, at least three "
        }
    },
    {
        "page_number": 11,
        "section_number": 34,
        "content": "times weekly for at least 6 months ( n = 126) or neither ( n = 69)). In",
        "metadata": {
            "section_title": "times weekly for at least 6 months ( n = 126) or neither ( n = 69)). In "
        }
    },
    {
        "page_number": 11,
        "section_number": 35,
        "content": "AZM-  treated patients, the rate of exacerbations per patient in a year",
        "metadata": {
            "section_title": "AZM-  treated patients, the rate of exacerbations per patient in a year "
        }
    },
    {
        "page_number": 11,
        "section_number": 36,
        "content": "before the treatment period was 3.2, but during the following year",
        "metadata": {
            "section_title": "before the treatment period was 3.2, but during the following year "
        }
    },
    {
        "page_number": 11,
        "section_number": 37,
        "content": "on therapy, the rate was 2.3. In the control group, the exacerbation",
        "metadata": {
            "section_title": "on therapy, the rate was 2.3. In the control group, the exacerbation "
        }
    },
    {
        "page_number": 11,
        "section_number": 38,
        "content": "rates were 1.7 and 2.5 during the first and second follow-  up year,",
        "metadata": {
            "section_title": "rates were 1.7 and 2.5 during the first and second follow-  up year, "
        }
    },
    {
        "page_number": 11,
        "section_number": 39,
        "content": "respectively. Therefore, long-  term AZM reduced the rate of exacer -",
        "metadata": {
            "section_title": "respectively. Therefore, long-  term AZM reduced the rate of exacer -"
        }
    },
    {
        "page_number": 11,
        "section_number": 40,
        "content": "bation in severe COPD patients.136",
        "metadata": {
            "section_title": "bation in severe COPD patients.136"
        }
    },
    {
        "page_number": 11,
        "section_number": 41,
        "content": "Han et al. carried out a secondary cohort analysis study to",
        "metadata": {
            "section_title": "Han et al. carried out a secondary cohort analysis study to "
        }
    },
    {
        "page_number": 11,
        "section_number": 42,
        "content": "demonstrate the effect of AZM in reducing exacerbation in COPD",
        "metadata": {
            "section_title": "demonstrate the effect of AZM in reducing exacerbation in COPD "
        }
    },
    {
        "page_number": 11,
        "section_number": 43,
        "content": "patients. They randomly grouped 1113 COPD patients, of which",
        "metadata": {
            "section_title": "patients. They randomly grouped 1113 COPD patients, of which "
        }
    },
    {
        "page_number": 11,
        "section_number": 44,
        "content": "557 and 556 subjects were received AZM and placebo, respectively.",
        "metadata": {
            "section_title": "557 and 556 subjects were received AZM and placebo, respectively. "
        }
    },
    {
        "page_number": 11,
        "section_number": 45,
        "content": "For a year, an AZM dose of 250 mg or placebo was prescribed daily.",
        "metadata": {
            "section_title": "For a year, an AZM dose of 250 mg or placebo was prescribed daily. "
        }
    },
    {
        "page_number": 11,
        "section_number": 46,
        "content": "AZM was more effective than placebo in reducing COPD, although",
        "metadata": {
            "section_title": "AZM was more effective than placebo in reducing COPD, although "
        }
    },
    {
        "page_number": 11,
        "section_number": 47,
        "content": "antibiotic and steroid therapy was required. The data also uncovered",
        "metadata": {
            "section_title": "antibiotic and steroid therapy was required. The data also uncovered "
        }
    },
    {
        "page_number": 11,
        "section_number": 48,
        "content": "that AZM is more effective in older patients and patients with mild",
        "metadata": {
            "section_title": "that AZM is more effective in older patients and patients with mild "
        }
    },
    {
        "page_number": 11,
        "section_number": 49,
        "content": "illness.137In a randomized double-  blinded placebo-  controlled trial per -",
        "metadata": {
            "section_title": "illness.137In a randomized double-  blinded placebo-  controlled trial per -"
        }
    },
    {
        "page_number": 11,
        "section_number": 50,
        "content": "formed by Uzun et al. in the Netherlands, AZM therapy was in -",
        "metadata": {
            "section_title": "formed by Uzun et al. in the Netherlands, AZM therapy was in -"
        }
    },
    {
        "page_number": 11,
        "section_number": 51,
        "content": "vestigated among patients with frequent exacerbations of COPD.",
        "metadata": {
            "section_title": "vestigated among patients with frequent exacerbations of COPD. "
        }
    },
    {
        "page_number": 11,
        "section_number": 52,
        "content": "Patients who experienced at the least three or more exacerbations",
        "metadata": {
            "section_title": "Patients who experienced at the least three or more exacerbations "
        }
    },
    {
        "page_number": 11,
        "section_number": 53,
        "content": "in the last year received 500 mg of AZM ( n = 47) or placebo ( n = 45),",
        "metadata": {
            "section_title": "in the last year received 500 mg of AZM ( n = 47) or placebo ( n = 45), "
        }
    },
    {
        "page_number": 11,
        "section_number": 54,
        "content": "three times a week for a year. Randomization was stratified by the",
        "metadata": {
            "section_title": "three times a week for a year. Randomization was stratified by the "
        }
    },
    {
        "page_number": 11,
        "section_number": 55,
        "content": "use\tof\tlong-\tterm,\tlow-\tdose\tprednisolone\t (≤10\tmg\tdaily).\tThe\tnumber",
        "metadata": {
            "section_title": "use\tof\tlong-\tterm,\tlow-\tdose\tprednisolone\t (≤10\tmg\tdaily).\tThe\tnumber\t"
        }
    },
    {
        "page_number": 11,
        "section_number": 56,
        "content": "of exacerbations in the AZM group was 84 compared with placebo,",
        "metadata": {
            "section_title": "of exacerbations in the AZM group was 84 compared with placebo, "
        }
    },
    {
        "page_number": 11,
        "section_number": 57,
        "content": "which was 129. In the AZM group, the rate of exacerbations per pa -",
        "metadata": {
            "section_title": "which was 129. In the AZM group, the rate of exacerbations per pa -"
        }
    },
    {
        "page_number": 11,
        "section_number": 58,
        "content": "tient per year was 1.94, while that of the placebo was 3.22. As a",
        "metadata": {
            "section_title": "tient per year was 1.94, while that of the placebo was 3.22. As a "
        }
    },
    {
        "page_number": 11,
        "section_number": 59,
        "content": "result, AZM can significantly reduce the exacerbation rate as com -",
        "metadata": {
            "section_title": "result, AZM can significantly reduce the exacerbation rate as com -"
        }
    },
    {
        "page_number": 11,
        "section_number": 60,
        "content": "pared to the placebo.138",
        "metadata": {
            "section_title": "pared to the placebo.138"
        }
    },
    {
        "page_number": 11,
        "section_number": 61,
        "content": "5.4 | Cystic fibrosis",
        "metadata": {
            "section_title": "5.4 | Cystic fibrosis"
        }
    },
    {
        "page_number": 11,
        "section_number": 62,
        "content": "Azithromycin has displayed great effects on cystic fibrosis patients.",
        "metadata": {
            "section_title": "Azithromycin has displayed great effects on cystic fibrosis patients. "
        }
    },
    {
        "page_number": 11,
        "section_number": 63,
        "content": "This claim was proven in a multi-  center randomized double-  blinded",
        "metadata": {
            "section_title": "This claim was proven in a multi-  center randomized double-  blinded "
        }
    },
    {
        "page_number": 11,
        "section_number": 64,
        "content": "placebo-  controlled trial conducted by Clement et al. who assessed",
        "metadata": {
            "section_title": "placebo-  controlled trial conducted by Clement et al. who assessed "
        }
    },
    {
        "page_number": 11,
        "section_number": 65,
        "content": "the long-  term effects of AZM in patients with cystic fibrosis. Their",
        "metadata": {
            "section_title": "the long-  term effects of AZM in patients with cystic fibrosis. Their "
        }
    },
    {
        "page_number": 11,
        "section_number": 66,
        "content": "study was initiated by the randomized selection of 82 subjects who",
        "metadata": {
            "section_title": "study was initiated by the randomized selection of 82 subjects who "
        }
    },
    {
        "page_number": 11,
        "section_number": 67,
        "content": "received oral AZM ( n = 40) or placebo ( n = 42) and ended with 35",
        "metadata": {
            "section_title": "received oral AZM ( n = 40) or placebo ( n = 42) and ended with 35 "
        }
    },
    {
        "page_number": 11,
        "section_number": 68,
        "content": "AZM and 37 placebo cases. The patients were prescribed 250 mg or",
        "metadata": {
            "section_title": "AZM and 37 placebo cases. The patients were prescribed 250 mg or "
        }
    },
    {
        "page_number": 11,
        "section_number": 69,
        "content": "500 mg of the mentioned agents depending on their body weight,",
        "metadata": {
            "section_title": "500 mg of the mentioned agents depending on their body weight, "
        }
    },
    {
        "page_number": 11,
        "section_number": 70,
        "content": "three times a week for 12 months. The results showed that the",
        "metadata": {
            "section_title": "three times a week for 12 months. The results showed that the "
        }
    },
    {
        "page_number": 11,
        "section_number": 71,
        "content": "rate of pulmonary exacerbations, the time elapsed before the first",
        "metadata": {
            "section_title": "rate of pulmonary exacerbations, the time elapsed before the first "
        }
    },
    {
        "page_number": 11,
        "section_number": 72,
        "content": "pulmonary exacerbation, and the number of additional courses of",
        "metadata": {
            "section_title": "pulmonary exacerbation, and the number of additional courses of "
        }
    },
    {
        "page_number": 11,
        "section_number": 73,
        "content": "oral antibiotics declined in the AZM group, but not in the placebo",
        "metadata": {
            "section_title": "oral antibiotics declined in the AZM group, but not in the placebo "
        }
    },
    {
        "page_number": 11,
        "section_number": 74,
        "content": "group.139",
        "metadata": {
            "section_title": "group.139"
        }
    },
    {
        "page_number": 11,
        "section_number": 75,
        "content": "5.5 | Enteric infections",
        "metadata": {
            "section_title": "5.5 | Enteric infections"
        }
    },
    {
        "page_number": 11,
        "section_number": 76,
        "content": "Due to increasing drug-  resistant Enterobacteriaceae, AZM is needed",
        "metadata": {
            "section_title": "Due to increasing drug-  resistant Enterobacteriaceae, AZM is needed "
        }
    },
    {
        "page_number": 11,
        "section_number": 77,
        "content": "to treat enteric infections. An open-  labeled, non-  comparative study",
        "metadata": {
            "section_title": "to treat enteric infections. An open-  labeled, non-  comparative study "
        }
    },
    {
        "page_number": 11,
        "section_number": 78,
        "content": "was carried out by Aggarwal et al. to uncover the effect of AZM on",
        "metadata": {
            "section_title": "was carried out by Aggarwal et al. to uncover the effect of AZM on "
        }
    },
    {
        "page_number": 11,
        "section_number": 79,
        "content": "the treatment of uncomplicated typhoid fever. In their investigation,",
        "metadata": {
            "section_title": "the treatment of uncomplicated typhoid fever. In their investigation, "
        }
    },
    {
        "page_number": 11,
        "section_number": 80,
        "content": "109 children received daily 20 mg of AZM per kg for 6 days; 102",
        "metadata": {
            "section_title": "109 children received daily 20 mg of AZM per kg for 6 days; 102 "
        }
    },
    {
        "page_number": 11,
        "section_number": 81,
        "content": "patients were cured completely.140 In another study, patients with",
        "metadata": {
            "section_title": "patients were cured completely.140 In another study, patients with "
        }
    },
    {
        "page_number": 11,
        "section_number": 82,
        "content": "uncomplicated typhoid fever received intravenous CRO (75 mg/day,",
        "metadata": {
            "section_title": "uncomplicated typhoid fever received intravenous CRO (75 mg/day, "
        }
    },
    {
        "page_number": 11,
        "section_number": 83,
        "content": "n = 36) or AZM (20 mg/kg/day, n = 32) for 5 days. Although the",
        "metadata": {
            "section_title": "n = 36) or AZM (20 mg/kg/day, n = 32) for 5 days. Although the "
        }
    },
    {
        "page_number": 11,
        "section_number": 84,
        "content": "result did not show a significant difference between AZM and CRO",
        "metadata": {
            "section_title": "result did not show a significant difference between AZM and CRO "
        }
    },
    {
        "page_number": 11,
        "section_number": 85,
        "content": "groups, treatment with AZM did not have any relapse, and they had",
        "metadata": {
            "section_title": "groups, treatment with AZM did not have any relapse, and they had "
        }
    },
    {
        "page_number": 11,
        "section_number": 86,
        "content": "a longer time to clearance of bacteremia. Thus, AZM can be an ap -",
        "metadata": {
            "section_title": "a longer time to clearance of bacteremia. Thus, AZM can be an ap -"
        }
    },
    {
        "page_number": 11,
        "section_number": 87,
        "content": "propriate treatment for children with typhoid fever.141",
        "metadata": {
            "section_title": "propriate treatment for children with typhoid fever.141"
        }
    },
    {
        "page_number": 11,
        "section_number": 88,
        "content": "Similarly, in a randomized controlled study, Parry et al. compared",
        "metadata": {
            "section_title": "Similarly, in a randomized controlled study, Parry et al. compared "
        }
    },
    {
        "page_number": 11,
        "section_number": 89,
        "content": "AZM with OFL for treating 187 patients with MDR typhoid fever.",
        "metadata": {
            "section_title": "AZM with OFL for treating 187 patients with MDR typhoid fever. "
        }
    },
    {
        "page_number": 11,
        "section_number": 90,
        "content": "Patients were randomly categorized into three groups to receive",
        "metadata": {
            "section_title": "Patients were randomly categorized into three groups to receive "
        }
    },
    {
        "page_number": 11,
        "section_number": 91,
        "content": "AZM (10 mg/day/kg, n = 62), OFL (20 mg/day/kg, n = 63), or their",
        "metadata": {
            "section_title": "AZM (10 mg/day/kg, n = 62), OFL (20 mg/day/kg, n = 63), or their "
        }
    },
    {
        "page_number": 11,
        "section_number": 92,
        "content": "combination (10 mg/day/kg AZM in days one to three and 15 mg/",
        "metadata": {
            "section_title": "combination (10 mg/day/kg AZM in days one to three and 15 mg/"
        }
    },
    {
        "page_number": 11,
        "section_number": 93,
        "content": "day/kg OFL for 7 days, n = 62). The results showed that AZM alone",
        "metadata": {
            "section_title": "day/kg OFL for 7 days, n = 62). The results showed that AZM alone "
        }
    },
    {
        "page_number": 11,
        "section_number": 94,
        "content": "may be a better choice to cure uncomplicated typhoid fever, and it",
        "metadata": {
            "section_title": "may be a better choice to cure uncomplicated typhoid fever, and it "
        }
    },
    {
        "page_number": 11,
        "section_number": 95,
        "content": "has a shorter treatment duration.142",
        "metadata": {
            "section_title": "has a shorter treatment duration.142"
        }
    },
    {
        "page_number": 12,
        "section_number": 1,
        "content": "12 of 16  |",
        "metadata": {
            "section_title": "12 of 16  |    "
        }
    },
    {
        "page_number": 12,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 12,
        "section_number": 3,
        "content": "In another prospective randomized trial, Vukelic et al. com -",
        "metadata": {
            "section_title": "In another prospective randomized trial, Vukelic et al. com -"
        }
    },
    {
        "page_number": 12,
        "section_number": 4,
        "content": "pared AZM with ERY in the treatment of children infected with",
        "metadata": {
            "section_title": "pared AZM with ERY in the treatment of children infected with "
        }
    },
    {
        "page_number": 12,
        "section_number": 5,
        "content": "Campylobacter concisus . They randomized 120 patients into four",
        "metadata": {
            "section_title": "Campylobacter concisus . They randomized 120 patients into four "
        }
    },
    {
        "page_number": 12,
        "section_number": 6,
        "content": "groups, including ERY (50 mg/day/kg for 5 days), AZM (a single dose",
        "metadata": {
            "section_title": "groups, including ERY (50 mg/day/kg for 5 days), AZM (a single dose "
        }
    },
    {
        "page_number": 12,
        "section_number": 7,
        "content": "of 20 mg/kg or 30 mg/kg), and control who received no treatment.",
        "metadata": {
            "section_title": "of 20 mg/kg or 30 mg/kg), and control who received no treatment. "
        }
    },
    {
        "page_number": 12,
        "section_number": 8,
        "content": "Results indicated that 30 mg/kg AZM was more efficient in curing",
        "metadata": {
            "section_title": "Results indicated that 30 mg/kg AZM was more efficient in curing "
        }
    },
    {
        "page_number": 12,
        "section_number": 9,
        "content": "Campylobacter enterocolitis  in children. Moreover, they proved that",
        "metadata": {
            "section_title": "Campylobacter enterocolitis  in children. Moreover, they proved that "
        }
    },
    {
        "page_number": 12,
        "section_number": 10,
        "content": "this effect was dose dependent.143",
        "metadata": {
            "section_title": "this effect was dose dependent.143"
        }
    },
    {
        "page_number": 12,
        "section_number": 11,
        "content": "5.6 | Sexually transmitted infections",
        "metadata": {
            "section_title": "5.6 | Sexually transmitted infections"
        }
    },
    {
        "page_number": 12,
        "section_number": 12,
        "content": "Azithromycin has been shown to be highly efficient in bacterial STIs",
        "metadata": {
            "section_title": "Azithromycin has been shown to be highly efficient in bacterial STIs "
        }
    },
    {
        "page_number": 12,
        "section_number": 13,
        "content": "caused by C.  trachomatis , N. gonorrhoeae , and T.  pallidum .144 Recently,",
        "metadata": {
            "section_title": "caused by C.  trachomatis , N. gonorrhoeae , and T.  pallidum .144 Recently, "
        }
    },
    {
        "page_number": 12,
        "section_number": 14,
        "content": "Macaux et al. performed a retrospective cohort study on the effect",
        "metadata": {
            "section_title": "Macaux et al. performed a retrospective cohort study on the effect "
        }
    },
    {
        "page_number": 12,
        "section_number": 15,
        "content": "of AZM on the treatment of C.  trachomatis - infected patients. They",
        "metadata": {
            "section_title": "of AZM on the treatment of C.  trachomatis - infected patients. They "
        }
    },
    {
        "page_number": 12,
        "section_number": 16,
        "content": "evaluated the efficiency of a single dose of AZM oral administration",
        "metadata": {
            "section_title": "evaluated the efficiency of a single dose of AZM oral administration "
        }
    },
    {
        "page_number": 12,
        "section_number": 17,
        "content": "in 50 patients with asymptomatic rectal infection. The overall results",
        "metadata": {
            "section_title": "in 50 patients with asymptomatic rectal infection. The overall results "
        }
    },
    {
        "page_number": 12,
        "section_number": 18,
        "content": "demonstrated that treatment with AZM can be effective against",
        "metadata": {
            "section_title": "demonstrated that treatment with AZM can be effective against "
        }
    },
    {
        "page_number": 12,
        "section_number": 19,
        "content": "asymptomatic rectal C.  trachomatis  infection.145",
        "metadata": {
            "section_title": "asymptomatic rectal C.  trachomatis  infection.145"
        }
    },
    {
        "page_number": 12,
        "section_number": 20,
        "content": "5.7 | Periodontal infections",
        "metadata": {
            "section_title": "5.7 | Periodontal infections"
        }
    },
    {
        "page_number": 12,
        "section_number": 21,
        "content": "Due to the penetration of periodontal infections in deep tissue or",
        "metadata": {
            "section_title": "Due to the penetration of periodontal infections in deep tissue or "
        }
    },
    {
        "page_number": 12,
        "section_number": 22,
        "content": "inaccessible areas, viz., the tooth furcation or gingival tissues, the",
        "metadata": {
            "section_title": "inaccessible areas, viz., the tooth furcation or gingival tissues, the "
        }
    },
    {
        "page_number": 12,
        "section_number": 23,
        "content": "function of AZM in treating these infections becomes more impor -",
        "metadata": {
            "section_title": "function of AZM in treating these infections becomes more impor -"
        }
    },
    {
        "page_number": 12,
        "section_number": 24,
        "content": "tant. AZM concentrates on neutrophils, macrophages, and fibro -",
        "metadata": {
            "section_title": "tant. AZM concentrates on neutrophils, macrophages, and fibro -"
        }
    },
    {
        "page_number": 12,
        "section_number": 25,
        "content": "blasts and plays a key role in fighting periodontal disease.146",
        "metadata": {
            "section_title": "blasts and plays a key role in fighting periodontal disease.146"
        }
    },
    {
        "page_number": 12,
        "section_number": 26,
        "content": "In a randomized trial, Mascarenhas et al. selected 31 patients",
        "metadata": {
            "section_title": "In a randomized trial, Mascarenhas et al. selected 31 patients "
        }
    },
    {
        "page_number": 12,
        "section_number": 27,
        "content": "who smoked more than a pack daily and investigated the effect of",
        "metadata": {
            "section_title": "who smoked more than a pack daily and investigated the effect of "
        }
    },
    {
        "page_number": 12,
        "section_number": 28,
        "content": "AZM in combination with scaling and root planning (SRP) for treating",
        "metadata": {
            "section_title": "AZM in combination with scaling and root planning (SRP) for treating "
        }
    },
    {
        "page_number": 12,
        "section_number": 29,
        "content": "severe chronic periodontitis.",
        "metadata": {
            "section_title": "severe chronic periodontitis."
        }
    },
    {
        "page_number": 12,
        "section_number": 30,
        "content": "Patients were randomly given SRP alone or SRP + AZM. The",
        "metadata": {
            "section_title": "Patients were randomly given SRP alone or SRP + AZM. The "
        }
    },
    {
        "page_number": 12,
        "section_number": 31,
        "content": "results indicated a clinical improvement in both groups within",
        "metadata": {
            "section_title": "results indicated a clinical improvement in both groups within "
        }
    },
    {
        "page_number": 12,
        "section_number": 32,
        "content": "6 months of treatment; however, the combination group indicated",
        "metadata": {
            "section_title": "6 months of treatment; however, the combination group indicated "
        }
    },
    {
        "page_number": 12,
        "section_number": 33,
        "content": "more reduction rate in probing depths and clinical attachment loss",
        "metadata": {
            "section_title": "more reduction rate in probing depths and clinical attachment loss "
        }
    },
    {
        "page_number": 12,
        "section_number": 34,
        "content": "and deep sites.147",
        "metadata": {
            "section_title": "and deep sites.147"
        }
    },
    {
        "page_number": 12,
        "section_number": 35,
        "content": "6 | CONCLUSIONS",
        "metadata": {
            "section_title": "6 | CONCLUSIONS"
        }
    },
    {
        "page_number": 12,
        "section_number": 36,
        "content": "Azithromycin is a semisynthetic macrolide that has a significant ef -",
        "metadata": {
            "section_title": "Azithromycin is a semisynthetic macrolide that has a significant ef -"
        }
    },
    {
        "page_number": 12,
        "section_number": 37,
        "content": "fect on a wide range of Gram-  positive and Gram-  negative bacte -",
        "metadata": {
            "section_title": "fect on a wide range of Gram-  positive and Gram-  negative bacte -"
        }
    },
    {
        "page_number": 12,
        "section_number": 38,
        "content": "ria. Both alone and/or in synergy with other antibiotics, AZM has",
        "metadata": {
            "section_title": "ria. Both alone and/or in synergy with other antibiotics, AZM has "
        }
    },
    {
        "page_number": 12,
        "section_number": 39,
        "content": "been used successfully for the treatment of respiratory diseases",
        "metadata": {
            "section_title": "been used successfully for the treatment of respiratory diseases "
        }
    },
    {
        "page_number": 12,
        "section_number": 40,
        "content": "(such as asthma, bronchiolitis, COPD, and cystic fibrosis), enteric",
        "metadata": {
            "section_title": "(such as asthma, bronchiolitis, COPD, and cystic fibrosis), enteric "
        }
    },
    {
        "page_number": 12,
        "section_number": 41,
        "content": "infections, periodontal infections, and STDs. However, pharma -",
        "metadata": {
            "section_title": "infections, periodontal infections, and STDs. However, pharma -"
        }
    },
    {
        "page_number": 12,
        "section_number": 42,
        "content": "cokinetics/pharmacodynamics studies have demonstrated an in -",
        "metadata": {
            "section_title": "cokinetics/pharmacodynamics studies have demonstrated an in -"
        }
    },
    {
        "page_number": 12,
        "section_number": 43,
        "content": "complete absorption of this antibiotic with low oral bioavailability.",
        "metadata": {
            "section_title": "complete absorption of this antibiotic with low oral bioavailability. "
        }
    },
    {
        "page_number": 12,
        "section_number": 44,
        "content": "Various bacteria in different countries have shown different levels",
        "metadata": {
            "section_title": "Various bacteria in different countries have shown different levels "
        }
    },
    {
        "page_number": 12,
        "section_number": 45,
        "content": "of antibiotic resistance to AZM. Thus, in this study, we reviewed",
        "metadata": {
            "section_title": "of antibiotic resistance to AZM. Thus, in this study, we reviewed "
        }
    },
    {
        "page_number": 12,
        "section_number": 46,
        "content": "the mechanisms and epidemiology of AZM resistance worldwide. Overall, the data show that the global prevalence of AZM resist -",
        "metadata": {
            "section_title": "the mechanisms and epidemiology of AZM resistance worldwide. Overall, the data show that the global prevalence of AZM resist -"
        }
    },
    {
        "page_number": 12,
        "section_number": 47,
        "content": "ance is increasing among bacteria. Resistance to AZM is developing",
        "metadata": {
            "section_title": "ance is increasing among bacteria. Resistance to AZM is developing "
        }
    },
    {
        "page_number": 12,
        "section_number": 48,
        "content": "similar to many other drugs; therefore, synergistic combinations",
        "metadata": {
            "section_title": "similar to many other drugs; therefore, synergistic combinations "
        }
    },
    {
        "page_number": 12,
        "section_number": 49,
        "content": "are prescribed and being studied to confront different pathogens.",
        "metadata": {
            "section_title": "are prescribed and being studied to confront different pathogens. "
        }
    },
    {
        "page_number": 12,
        "section_number": 50,
        "content": "Therefore, it is necessary to discover the AZM mechanism of action",
        "metadata": {
            "section_title": "Therefore, it is necessary to discover the AZM mechanism of action "
        }
    },
    {
        "page_number": 12,
        "section_number": 51,
        "content": "and the underlying mechanism behind the synergism with differ -",
        "metadata": {
            "section_title": "and the underlying mechanism behind the synergism with differ -"
        }
    },
    {
        "page_number": 12,
        "section_number": 52,
        "content": "ent drugs that effectively act against different organisms. A great",
        "metadata": {
            "section_title": "ent drugs that effectively act against different organisms. A great "
        }
    },
    {
        "page_number": 12,
        "section_number": 53,
        "content": "variety of combinations could be studied in various outlooks in -",
        "metadata": {
            "section_title": "variety of combinations could be studied in various outlooks in -"
        }
    },
    {
        "page_number": 12,
        "section_number": 54,
        "content": "cluding synergism and effects on the human body and different",
        "metadata": {
            "section_title": "cluding synergism and effects on the human body and different "
        }
    },
    {
        "page_number": 12,
        "section_number": 55,
        "content": "AZM combinations are no exception. Therefore, continuous moni -",
        "metadata": {
            "section_title": "AZM combinations are no exception. Therefore, continuous moni -"
        }
    },
    {
        "page_number": 12,
        "section_number": 56,
        "content": "toring of AZM resistance by AST methods, the establishment of an",
        "metadata": {
            "section_title": "toring of AZM resistance by AST methods, the establishment of an "
        }
    },
    {
        "page_number": 12,
        "section_number": 57,
        "content": "antibiotic resistance registry center, using electronically reporting",
        "metadata": {
            "section_title": "antibiotic resistance registry center, using electronically reporting "
        }
    },
    {
        "page_number": 12,
        "section_number": 58,
        "content": "systems, and the development of more rapid diagnostic assays are",
        "metadata": {
            "section_title": "systems, and the development of more rapid diagnostic assays are "
        }
    },
    {
        "page_number": 12,
        "section_number": 59,
        "content": "recommended.",
        "metadata": {
            "section_title": "recommended."
        }
    },
    {
        "page_number": 12,
        "section_number": 60,
        "content": "CONFLICT OF INTEREST",
        "metadata": {
            "section_title": "CONFLICT OF INTEREST"
        }
    },
    {
        "page_number": 12,
        "section_number": 61,
        "content": "The authors report no conflicts of interest in this work.",
        "metadata": {
            "section_title": "The authors report no conflicts of interest in this work."
        }
    },
    {
        "page_number": 12,
        "section_number": 62,
        "content": "AUTHOR CONTRIBUTIONS",
        "metadata": {
            "section_title": "AUTHOR CONTRIBUTIONS"
        }
    },
    {
        "page_number": 12,
        "section_number": 63,
        "content": "S.K., M.H., and E.T. involved in study concept and design. M.H.,",
        "metadata": {
            "section_title": "S.K., M.H., and E.T. involved in study concept and design. M.H., "
        }
    },
    {
        "page_number": 12,
        "section_number": 64,
        "content": "A.E.S., A.K., A.k.N., I.Y., M.M., E.T., and S.K. drafted the article. S.K.,",
        "metadata": {
            "section_title": "A.E.S., A.K., A.k.N., I.Y., M.M., E.T., and S.K. drafted the article. S.K., "
        }
    },
    {
        "page_number": 12,
        "section_number": 65,
        "content": "M.H., and E.T. involved in critical revision of the article for important",
        "metadata": {
            "section_title": "M.H., and E.T. involved in critical revision of the article for important "
        }
    },
    {
        "page_number": 12,
        "section_number": 66,
        "content": "intellectual content. S.K. and E.T involved in study supervision. All",
        "metadata": {
            "section_title": "intellectual content. S.K. and E.T involved in study supervision. All "
        }
    },
    {
        "page_number": 12,
        "section_number": 67,
        "content": "the authors have read and agreed to the published version of the",
        "metadata": {
            "section_title": "the authors have read and agreed to the published version of the "
        }
    },
    {
        "page_number": 12,
        "section_number": 68,
        "content": "article.",
        "metadata": {
            "section_title": "article."
        }
    },
    {
        "page_number": 12,
        "section_number": 69,
        "content": "ORCID",
        "metadata": {
            "section_title": "ORCID"
        }
    },
    {
        "page_number": 12,
        "section_number": 70,
        "content": "Mohsen Heidary   https:/ /orcid.org/0000-0002-9839-5017",
        "metadata": {
            "section_title": "Mohsen Heidary   https:/ /orcid.org/0000-0002-9839-5017  "
        }
    },
    {
        "page_number": 12,
        "section_number": 71,
        "content": "Saeed Khoshnood   https:/ /orcid.org/0000-0002-5143-3178",
        "metadata": {
            "section_title": "Saeed Khoshnood   https:/ /orcid.org/0000-0002-5143-3178  "
        }
    },
    {
        "page_number": 12,
        "section_number": 72,
        "content": "REFERENCES",
        "metadata": {
            "section_title": "REFERENCES"
        }
    },
    {
        "page_number": 12,
        "section_number": 73,
        "content": "1.\t Tomišić\t Z.\tThe\tstory\tof\tazithromycin.\t Kem Ind J Chem Chem Eng .",
        "metadata": {
            "section_title": "\t 1.\t Tomišić\t Z.\tThe\tstory\tof\tazithromycin.\t Kem Ind J Chem Chem Eng . "
        }
    },
    {
        "page_number": 12,
        "section_number": 74,
        "content": "2011;60:603-  617.",
        "metadata": {
            "section_title": "2011;60:603-  617."
        }
    },
    {
        "page_number": 12,
        "section_number": 75,
        "content": "2. Retsema J, Girard A, Schelkly W, et al. Spectrum and mode of ac -",
        "metadata": {
            "section_title": " 2. Retsema J, Girard A, Schelkly W, et al. Spectrum and mode of ac -"
        }
    },
    {
        "page_number": 12,
        "section_number": 76,
        "content": "tion of azithromycin (CP-  62,993), a new 15-  membered-  ring mac -",
        "metadata": {
            "section_title": "tion of azithromycin (CP-  62,993), a new 15-  membered-  ring mac -"
        }
    },
    {
        "page_number": 12,
        "section_number": 77,
        "content": "rolide with improved potency against gram-  negative organisms.",
        "metadata": {
            "section_title": "rolide with improved potency against gram-  negative organisms. "
        }
    },
    {
        "page_number": 12,
        "section_number": 78,
        "content": "Antimicrob Agents Chemother . 1987;31:1939-  1947. doi: 10.1128/",
        "metadata": {
            "section_title": "Antimicrob Agents Chemother . 1987;31:1939-  1947. doi: 10.1128/"
        }
    },
    {
        "page_number": 12,
        "section_number": 79,
        "content": "aac.31.12.1939",
        "metadata": {
            "section_title": "aac.31.12.1939"
        }
    },
    {
        "page_number": 12,
        "section_number": 80,
        "content": "3. Mosholder AD, Mathew J, Alexander JJ, Smith H, Nambiar S.",
        "metadata": {
            "section_title": " 3. Mosholder AD, Mathew J, Alexander JJ, Smith H, Nambiar S. "
        }
    },
    {
        "page_number": 12,
        "section_number": 81,
        "content": "Cardiovascular risks with azithromycin and other antibacterial",
        "metadata": {
            "section_title": "Cardiovascular risks with azithromycin and other antibacterial "
        }
    },
    {
        "page_number": 12,
        "section_number": 82,
        "content": "drugs. N Engl J Med . 2013;368:1665-  1668. doi: 10.1056/NEJMp",
        "metadata": {
            "section_title": "drugs. N Engl J Med . 2013;368:1665-  1668. doi: 10.1056/NEJMp  "
        }
    },
    {
        "page_number": 12,
        "section_number": 83,
        "content": "1302726",
        "metadata": {
            "section_title": "1302726"
        }
    },
    {
        "page_number": 12,
        "section_number": 84,
        "content": "4. Amsden GW. Erythromycin, clarithromycin, and azithromycin: are",
        "metadata": {
            "section_title": " 4. Amsden GW. Erythromycin, clarithromycin, and azithromycin: are "
        }
    },
    {
        "page_number": 12,
        "section_number": 85,
        "content": "the differences real? Clin Ther . 1996;18:56-  72.",
        "metadata": {
            "section_title": "the differences real? Clin Ther . 1996;18:56-  72."
        }
    },
    {
        "page_number": 12,
        "section_number": 86,
        "content": "5. Imamura Y, Higashiyama Y, Tomono K, et al. Azithromycin exhibits",
        "metadata": {
            "section_title": " 5. Imamura Y, Higashiyama Y, Tomono K, et al. Azithromycin exhibits "
        }
    },
    {
        "page_number": 12,
        "section_number": 87,
        "content": "bactericidal effects on Pseudomonas aeruginosa through inter -",
        "metadata": {
            "section_title": "bactericidal effects on Pseudomonas aeruginosa through inter -"
        }
    },
    {
        "page_number": 12,
        "section_number": 88,
        "content": "action with the outer membrane. Antimicrob Agents Chemother .",
        "metadata": {
            "section_title": "action with the outer membrane. Antimicrob Agents Chemother . "
        }
    },
    {
        "page_number": 12,
        "section_number": 89,
        "content": "2005;49:1377-  1380. doi: 10.1128/aac.49.4.1377-  1380.2005",
        "metadata": {
            "section_title": "2005;49:1377-  1380. doi: 10.1128/aac.49.4.1377-  1380.2005"
        }
    },
    {
        "page_number": 12,
        "section_number": 90,
        "content": "6.\t Jelić\t D,\tAntolović\t R.\tFrom\terythromycin\t to\tazithromycin\t and\tnew",
        "metadata": {
            "section_title": "\t 6.\t Jelić\t D,\tAntolović\t R.\tFrom\terythromycin\t to\tazithromycin\t and\tnew\t"
        }
    },
    {
        "page_number": 12,
        "section_number": 91,
        "content": "potential ribosome-  binding antimicrobials. Antibiotics. 2016;5:29.",
        "metadata": {
            "section_title": "potential ribosome-  binding antimicrobials. Antibiotics. 2016;5:29. "
        }
    },
    {
        "page_number": 12,
        "section_number": 92,
        "content": "doi:10.3390/antib  iotic  s5030029",
        "metadata": {
            "section_title": "doi:10.3390/antib  iotic  s5030029"
        }
    },
    {
        "page_number": 12,
        "section_number": 93,
        "content": "7. Gladue RP, Snider ME. Intracellular accumulation of azithromy -",
        "metadata": {
            "section_title": " 7. Gladue RP, Snider ME. Intracellular accumulation of azithromy -"
        }
    },
    {
        "page_number": 12,
        "section_number": 94,
        "content": "cin by cultured human fibroblasts. Antimicrob Agents Chemother .",
        "metadata": {
            "section_title": "cin by cultured human fibroblasts. Antimicrob Agents Chemother . "
        }
    },
    {
        "page_number": 12,
        "section_number": 95,
        "content": "1990;34:1056. doi: 10.1128/AAC.34.6.1056",
        "metadata": {
            "section_title": "1990;34:1056. doi: 10.1128/AAC.34.6.1056"
        }
    },
    {
        "page_number": 12,
        "section_number": 96,
        "content": "8. Rapp RP. Pharmacokinetics and pharmacodynamics of intravenous",
        "metadata": {
            "section_title": " 8. Rapp RP. Pharmacokinetics and pharmacodynamics of intravenous "
        }
    },
    {
        "page_number": 12,
        "section_number": 97,
        "content": "and oral azithromycin: enhanced tissue activity and minimal drug",
        "metadata": {
            "section_title": "and oral azithromycin: enhanced tissue activity and minimal drug "
        }
    },
    {
        "page_number": 12,
        "section_number": 98,
        "content": "interactions. Ann Pharmacother . 1998;32:785-  793. doi: 10.1345/",
        "metadata": {
            "section_title": "interactions. Ann Pharmacother . 1998;32:785-  793. doi: 10.1345/"
        }
    },
    {
        "page_number": 12,
        "section_number": 99,
        "content": "aph.17299",
        "metadata": {
            "section_title": "aph.17299"
        }
    },
    {
        "page_number": 13,
        "section_number": 1,
        "content": "|  13 of 16",
        "metadata": {
            "section_title": "|  13 of 16"
        }
    },
    {
        "page_number": 13,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 13,
        "section_number": 3,
        "content": "9. Albert RK, Connett J, Bailey WC, et al. Azithromycin for preven -",
        "metadata": {
            "section_title": " 9. Albert RK, Connett J, Bailey WC, et al. Azithromycin for preven -"
        }
    },
    {
        "page_number": 13,
        "section_number": 4,
        "content": "tion of exacerbations of COPD. N Engl J Med . 2011;365:689-  698.",
        "metadata": {
            "section_title": "tion of exacerbations of COPD. N Engl J Med . 2011;365:689-  698. "
        }
    },
    {
        "page_number": 13,
        "section_number": 5,
        "content": "doi:10.1056/NEJMo  a1104623",
        "metadata": {
            "section_title": "doi:10.1056/NEJMo  a1104623"
        }
    },
    {
        "page_number": 13,
        "section_number": 6,
        "content": "10. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azith -",
        "metadata": {
            "section_title": " 10. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azith -"
        }
    },
    {
        "page_number": 13,
        "section_number": 7,
        "content": "romycin as a treatment of COVID-  19: results of an open-  label non-",
        "metadata": {
            "section_title": "romycin as a treatment of COVID-  19: results of an open-  label non- "
        }
    },
    {
        "page_number": 13,
        "section_number": 8,
        "content": "randomized clinical trial. Int J Antimicrob Agents . 2020;56:105949.",
        "metadata": {
            "section_title": "randomized clinical trial. Int J Antimicrob Agents . 2020;56:105949. "
        }
    },
    {
        "page_number": 13,
        "section_number": 9,
        "content": "doi:10.1016/j.ijant  imicag.2020.105949",
        "metadata": {
            "section_title": "doi:10.1016/j.ijant  imicag.2020.105949"
        }
    },
    {
        "page_number": 13,
        "section_number": 10,
        "content": "11. Horowitz RI, Freeman PR. Precision medicine: retrospective chart",
        "metadata": {
            "section_title": " 11. Horowitz RI, Freeman PR. Precision medicine: retrospective chart "
        }
    },
    {
        "page_number": 13,
        "section_number": 11,
        "content": "review and data analysis of 200 patients on dapsone combination",
        "metadata": {
            "section_title": "review and data analysis of 200 patients on dapsone combination "
        }
    },
    {
        "page_number": 13,
        "section_number": 12,
        "content": "therapy for chronic Lyme disease/post-  treatment Lyme disease",
        "metadata": {
            "section_title": "therapy for chronic Lyme disease/post-  treatment Lyme disease "
        }
    },
    {
        "page_number": 13,
        "section_number": 13,
        "content": "syndrome: part 1. Int J Gen Med . 2019;12:101-  119. doi: 10.2147/",
        "metadata": {
            "section_title": "syndrome: part 1. Int J Gen Med . 2019;12:101-  119. doi: 10.2147/"
        }
    },
    {
        "page_number": 13,
        "section_number": 14,
        "content": "ijgm.S193608",
        "metadata": {
            "section_title": "ijgm.S193608"
        }
    },
    {
        "page_number": 13,
        "section_number": 15,
        "content": "12. Liu P, Allaudeen H, Chandra R, et al. Comparative pharmacoki -",
        "metadata": {
            "section_title": " 12. Liu P, Allaudeen H, Chandra R, et al. Comparative pharmacoki -"
        }
    },
    {
        "page_number": 13,
        "section_number": 16,
        "content": "netics of azithromycin in serum and white blood cells of healthy",
        "metadata": {
            "section_title": "netics of azithromycin in serum and white blood cells of healthy "
        }
    },
    {
        "page_number": 13,
        "section_number": 17,
        "content": "subjects receiving a single- dose extended-  release regimen versus",
        "metadata": {
            "section_title": "subjects receiving a single- dose extended-  release regimen versus "
        }
    },
    {
        "page_number": 13,
        "section_number": 18,
        "content": "a 3- day immediate-  release regimen. Antimicrob Agents Chemother .",
        "metadata": {
            "section_title": "a 3- day immediate-  release regimen. Antimicrob Agents Chemother . "
        }
    },
    {
        "page_number": 13,
        "section_number": 19,
        "content": "2007;51:103. doi: 10.1128/AAC.00852  - 06",
        "metadata": {
            "section_title": "2007;51:103. doi: 10.1128/AAC.00852  - 06"
        }
    },
    {
        "page_number": 13,
        "section_number": 20,
        "content": "13. Padayachee N, Schellack N. Focus on azithromycin. S Afr Gen Pract .",
        "metadata": {
            "section_title": " 13. Padayachee N, Schellack N. Focus on azithromycin. S Afr Gen Pract . "
        }
    },
    {
        "page_number": 13,
        "section_number": 21,
        "content": "2021;2:6-  8.",
        "metadata": {
            "section_title": "2021;2:6-  8."
        }
    },
    {
        "page_number": 13,
        "section_number": 22,
        "content": "14. Champney WS, Burdine R. Azithromycin and clarithromycin inhi -",
        "metadata": {
            "section_title": " 14. Champney WS, Burdine R. Azithromycin and clarithromycin inhi -"
        }
    },
    {
        "page_number": 13,
        "section_number": 23,
        "content": "bition of 50S ribosomal subunit formation in Staphylococcus aureus",
        "metadata": {
            "section_title": "bition of 50S ribosomal subunit formation in Staphylococcus aureus  "
        }
    },
    {
        "page_number": 13,
        "section_number": 24,
        "content": "cells. Curr Microbiol . 1998;36:119-  123.",
        "metadata": {
            "section_title": "cells. Curr Microbiol . 1998;36:119-  123."
        }
    },
    {
        "page_number": 13,
        "section_number": 25,
        "content": "15. Bakheit A, Al-  Hadiya B, Abd-  Elgalil A. Azithromycin. Profiles Drug",
        "metadata": {
            "section_title": " 15. Bakheit A, Al-  Hadiya B, Abd-  Elgalil A. Azithromycin. Profiles Drug "
        }
    },
    {
        "page_number": 13,
        "section_number": 26,
        "content": "Subst Excip Relat Methodol . 2014;39:1-  40.",
        "metadata": {
            "section_title": "Subst Excip Relat Methodol . 2014;39:1-  40."
        }
    },
    {
        "page_number": 13,
        "section_number": 27,
        "content": "16. Vázquez-  Laslop N, Mankin AS. How macrolide antibiotics work.",
        "metadata": {
            "section_title": " 16. Vázquez-  Laslop N, Mankin AS. How macrolide antibiotics work. "
        }
    },
    {
        "page_number": 13,
        "section_number": 28,
        "content": "Trends Biochem Sci . 2018;43:668- 684.",
        "metadata": {
            "section_title": "Trends Biochem Sci . 2018;43:668- 684."
        }
    },
    {
        "page_number": 13,
        "section_number": 29,
        "content": "17. Parnham MJ, Haber VE, Giamarellos-  Bourboulis EJ, Perletti",
        "metadata": {
            "section_title": " 17. Parnham MJ, Haber VE, Giamarellos-  Bourboulis EJ, Perletti "
        }
    },
    {
        "page_number": 13,
        "section_number": 30,
        "content": "G, Verleden GM, Vos R. Azithromycin: mechanisms of action",
        "metadata": {
            "section_title": "G, Verleden GM, Vos R. Azithromycin: mechanisms of action "
        }
    },
    {
        "page_number": 13,
        "section_number": 31,
        "content": "and their relevance for clinical applications. Pharmacol Ther .",
        "metadata": {
            "section_title": "and their relevance for clinical applications. Pharmacol Ther . "
        }
    },
    {
        "page_number": 13,
        "section_number": 32,
        "content": "2014;143:225-  245.",
        "metadata": {
            "section_title": "2014;143:225-  245."
        }
    },
    {
        "page_number": 13,
        "section_number": 33,
        "content": "18. Bulkley D, Innis CA, Blaha G, Steitz TA. Revisiting the structures of",
        "metadata": {
            "section_title": " 18. Bulkley D, Innis CA, Blaha G, Steitz TA. Revisiting the structures of "
        }
    },
    {
        "page_number": 13,
        "section_number": 34,
        "content": "several antibiotics bound to the bacterial ribosome. Proc Natl Acad",
        "metadata": {
            "section_title": "several antibiotics bound to the bacterial ribosome. Proc Natl Acad "
        }
    },
    {
        "page_number": 13,
        "section_number": 35,
        "content": "Sci USA . 2010;107:17158-  17163.",
        "metadata": {
            "section_title": "Sci USA . 2010;107:17158-  17163."
        }
    },
    {
        "page_number": 13,
        "section_number": 36,
        "content": "19. Cigana C, Assael BM, Melotti P. Azithromycin selectively reduces",
        "metadata": {
            "section_title": " 19. Cigana C, Assael BM, Melotti P. Azithromycin selectively reduces "
        }
    },
    {
        "page_number": 13,
        "section_number": 37,
        "content": "tumor necrosis factor alpha levels in cystic fibrosis airway epithe -",
        "metadata": {
            "section_title": "tumor necrosis factor alpha levels in cystic fibrosis airway epithe -"
        }
    },
    {
        "page_number": 13,
        "section_number": 38,
        "content": "lial cells. Antimicrob Agents Chemother . 2007;51:975-  981.",
        "metadata": {
            "section_title": "lial cells. Antimicrob Agents Chemother . 2007;51:975-  981."
        }
    },
    {
        "page_number": 13,
        "section_number": 39,
        "content": "20. Aghai ZH, Kode A, Saslow JG, et al. Azithromycin suppresses",
        "metadata": {
            "section_title": " 20. Aghai ZH, Kode A, Saslow JG, et al. Azithromycin suppresses "
        }
    },
    {
        "page_number": 13,
        "section_number": 40,
        "content": "activation of nuclear factor-  kappa B and synthesis of pro-",
        "metadata": {
            "section_title": "activation of nuclear factor-  kappa B and synthesis of pro- "
        }
    },
    {
        "page_number": 13,
        "section_number": 41,
        "content": "inflammatory cytokines in tracheal aspirate cells from premature",
        "metadata": {
            "section_title": "inflammatory cytokines in tracheal aspirate cells from premature "
        }
    },
    {
        "page_number": 13,
        "section_number": 42,
        "content": "infants. Pediatric Res . 2007;62:483-  488.",
        "metadata": {
            "section_title": "infants. Pediatric Res . 2007;62:483-  488."
        }
    },
    {
        "page_number": 13,
        "section_number": 43,
        "content": "21. Venditto VJ, Haydar D, Abdel-  Latif A, et al. Immunomodulatory ef -",
        "metadata": {
            "section_title": " 21. Venditto VJ, Haydar D, Abdel-  Latif A, et al. Immunomodulatory ef -"
        }
    },
    {
        "page_number": 13,
        "section_number": 44,
        "content": "fects of azithromycin revisited: potential applications to COVID-  19.",
        "metadata": {
            "section_title": "fects of azithromycin revisited: potential applications to COVID-  19. "
        }
    },
    {
        "page_number": 13,
        "section_number": 45,
        "content": "Front Immunol . 2021;12:285.",
        "metadata": {
            "section_title": "Front Immunol . 2021;12:285."
        }
    },
    {
        "page_number": 13,
        "section_number": 46,
        "content": "22. Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck",
        "metadata": {
            "section_title": " 22. Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck "
        }
    },
    {
        "page_number": 13,
        "section_number": 47,
        "content": "DE. Azithromycin reduces airway neutrophilia and interleukin-  8 in",
        "metadata": {
            "section_title": "DE. Azithromycin reduces airway neutrophilia and interleukin-  8 in "
        }
    },
    {
        "page_number": 13,
        "section_number": 48,
        "content": "patients with bronchiolitis obliterans syndrome. Am J Respir Crit",
        "metadata": {
            "section_title": "patients with bronchiolitis obliterans syndrome. Am J Respir Crit "
        }
    },
    {
        "page_number": 13,
        "section_number": 49,
        "content": "Care Med . 2006;174:566-  570.",
        "metadata": {
            "section_title": "Care Med . 2006;174:566-  570."
        }
    },
    {
        "page_number": 13,
        "section_number": 50,
        "content": "23.\t Čulić\t O,\tEraković\t V,\tČepelak\t I,\tet\tal.\tAzithromycin\t modulates\t neu-",
        "metadata": {
            "section_title": "\t 23.\t Čulić\t O,\tEraković\t V,\tČepelak\t I,\tet\tal.\tAzithromycin\t modulates\t neu-"
        }
    },
    {
        "page_number": 13,
        "section_number": 51,
        "content": "trophil function and circulating inflammatory mediators in healthy",
        "metadata": {
            "section_title": "trophil function and circulating inflammatory mediators in healthy "
        }
    },
    {
        "page_number": 13,
        "section_number": 52,
        "content": "human subjects. Eur J Pharmacol . 2002;450:277-  289.",
        "metadata": {
            "section_title": "human subjects. Eur J Pharmacol . 2002;450:277-  289."
        }
    },
    {
        "page_number": 13,
        "section_number": 53,
        "content": "24. Wales D, Woodhead M. The anti- inflammatory effects of macro -",
        "metadata": {
            "section_title": " 24. Wales D, Woodhead M. The anti- inflammatory effects of macro -"
        }
    },
    {
        "page_number": 13,
        "section_number": 54,
        "content": "lides. Thorax . 1999;54:S58.",
        "metadata": {
            "section_title": "lides. Thorax . 1999;54:S58."
        }
    },
    {
        "page_number": 13,
        "section_number": 55,
        "content": "25. Kannan K, Mankin AS. Macrolide antibiotics in the ribosome exit",
        "metadata": {
            "section_title": " 25. Kannan K, Mankin AS. Macrolide antibiotics in the ribosome exit "
        }
    },
    {
        "page_number": 13,
        "section_number": 56,
        "content": "tunnel: species-  specific binding and action. Ann N Y Acad Sci .",
        "metadata": {
            "section_title": "tunnel: species-  specific binding and action. Ann N Y Acad Sci . "
        }
    },
    {
        "page_number": 13,
        "section_number": 57,
        "content": "2011;1241:33-  47.",
        "metadata": {
            "section_title": "2011;1241:33-  47."
        }
    },
    {
        "page_number": 13,
        "section_number": 58,
        "content": "26. Lode H. The pharmacokinetics of azithromycin and",
        "metadata": {
            "section_title": " 26. Lode H. The pharmacokinetics of azithromycin and "
        }
    },
    {
        "page_number": 13,
        "section_number": 59,
        "content": "their clinical significance. Eur J Clin Microbiol Infect Dis .",
        "metadata": {
            "section_title": "their clinical significance. Eur J Clin Microbiol Infect Dis . "
        }
    },
    {
        "page_number": 13,
        "section_number": 60,
        "content": "1991;10:807-  812.",
        "metadata": {
            "section_title": "1991;10:807-  812."
        }
    },
    {
        "page_number": 13,
        "section_number": 61,
        "content": "27. Fohner AE, Sparreboom A, Altman RB, Klein TE. PharmGKB sum -",
        "metadata": {
            "section_title": " 27. Fohner AE, Sparreboom A, Altman RB, Klein TE. PharmGKB sum -"
        }
    },
    {
        "page_number": 13,
        "section_number": 62,
        "content": "mary: macrolide antibiotic pathway, pharmacokinetics/pharmaco-",
        "metadata": {
            "section_title": "mary: macrolide antibiotic pathway, pharmacokinetics/pharmaco-"
        }
    },
    {
        "page_number": 13,
        "section_number": 63,
        "content": "dynamics. Pharm Genom . 2017;27:164.",
        "metadata": {
            "section_title": "dynamics. Pharm Genom . 2017;27:164."
        }
    },
    {
        "page_number": 13,
        "section_number": 64,
        "content": "28. Drew RH, Gallis HA. Azithromycin—  spectrum of activity, pharma -",
        "metadata": {
            "section_title": " 28. Drew RH, Gallis HA. Azithromycin—  spectrum of activity, pharma -"
        }
    },
    {
        "page_number": 13,
        "section_number": 65,
        "content": "cokinetics, and clinical applications. Pharmacother J Hum Pharmacol",
        "metadata": {
            "section_title": "cokinetics, and clinical applications. Pharmacother J Hum Pharmacol "
        }
    },
    {
        "page_number": 13,
        "section_number": 66,
        "content": "Drug Ther . 1992;12:161-  173.",
        "metadata": {
            "section_title": "Drug Ther . 1992;12:161-  173."
        }
    },
    {
        "page_number": 13,
        "section_number": 67,
        "content": "29. Nahata MC, Koranyi K, Gadgil S, Hilligoss D, Fouda H, Gardner M.",
        "metadata": {
            "section_title": " 29. Nahata MC, Koranyi K, Gadgil S, Hilligoss D, Fouda H, Gardner M. "
        }
    },
    {
        "page_number": 13,
        "section_number": 68,
        "content": "Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. Antimicrob Agents",
        "metadata": {
            "section_title": "Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. Antimicrob Agents "
        }
    },
    {
        "page_number": 13,
        "section_number": 69,
        "content": "Chemother . 1993;37:314- 316.",
        "metadata": {
            "section_title": "Chemother . 1993;37:314- 316."
        }
    },
    {
        "page_number": 13,
        "section_number": 70,
        "content": "30. McMullan BJ, Mostaghim M. Prescribing azithromycin. Aust Prescr .",
        "metadata": {
            "section_title": " 30. McMullan BJ, Mostaghim M. Prescribing azithromycin. Aust Prescr . "
        }
    },
    {
        "page_number": 13,
        "section_number": 71,
        "content": "2015;38:87.",
        "metadata": {
            "section_title": "2015;38:87."
        }
    },
    {
        "page_number": 13,
        "section_number": 72,
        "content": "31. Chandra R, Liu P, Breen JD, et al. Clinical pharmacokinetics and gas -",
        "metadata": {
            "section_title": " 31. Chandra R, Liu P, Breen JD, et al. Clinical pharmacokinetics and gas -"
        }
    },
    {
        "page_number": 13,
        "section_number": 73,
        "content": "trointestinal tolerability of a novel extended-  release microsphere",
        "metadata": {
            "section_title": "trointestinal tolerability of a novel extended-  release microsphere "
        }
    },
    {
        "page_number": 13,
        "section_number": 74,
        "content": "formulation of azithromycin. Clin Pharmacokinet . 2007;46:247-",
        "metadata": {
            "section_title": "formulation of azithromycin. Clin Pharmacokinet . 2007;46:247- "
        }
    },
    {
        "page_number": 13,
        "section_number": 75,
        "content": "259. doi: 10.2165/00003  088-  20074  6030-  00005",
        "metadata": {
            "section_title": "259. doi: 10.2165/00003  088-  20074  6030-  00005"
        }
    },
    {
        "page_number": 13,
        "section_number": 76,
        "content": "32. Swainston Harrison T, Keam SJ. Azithromycin extended release: a",
        "metadata": {
            "section_title": " 32. Swainston Harrison T, Keam SJ. Azithromycin extended release: a "
        }
    },
    {
        "page_number": 13,
        "section_number": 77,
        "content": "review of its use in the treatment of acute bacterial sinusitis and",
        "metadata": {
            "section_title": "review of its use in the treatment of acute bacterial sinusitis and "
        }
    },
    {
        "page_number": 13,
        "section_number": 78,
        "content": "community-  acquired pneumonia in the US. Drugs . 2007;67:773-",
        "metadata": {
            "section_title": "community-  acquired pneumonia in the US. Drugs . 2007;67:773-  "
        }
    },
    {
        "page_number": 13,
        "section_number": 79,
        "content": "792. doi: 10.2165/00003  495-  20076  7050-  00010",
        "metadata": {
            "section_title": "792. doi: 10.2165/00003  495-  20076  7050-  00010"
        }
    },
    {
        "page_number": 13,
        "section_number": 80,
        "content": "33. Harrison TS, Keam SJ. Azithromycin extended release. Drugs .",
        "metadata": {
            "section_title": " 33. Harrison TS, Keam SJ. Azithromycin extended release. Drugs . "
        }
    },
    {
        "page_number": 13,
        "section_number": 81,
        "content": "2007;67:773-  792. doi: 10.2165/00003  495-  20076  7050-  00010",
        "metadata": {
            "section_title": "2007;67:773-  792. doi: 10.2165/00003  495-  20076  7050-  00010"
        }
    },
    {
        "page_number": 13,
        "section_number": 82,
        "content": "34. Lozano C, López M, Rojo-  Bezares B, Sáenz Y. Antimicrobial suscep -",
        "metadata": {
            "section_title": " 34. Lozano C, López M, Rojo-  Bezares B, Sáenz Y. Antimicrobial suscep -"
        }
    },
    {
        "page_number": 13,
        "section_number": 83,
        "content": "tibility testing in Pseudomonas aeruginosa  biofilms: one step closer",
        "metadata": {
            "section_title": "tibility testing in Pseudomonas aeruginosa  biofilms: one step closer "
        }
    },
    {
        "page_number": 13,
        "section_number": 84,
        "content": "to a standardized method. Antibiotics. 2020;9:880. doi: 10.3390/",
        "metadata": {
            "section_title": "to a standardized method. Antibiotics. 2020;9:880. doi: 10.3390/"
        }
    },
    {
        "page_number": 13,
        "section_number": 85,
        "content": "antib iotic  s9120880",
        "metadata": {
            "section_title": "antib iotic  s9120880"
        }
    },
    {
        "page_number": 13,
        "section_number": 86,
        "content": "35. Anggani HS, Perdana RG, Siregar E, Bachtiar EW. The effect of",
        "metadata": {
            "section_title": " 35. Anggani HS, Perdana RG, Siregar E, Bachtiar EW. The effect of "
        }
    },
    {
        "page_number": 13,
        "section_number": 87,
        "content": "coating chitosan on Porphyromonas gingivalis  biofilm formation in",
        "metadata": {
            "section_title": "coating chitosan on Porphyromonas gingivalis  biofilm formation in "
        }
    },
    {
        "page_number": 13,
        "section_number": 88,
        "content": "the surface of orthodontic mini- implant. J Adv Pharm Technol Res .",
        "metadata": {
            "section_title": "the surface of orthodontic mini- implant. J Adv Pharm Technol Res . "
        }
    },
    {
        "page_number": 13,
        "section_number": 89,
        "content": "2021;12:84-  88. doi: 10.4103/japtr.JAPTR_95_20",
        "metadata": {
            "section_title": "2021;12:84-  88. doi: 10.4103/japtr.JAPTR_95_20"
        }
    },
    {
        "page_number": 13,
        "section_number": 90,
        "content": "36. Horowitz RI, Murali K, Gaur G, Freeman PR, Sapi E. Effect of dap -",
        "metadata": {
            "section_title": " 36. Horowitz RI, Murali K, Gaur G, Freeman PR, Sapi E. Effect of dap -"
        }
    },
    {
        "page_number": 13,
        "section_number": 91,
        "content": "sone alone and in combination with intracellular antibiotics against",
        "metadata": {
            "section_title": "sone alone and in combination with intracellular antibiotics against "
        }
    },
    {
        "page_number": 13,
        "section_number": 92,
        "content": "the biofilm form of B. burgdorferi . BMC Res Notes . 2020;13:455.",
        "metadata": {
            "section_title": "the biofilm form of B. burgdorferi . BMC Res Notes . 2020;13:455. "
        }
    },
    {
        "page_number": 13,
        "section_number": 93,
        "content": "doi:10.1186/s1310  4- 020-  05298  - 6",
        "metadata": {
            "section_title": "doi:10.1186/s1310  4- 020-  05298  - 6"
        }
    },
    {
        "page_number": 13,
        "section_number": 94,
        "content": "37. Zheng X, Ma X, Li T, Shi W, Zhang Y. Effect of different drugs",
        "metadata": {
            "section_title": " 37. Zheng X, Ma X, Li T, Shi W, Zhang Y. Effect of different drugs "
        }
    },
    {
        "page_number": 13,
        "section_number": 95,
        "content": "and drug combinations on killing stationary phase and biofilms",
        "metadata": {
            "section_title": "and drug combinations on killing stationary phase and biofilms "
        }
    },
    {
        "page_number": 13,
        "section_number": 96,
        "content": "recovered cells of Bartonella henselae in vitro. BMC Microbiol .",
        "metadata": {
            "section_title": "recovered cells of Bartonella henselae in vitro. BMC Microbiol . "
        }
    },
    {
        "page_number": 13,
        "section_number": 97,
        "content": "2020;20:87. doi: 10.1186/s1286  6- 020- 01777  - 9",
        "metadata": {
            "section_title": "2020;20:87. doi: 10.1186/s1286  6- 020- 01777  - 9"
        }
    },
    {
        "page_number": 13,
        "section_number": 98,
        "content": "38. Yue C, Shen W, Hu L, et al. Effects of tigecycline combined",
        "metadata": {
            "section_title": " 38. Yue C, Shen W, Hu L, et al. Effects of tigecycline combined "
        }
    },
    {
        "page_number": 13,
        "section_number": 99,
        "content": "with azithromycin against biofilms of multidrug-  resistant",
        "metadata": {
            "section_title": "with azithromycin against biofilms of multidrug-  resistant "
        }
    },
    {
        "page_number": 13,
        "section_number": 100,
        "content": "Stenotrophomonas maltophilia isolates from a patient in China.",
        "metadata": {
            "section_title": "Stenotrophomonas maltophilia isolates from a patient in China. "
        }
    },
    {
        "page_number": 13,
        "section_number": 101,
        "content": "Infect Drug Resist . 2021;14:775-  786. doi: 10.2147/idr.S298274",
        "metadata": {
            "section_title": "Infect Drug Resist . 2021;14:775-  786. doi: 10.2147/idr.S298274"
        }
    },
    {
        "page_number": 13,
        "section_number": 102,
        "content": "39. Derbie A, Mekonnen D, Woldeamanuel Y, Abebe T. Azithromycin",
        "metadata": {
            "section_title": " 39. Derbie A, Mekonnen D, Woldeamanuel Y, Abebe T. Azithromycin "
        }
    },
    {
        "page_number": 13,
        "section_number": 103,
        "content": "resistant gonococci: a literature review. Antimicrob Resist Infect",
        "metadata": {
            "section_title": "resistant gonococci: a literature review. Antimicrob Resist Infect "
        }
    },
    {
        "page_number": 13,
        "section_number": 104,
        "content": "Control . 2020;9:1-  7.",
        "metadata": {
            "section_title": "Control . 2020;9:1-  7."
        }
    },
    {
        "page_number": 13,
        "section_number": 105,
        "content": "40. Belkacem A, Jacquier H, Goubard A, et al. Molecular epidemiology",
        "metadata": {
            "section_title": " 40. Belkacem A, Jacquier H, Goubard A, et al. Molecular epidemiology "
        }
    },
    {
        "page_number": 13,
        "section_number": 106,
        "content": "and mechanisms of resistance of azithromycin-  resistant Neisseria",
        "metadata": {
            "section_title": "and mechanisms of resistance of azithromycin-  resistant Neisseria "
        }
    },
    {
        "page_number": 13,
        "section_number": 107,
        "content": "gonorrhoeae isolated in France during 2013–  14. J Antimicrob",
        "metadata": {
            "section_title": "gonorrhoeae isolated in France during 2013–  14. J Antimicrob "
        }
    },
    {
        "page_number": 13,
        "section_number": 108,
        "content": "Chemother . 2016;71:2471-  2478.",
        "metadata": {
            "section_title": "Chemother . 2016;71:2471-  2478."
        }
    },
    {
        "page_number": 13,
        "section_number": 109,
        "content": "41. Gillis RJ, White KG, Choi KH, Wagner VE, Schweizer HP, Iglewski",
        "metadata": {
            "section_title": " 41. Gillis RJ, White KG, Choi KH, Wagner VE, Schweizer HP, Iglewski "
        }
    },
    {
        "page_number": 13,
        "section_number": 110,
        "content": "BH. Molecular basis of azithromycin-  resistant Pseudomonas aeru -",
        "metadata": {
            "section_title": "BH. Molecular basis of azithromycin-  resistant Pseudomonas aeru -"
        }
    },
    {
        "page_number": 13,
        "section_number": 111,
        "content": "ginosa  biofilms. Antimicrob Agents Chemother . 2005;49:3858- 3867.",
        "metadata": {
            "section_title": "ginosa  biofilms. Antimicrob Agents Chemother . 2005;49:3858- 3867. "
        }
    },
    {
        "page_number": 13,
        "section_number": 112,
        "content": "doi:10.1128/aac.49.9.3858-  3867.2005",
        "metadata": {
            "section_title": "doi:10.1128/aac.49.9.3858-  3867.2005"
        }
    },
    {
        "page_number": 13,
        "section_number": 113,
        "content": "42. Chalmers JD. Macrolide resistance in Pseudomonas aeruginosa : im-",
        "metadata": {
            "section_title": " 42. Chalmers JD. Macrolide resistance in Pseudomonas aeruginosa : im-"
        }
    },
    {
        "page_number": 13,
        "section_number": 114,
        "content": "plications for practice. Eur Respir Soc . 2017;49:1700689.",
        "metadata": {
            "section_title": "plications for practice. Eur Respir Soc . 2017;49:1700689."
        }
    },
    {
        "page_number": 13,
        "section_number": 115,
        "content": "43. Gomes C, Martínez-  Puchol S, Palma N, et al. Macrolide resistance",
        "metadata": {
            "section_title": " 43. Gomes C, Martínez-  Puchol S, Palma N, et al. Macrolide resistance "
        }
    },
    {
        "page_number": 13,
        "section_number": 116,
        "content": "mechanisms in Enterobacteriaceae: focus on azithromycin. Crit Rev",
        "metadata": {
            "section_title": "mechanisms in Enterobacteriaceae: focus on azithromycin. Crit Rev "
        }
    },
    {
        "page_number": 13,
        "section_number": 117,
        "content": "Microbiol . 2017;43:1-  30.",
        "metadata": {
            "section_title": "Microbiol . 2017;43:1-  30."
        }
    },
    {
        "page_number": 13,
        "section_number": 118,
        "content": "44. Gomes C, Ruiz-  Roldán L, Mateu J, Ochoa TJ, Ruiz J. Azithromycin",
        "metadata": {
            "section_title": " 44. Gomes C, Ruiz-  Roldán L, Mateu J, Ochoa TJ, Ruiz J. Azithromycin "
        }
    },
    {
        "page_number": 13,
        "section_number": 119,
        "content": "resistance levels and mechanisms in Escherichia coli . Sci Rep .",
        "metadata": {
            "section_title": "resistance levels and mechanisms in Escherichia coli . Sci Rep . "
        }
    },
    {
        "page_number": 13,
        "section_number": 120,
        "content": "2019;9:1-  10.",
        "metadata": {
            "section_title": "2019;9:1-  10."
        }
    },
    {
        "page_number": 13,
        "section_number": 121,
        "content": "45. Mestrovic T, Ljubin-  Sternak S. Molecular mechanisms of",
        "metadata": {
            "section_title": " 45. Mestrovic T, Ljubin-  Sternak S. Molecular mechanisms of "
        }
    },
    {
        "page_number": 13,
        "section_number": 122,
        "content": "Chlamydia trachomatis resistance to antimicrobial drugs. Front",
        "metadata": {
            "section_title": "Chlamydia trachomatis resistance to antimicrobial drugs. Front "
        }
    },
    {
        "page_number": 13,
        "section_number": 123,
        "content": "Biosci . 2018;23:656-  670.",
        "metadata": {
            "section_title": "Biosci . 2018;23:656-  670."
        }
    },
    {
        "page_number": 13,
        "section_number": 124,
        "content": "46.\t Šmajs\t D,\tPaštěková\t L,\tGrillová\t L.\tMacrolide\t resistance\t in\tthe",
        "metadata": {
            "section_title": "\t 46.\t Šmajs\t D,\tPaštěková\t L,\tGrillová\t L.\tMacrolide\t resistance\t in\tthe\t"
        }
    },
    {
        "page_number": 13,
        "section_number": 125,
        "content": "syphilis spirochete, Treponema pallidum ssp. pallidum: can we",
        "metadata": {
            "section_title": "syphilis spirochete, Treponema pallidum ssp. pallidum: can we "
        }
    },
    {
        "page_number": 13,
        "section_number": 126,
        "content": "also expect macrolide-  resistant yaws strains? Am J Trop Med Hyg .",
        "metadata": {
            "section_title": "also expect macrolide-  resistant yaws strains? Am J Trop Med Hyg . "
        }
    },
    {
        "page_number": 13,
        "section_number": 127,
        "content": "2015;93:678- 683.",
        "metadata": {
            "section_title": "2015;93:678- 683."
        }
    },
    {
        "page_number": 13,
        "section_number": 128,
        "content": "47. Gingras H, Patron K, Leprohon P, Ouellette M. Azithromycin re -",
        "metadata": {
            "section_title": " 47. Gingras H, Patron K, Leprohon P, Ouellette M. Azithromycin re -"
        }
    },
    {
        "page_number": 13,
        "section_number": 129,
        "content": "sistance mutations in Streptococcus pneumoniae as revealed by a",
        "metadata": {
            "section_title": "sistance mutations in Streptococcus pneumoniae as revealed by a "
        }
    },
    {
        "page_number": 13,
        "section_number": 130,
        "content": "chemogenomic screen. Microb Genom . 2020;6:454.",
        "metadata": {
            "section_title": "chemogenomic screen. Microb Genom . 2020;6:454."
        }
    },
    {
        "page_number": 13,
        "section_number": 131,
        "content": "48. Prunier A-  L, Malbruny B, Laurans M, Brouard J, Duhamel",
        "metadata": {
            "section_title": " 48. Prunier A-  L, Malbruny B, Laurans M, Brouard J, Duhamel "
        }
    },
    {
        "page_number": 13,
        "section_number": 132,
        "content": "J- F, Leclercq R. High rate of macrolide resistance in",
        "metadata": {
            "section_title": "J- F, Leclercq R. High rate of macrolide resistance in "
        }
    },
    {
        "page_number": 13,
        "section_number": 133,
        "content": "Staphylococcus aureus  strains from patients with cystic fibrosis",
        "metadata": {
            "section_title": "Staphylococcus aureus  strains from patients with cystic fibrosis"
        }
    },
    {
        "page_number": 14,
        "section_number": 1,
        "content": "14 of 16  |",
        "metadata": {
            "section_title": "14 of 16  |    "
        }
    },
    {
        "page_number": 14,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 14,
        "section_number": 3,
        "content": "reveals high proportions of hypermutable strains. J Infect Dis .",
        "metadata": {
            "section_title": "reveals high proportions of hypermutable strains. J Infect Dis . "
        }
    },
    {
        "page_number": 14,
        "section_number": 4,
        "content": "2003;187:1709-  1716.",
        "metadata": {
            "section_title": "2003;187:1709-  1716."
        }
    },
    {
        "page_number": 14,
        "section_number": 5,
        "content": "49. Gunell M, Kotilainen P, Jalava J, Huovinen P, Siitonen A,",
        "metadata": {
            "section_title": " 49. Gunell M, Kotilainen P, Jalava J, Huovinen P, Siitonen A, "
        }
    },
    {
        "page_number": 14,
        "section_number": 6,
        "content": "Hakanen AJ. In vitro activity of azithromycin against nonty -",
        "metadata": {
            "section_title": "Hakanen AJ. In vitro activity of azithromycin against nonty -"
        }
    },
    {
        "page_number": 14,
        "section_number": 7,
        "content": "phoidal Salmonella enterica. Antimicrob Agents Chemother .",
        "metadata": {
            "section_title": "phoidal Salmonella enterica. Antimicrob Agents Chemother . "
        }
    },
    {
        "page_number": 14,
        "section_number": 8,
        "content": "2010;54:3498- 3501.",
        "metadata": {
            "section_title": "2010;54:3498- 3501."
        }
    },
    {
        "page_number": 14,
        "section_number": 9,
        "content": "50. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in",
        "metadata": {
            "section_title": " 50. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in "
        }
    },
    {
        "page_number": 14,
        "section_number": 10,
        "content": "Haemophilus influenzae. Clin Microbiol Rev . 2007;20:368-  389.",
        "metadata": {
            "section_title": "Haemophilus influenzae. Clin Microbiol Rev . 2007;20:368-  389."
        }
    },
    {
        "page_number": 14,
        "section_number": 11,
        "content": "51. Massip C, Descours G, Ginevra C, Doublet P, Jarraud S, Gilbert C.",
        "metadata": {
            "section_title": " 51. Massip C, Descours G, Ginevra C, Doublet P, Jarraud S, Gilbert C. "
        }
    },
    {
        "page_number": 14,
        "section_number": 12,
        "content": "Macrolide resistance in Legionella pneumophila: the role of LpeAB",
        "metadata": {
            "section_title": "Macrolide resistance in Legionella pneumophila: the role of LpeAB "
        }
    },
    {
        "page_number": 14,
        "section_number": 13,
        "content": "efflux pump. J Antimicrob Chemother . 2017;72:1327-  1333.",
        "metadata": {
            "section_title": "efflux pump. J Antimicrob Chemother . 2017;72:1327-  1333."
        }
    },
    {
        "page_number": 14,
        "section_number": 14,
        "content": "52. Bolinger H, Kathariou S. The current state of macrolide resistance",
        "metadata": {
            "section_title": " 52. Bolinger H, Kathariou S. The current state of macrolide resistance "
        }
    },
    {
        "page_number": 14,
        "section_number": 15,
        "content": "in Campylobacter spp.: trends and impacts of resistance mecha -",
        "metadata": {
            "section_title": "in Campylobacter spp.: trends and impacts of resistance mecha -"
        }
    },
    {
        "page_number": 14,
        "section_number": 16,
        "content": "nisms. Appl Environ Microbiol . 2017;83:e00416-  e00417.",
        "metadata": {
            "section_title": "nisms. Appl Environ Microbiol . 2017;83:e00416-  e00417."
        }
    },
    {
        "page_number": 14,
        "section_number": 17,
        "content": "53. Iovine NM. Resistance mechanisms in Campylobacter jejuni .",
        "metadata": {
            "section_title": " 53. Iovine NM. Resistance mechanisms in Campylobacter jejuni . "
        }
    },
    {
        "page_number": 14,
        "section_number": 18,
        "content": "Virulence . 2013;4:230-  240.",
        "metadata": {
            "section_title": "Virulence . 2013;4:230-  240."
        }
    },
    {
        "page_number": 14,
        "section_number": 19,
        "content": "54. Gaudreau C, Barkati S, Leduc J-  M, Pilon PA, Favreau J, Bekal S.",
        "metadata": {
            "section_title": " 54. Gaudreau C, Barkati S, Leduc J-  M, Pilon PA, Favreau J, Bekal S. "
        }
    },
    {
        "page_number": 14,
        "section_number": 20,
        "content": "Shigella spp. with reduced azithromycin susceptibility, Quebec,",
        "metadata": {
            "section_title": "Shigella spp. with reduced azithromycin susceptibility, Quebec, "
        }
    },
    {
        "page_number": 14,
        "section_number": 21,
        "content": "Canada, 2012–  2013. Emerg Infect Dis . 2014;20:854.",
        "metadata": {
            "section_title": "Canada, 2012–  2013. Emerg Infect Dis . 2014;20:854."
        }
    },
    {
        "page_number": 14,
        "section_number": 22,
        "content": "55. Sjölund Karlsson M, Bowen A, Reporter R, et al. Outbreak of in -",
        "metadata": {
            "section_title": " 55. Sjölund Karlsson M, Bowen A, Reporter R, et al. Outbreak of in -"
        }
    },
    {
        "page_number": 14,
        "section_number": 23,
        "content": "fections caused by Shigella sonnei  with reduced susceptibility to",
        "metadata": {
            "section_title": "fections caused by Shigella sonnei  with reduced susceptibility to "
        }
    },
    {
        "page_number": 14,
        "section_number": 24,
        "content": "azithromycin in the United States. Antimicrob Agents Chemother .",
        "metadata": {
            "section_title": "azithromycin in the United States. Antimicrob Agents Chemother . "
        }
    },
    {
        "page_number": 14,
        "section_number": 25,
        "content": "2013;57:1559-  1560. doi: 10.1128/AAC.02360  - 12",
        "metadata": {
            "section_title": "2013;57:1559-  1560. doi: 10.1128/AAC.02360  - 12"
        }
    },
    {
        "page_number": 14,
        "section_number": 26,
        "content": "56. Yousfi K, Gaudreau C, Pilon PA, et al. Genetic mechanisms behind",
        "metadata": {
            "section_title": " 56. Yousfi K, Gaudreau C, Pilon PA, et al. Genetic mechanisms behind "
        }
    },
    {
        "page_number": 14,
        "section_number": 27,
        "content": "the spread of reduced susceptibility to azithromycin in Shigella",
        "metadata": {
            "section_title": "the spread of reduced susceptibility to azithromycin in Shigella "
        }
    },
    {
        "page_number": 14,
        "section_number": 28,
        "content": "strains isolated from men who have sex with men in Québec,",
        "metadata": {
            "section_title": "strains isolated from men who have sex with men in Québec, "
        }
    },
    {
        "page_number": 14,
        "section_number": 29,
        "content": "Canada. Antimicrob Agents Chemother . 2019;63:e01679-  18.",
        "metadata": {
            "section_title": "Canada. Antimicrob Agents Chemother . 2019;63:e01679-  18. "
        }
    },
    {
        "page_number": 14,
        "section_number": 30,
        "content": "doi:10.1128/aac.01679  - 18",
        "metadata": {
            "section_title": "doi:10.1128/aac.01679  - 18"
        }
    },
    {
        "page_number": 14,
        "section_number": 31,
        "content": "57. Dillon J-  AR, Trecker MA, Thakur SD. Two decades of the gono -",
        "metadata": {
            "section_title": " 57. Dillon J-  AR, Trecker MA, Thakur SD. Two decades of the gono -"
        }
    },
    {
        "page_number": 14,
        "section_number": 32,
        "content": "coccal antimicrobial surveillance program in South America and",
        "metadata": {
            "section_title": "coccal antimicrobial surveillance program in South America and "
        }
    },
    {
        "page_number": 14,
        "section_number": 33,
        "content": "the Caribbean: challenges and opportunities. Sex Transm Infect .",
        "metadata": {
            "section_title": "the Caribbean: challenges and opportunities. Sex Transm Infect . "
        }
    },
    {
        "page_number": 14,
        "section_number": 34,
        "content": "2013;89:iv36-  iv41.",
        "metadata": {
            "section_title": "2013;89:iv36-  iv41."
        }
    },
    {
        "page_number": 14,
        "section_number": 35,
        "content": "58. Kirkcaldy RD, Bartoces MG, Soge OO, et al. Antimicrobial drug pre -",
        "metadata": {
            "section_title": " 58. Kirkcaldy RD, Bartoces MG, Soge OO, et al. Antimicrobial drug pre -"
        }
    },
    {
        "page_number": 14,
        "section_number": 36,
        "content": "scription and Neisseria gonorrhoeae susceptibility, United States,",
        "metadata": {
            "section_title": "scription and Neisseria gonorrhoeae susceptibility, United States, "
        }
    },
    {
        "page_number": 14,
        "section_number": 37,
        "content": "2005-  2013. Emerg Infect Dis . 2017;23:1657-  1663. doi: 10.3201/",
        "metadata": {
            "section_title": "2005-  2013. Emerg Infect Dis . 2017;23:1657-  1663. doi: 10.3201/"
        }
    },
    {
        "page_number": 14,
        "section_number": 38,
        "content": "eid23  10.170488",
        "metadata": {
            "section_title": "eid23  10.170488"
        }
    },
    {
        "page_number": 14,
        "section_number": 39,
        "content": "59. Clark C, Bozdogan BI, Peric M, Dewasse B, Jacobs MR, Appelbaum",
        "metadata": {
            "section_title": " 59. Clark C, Bozdogan BI, Peric M, Dewasse B, Jacobs MR, Appelbaum "
        }
    },
    {
        "page_number": 14,
        "section_number": 40,
        "content": "PC. In vitro selection of resistance in Haemophilus influenzae by",
        "metadata": {
            "section_title": "PC. In vitro selection of resistance in Haemophilus influenzae by "
        }
    },
    {
        "page_number": 14,
        "section_number": 41,
        "content": "amoxicillin- clavulanate, cefpodoxime, cefprozil, azithromycin, and",
        "metadata": {
            "section_title": "amoxicillin- clavulanate, cefpodoxime, cefprozil, azithromycin, and "
        }
    },
    {
        "page_number": 14,
        "section_number": 42,
        "content": "clarithromycin. Antimicrob Agents Chemother . 2002;46:2956-  2962.",
        "metadata": {
            "section_title": "clarithromycin. Antimicrob Agents Chemother . 2002;46:2956-  2962."
        }
    },
    {
        "page_number": 14,
        "section_number": 43,
        "content": "60. Peric M, Bozdogan BI, Jacobs MR, Appelbaum PC. Effects of an ef -",
        "metadata": {
            "section_title": " 60. Peric M, Bozdogan BI, Jacobs MR, Appelbaum PC. Effects of an ef -"
        }
    },
    {
        "page_number": 14,
        "section_number": 44,
        "content": "flux mechanism and ribosomal mutations on macrolide susceptibil -",
        "metadata": {
            "section_title": "flux mechanism and ribosomal mutations on macrolide susceptibil -"
        }
    },
    {
        "page_number": 14,
        "section_number": 45,
        "content": "ity of Haemophilus influenzae clinical isolates. Antimicrob Agents",
        "metadata": {
            "section_title": "ity of Haemophilus influenzae clinical isolates. Antimicrob Agents "
        }
    },
    {
        "page_number": 14,
        "section_number": 46,
        "content": "Chemother . 2003;47:1017-  1022.",
        "metadata": {
            "section_title": "Chemother . 2003;47:1017-  1022."
        }
    },
    {
        "page_number": 14,
        "section_number": 47,
        "content": "61. Nagai K, Davies TA, Dewasse BE, Pankuch GA, Jacobs MR,",
        "metadata": {
            "section_title": " 61. Nagai K, Davies TA, Dewasse BE, Pankuch GA, Jacobs MR, "
        }
    },
    {
        "page_number": 14,
        "section_number": 48,
        "content": "Appelbaum PC. In vitro development of resistance to ceftriax -",
        "metadata": {
            "section_title": "Appelbaum PC. In vitro development of resistance to ceftriax -"
        }
    },
    {
        "page_number": 14,
        "section_number": 49,
        "content": "one, cefprozil and azithromycin in Streptococcus pneumoniae. J",
        "metadata": {
            "section_title": "one, cefprozil and azithromycin in Streptococcus pneumoniae. J "
        }
    },
    {
        "page_number": 14,
        "section_number": 50,
        "content": "Antimicrob Chemother . 2000;46:909-  915.",
        "metadata": {
            "section_title": "Antimicrob Chemother . 2000;46:909-  915."
        }
    },
    {
        "page_number": 14,
        "section_number": 51,
        "content": "62. Mitchell SJ, Engelman J, Kent CK, Lukehart SA, Godornes C,",
        "metadata": {
            "section_title": " 62. Mitchell SJ, Engelman J, Kent CK, Lukehart SA, Godornes C, "
        }
    },
    {
        "page_number": 14,
        "section_number": 52,
        "content": "Klausner JD. Azithromycin-  resistant syphilis infection: San",
        "metadata": {
            "section_title": "Klausner JD. Azithromycin-  resistant syphilis infection: San "
        }
    },
    {
        "page_number": 14,
        "section_number": 53,
        "content": "Francisco, California, 2000–  2004. Clin Infect Dis off Publ Infect Dis",
        "metadata": {
            "section_title": "Francisco, California, 2000–  2004. Clin Infect Dis off Publ Infect Dis "
        }
    },
    {
        "page_number": 14,
        "section_number": 54,
        "content": "Soc Am . 2006;42:337- 345. doi: 10.1086/498899",
        "metadata": {
            "section_title": "Soc Am . 2006;42:337- 345. doi: 10.1086/498899"
        }
    },
    {
        "page_number": 14,
        "section_number": 55,
        "content": "63. Somani J, Bhullar VB, Workowski KA, Farshy CE, Black CM.",
        "metadata": {
            "section_title": " 63. Somani J, Bhullar VB, Workowski KA, Farshy CE, Black CM. "
        }
    },
    {
        "page_number": 14,
        "section_number": 56,
        "content": "Multiple drug-  resistant Chlamydia trachomatis associated with",
        "metadata": {
            "section_title": "Multiple drug-  resistant Chlamydia trachomatis associated with "
        }
    },
    {
        "page_number": 14,
        "section_number": 57,
        "content": "clinical treatment failure. J Infect Dis . 2000;181:1421-  1427.",
        "metadata": {
            "section_title": "clinical treatment failure. J Infect Dis . 2000;181:1421-  1427."
        }
    },
    {
        "page_number": 14,
        "section_number": 58,
        "content": "64. Bhengraj AR, Vardhan H, Srivastava P, Salhan S, Mittal A.",
        "metadata": {
            "section_title": " 64. Bhengraj AR, Vardhan H, Srivastava P, Salhan S, Mittal A. "
        }
    },
    {
        "page_number": 14,
        "section_number": 59,
        "content": "Decreased susceptibility to azithromycin and doxycycline in clin -",
        "metadata": {
            "section_title": "Decreased susceptibility to azithromycin and doxycycline in clin -"
        }
    },
    {
        "page_number": 14,
        "section_number": 60,
        "content": "ical isolates of Chlamydia trachomatis obtained from recurrently",
        "metadata": {
            "section_title": "ical isolates of Chlamydia trachomatis obtained from recurrently "
        }
    },
    {
        "page_number": 14,
        "section_number": 61,
        "content": "infected female patients in India. Chemotherapy . 2010;56:371-  377.",
        "metadata": {
            "section_title": "infected female patients in India. Chemotherapy . 2010;56:371-  377."
        }
    },
    {
        "page_number": 14,
        "section_number": 62,
        "content": "65. Misyurina O, Chipitsyna E, Finashutina Y, et al. Mutations in a 23S",
        "metadata": {
            "section_title": " 65. Misyurina O, Chipitsyna E, Finashutina Y, et al. Mutations in a 23S "
        }
    },
    {
        "page_number": 14,
        "section_number": 63,
        "content": "rRNA gene of Chlamydia trachomatis associated with resistance to",
        "metadata": {
            "section_title": "rRNA gene of Chlamydia trachomatis associated with resistance to "
        }
    },
    {
        "page_number": 14,
        "section_number": 64,
        "content": "macrolides. Antimicrob Agents Chemother . 2004;48:1347-  1349.",
        "metadata": {
            "section_title": "macrolides. Antimicrob Agents Chemother . 2004;48:1347-  1349."
        }
    },
    {
        "page_number": 14,
        "section_number": 65,
        "content": "66. Wolter N, Smith AM, Farrell DJ, et al. Novel mechanism of re -",
        "metadata": {
            "section_title": " 66. Wolter N, Smith AM, Farrell DJ, et al. Novel mechanism of re -"
        }
    },
    {
        "page_number": 14,
        "section_number": 66,
        "content": "sistance to oxazolidinones, macrolides, and chloramphenicol in",
        "metadata": {
            "section_title": "sistance to oxazolidinones, macrolides, and chloramphenicol in "
        }
    },
    {
        "page_number": 14,
        "section_number": 67,
        "content": "ribosomal protein L4 of the pneumococcus. Antimicrob Agents",
        "metadata": {
            "section_title": "ribosomal protein L4 of the pneumococcus. Antimicrob Agents "
        }
    },
    {
        "page_number": 14,
        "section_number": 68,
        "content": "Chemother . 2005;49:3554- 3557. 67. Gür D, Ozalp M, Sümerkan B, et al. Prevalence of antimicrobial",
        "metadata": {
            "section_title": "Chemother . 2005;49:3554- 3557. 67. Gür D, Ozalp M, Sümerkan B, et al. Prevalence of antimicrobial "
        }
    },
    {
        "page_number": 14,
        "section_number": 69,
        "content": "resistance in Haemophilus influenzae, Streptococcus pneumoniae,",
        "metadata": {
            "section_title": "resistance in Haemophilus influenzae, Streptococcus pneumoniae, "
        }
    },
    {
        "page_number": 14,
        "section_number": 70,
        "content": "Moraxella catarrhalis and Streptococcus pyogenes: results of a",
        "metadata": {
            "section_title": "Moraxella catarrhalis and Streptococcus pyogenes: results of a "
        }
    },
    {
        "page_number": 14,
        "section_number": 71,
        "content": "multicentre study in Turkey. Int J Antimicrob Agents . 2002;19:207-",
        "metadata": {
            "section_title": "multicentre study in Turkey. Int J Antimicrob Agents . 2002;19:207-  "
        }
    },
    {
        "page_number": 14,
        "section_number": 72,
        "content": "211. doi: 10.1016/s0924  - 8579(02)00003  - 1",
        "metadata": {
            "section_title": "211. doi: 10.1016/s0924  - 8579(02)00003  - 1"
        }
    },
    {
        "page_number": 14,
        "section_number": 73,
        "content": "68. Baker KS, Dallman TJ, Ashton PM, et al. Intercontinental dissemina -",
        "metadata": {
            "section_title": " 68. Baker KS, Dallman TJ, Ashton PM, et al. Intercontinental dissemina -"
        }
    },
    {
        "page_number": 14,
        "section_number": 74,
        "content": "tion of azithromycin-  resistant shigellosis through sexual transmis -",
        "metadata": {
            "section_title": "tion of azithromycin-  resistant shigellosis through sexual transmis -"
        }
    },
    {
        "page_number": 14,
        "section_number": 75,
        "content": "sion: a cross-  sectional study. Lancet Infect Dis . 2015;15:913-  921.",
        "metadata": {
            "section_title": "sion: a cross-  sectional study. Lancet Infect Dis . 2015;15:913-  921."
        }
    },
    {
        "page_number": 14,
        "section_number": 76,
        "content": "69. Benmessaoud R, Nezha M, Moraleda C, et al. Antimicrobial resis -",
        "metadata": {
            "section_title": " 69. Benmessaoud R, Nezha M, Moraleda C, et al. Antimicrobial resis -"
        }
    },
    {
        "page_number": 14,
        "section_number": 77,
        "content": "tance levels among diarrhoeagenic micro- organisms recovered",
        "metadata": {
            "section_title": "tance levels among diarrhoeagenic micro- organisms recovered "
        }
    },
    {
        "page_number": 14,
        "section_number": 78,
        "content": "from children under-  5 with acute moderate-  to- severe diarrhoea in",
        "metadata": {
            "section_title": "from children under-  5 with acute moderate-  to- severe diarrhoea in "
        }
    },
    {
        "page_number": 14,
        "section_number": 79,
        "content": "Rabat, Morocco. J Glob Antimicrob Resist . 2016;7:34-  36.",
        "metadata": {
            "section_title": "Rabat, Morocco. J Glob Antimicrob Resist . 2016;7:34-  36."
        }
    },
    {
        "page_number": 14,
        "section_number": 80,
        "content": "70. Xiang Y, Wu F, Chai Y, et al. A new plasmid carrying mphA",
        "metadata": {
            "section_title": " 70. Xiang Y, Wu F, Chai Y, et al. A new plasmid carrying mphA "
        }
    },
    {
        "page_number": 14,
        "section_number": 81,
        "content": "causes prevalence of azithromycin resistance in enterotoxigenic",
        "metadata": {
            "section_title": "causes prevalence of azithromycin resistance in enterotoxigenic "
        }
    },
    {
        "page_number": 14,
        "section_number": 82,
        "content": "Escherichia coli  serogroup O6. BMC Microbiol . 2020;20:1-  9.",
        "metadata": {
            "section_title": "Escherichia coli  serogroup O6. BMC Microbiol . 2020;20:1-  9."
        }
    },
    {
        "page_number": 14,
        "section_number": 83,
        "content": "71. Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P. Trends",
        "metadata": {
            "section_title": " 71. Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P. Trends "
        }
    },
    {
        "page_number": 14,
        "section_number": 84,
        "content": "in antibiotic resistance among diarrheal pathogens isolated in",
        "metadata": {
            "section_title": "in antibiotic resistance among diarrheal pathogens isolated in "
        }
    },
    {
        "page_number": 14,
        "section_number": 85,
        "content": "Thailand over 15 years. Clin Infect Dis . 1998;26:341-  345.",
        "metadata": {
            "section_title": "Thailand over 15 years. Clin Infect Dis . 1998;26:341-  345."
        }
    },
    {
        "page_number": 14,
        "section_number": 86,
        "content": "72. Vlieghe ER, Phe T, De Smet B, et al. Azithromycin and ciprofloxa -",
        "metadata": {
            "section_title": " 72. Vlieghe ER, Phe T, De Smet B, et al. Azithromycin and ciprofloxa -"
        }
    },
    {
        "page_number": 14,
        "section_number": 87,
        "content": "cin resistance in Salmonella bloodstream infections in Cambodian",
        "metadata": {
            "section_title": "cin resistance in Salmonella bloodstream infections in Cambodian "
        }
    },
    {
        "page_number": 14,
        "section_number": 88,
        "content": "adults. PLoS Negl Trop Dis . 2012;6:e1933.",
        "metadata": {
            "section_title": "adults. PLoS Negl Trop Dis . 2012;6:e1933."
        }
    },
    {
        "page_number": 14,
        "section_number": 89,
        "content": "73. Nair S, Ashton P, Doumith M, et al. WGS for surveillance of an -",
        "metadata": {
            "section_title": " 73. Nair S, Ashton P, Doumith M, et al. WGS for surveillance of an -"
        }
    },
    {
        "page_number": 14,
        "section_number": 90,
        "content": "timicrobial resistance: a pilot study to detect the prevalence",
        "metadata": {
            "section_title": "timicrobial resistance: a pilot study to detect the prevalence "
        }
    },
    {
        "page_number": 14,
        "section_number": 91,
        "content": "and mechanism of resistance to azithromycin in a UK popu -",
        "metadata": {
            "section_title": "and mechanism of resistance to azithromycin in a UK popu -"
        }
    },
    {
        "page_number": 14,
        "section_number": 92,
        "content": "lation of non-  typhoidal Salmonella. J Antimicrob Chemother .",
        "metadata": {
            "section_title": "lation of non-  typhoidal Salmonella. J Antimicrob Chemother . "
        }
    },
    {
        "page_number": 14,
        "section_number": 93,
        "content": "2016;71:3400- 3408.",
        "metadata": {
            "section_title": "2016;71:3400- 3408."
        }
    },
    {
        "page_number": 14,
        "section_number": 94,
        "content": "74. Brunner A, Nemes-  Nikodem E, Jeney C, et al. Emerging",
        "metadata": {
            "section_title": " 74. Brunner A, Nemes-  Nikodem E, Jeney C, et al. Emerging "
        }
    },
    {
        "page_number": 14,
        "section_number": 95,
        "content": "azithromycin-  resistance among the Neisseria gonorrhoeae strains",
        "metadata": {
            "section_title": "azithromycin-  resistance among the Neisseria gonorrhoeae strains "
        }
    },
    {
        "page_number": 14,
        "section_number": 96,
        "content": "isolated in Hungary. Ann Clin Microbiol Antimicrob . 2016;15:1-  6.",
        "metadata": {
            "section_title": "isolated in Hungary. Ann Clin Microbiol Antimicrob . 2016;15:1-  6."
        }
    },
    {
        "page_number": 14,
        "section_number": 97,
        "content": "75. Kulkarni SV, Bala M, Muqeeth SA, et al. Antibiotic susceptibility",
        "metadata": {
            "section_title": " 75. Kulkarni SV, Bala M, Muqeeth SA, et al. Antibiotic susceptibility "
        }
    },
    {
        "page_number": 14,
        "section_number": 98,
        "content": "pattern of Neisseria gonorrhoeae strains isolated from five cities",
        "metadata": {
            "section_title": "pattern of Neisseria gonorrhoeae strains isolated from five cities "
        }
    },
    {
        "page_number": 14,
        "section_number": 99,
        "content": "in India during 2013–  2016. J Med Microbiol . 2018;67:22-  28.",
        "metadata": {
            "section_title": "in India during 2013–  2016. J Med Microbiol . 2018;67:22-  28."
        }
    },
    {
        "page_number": 14,
        "section_number": 100,
        "content": "76. Cole M, Spiteri G, Chisholm S, et al. Emerging cephalosporin",
        "metadata": {
            "section_title": " 76. Cole M, Spiteri G, Chisholm S, et al. Emerging cephalosporin "
        }
    },
    {
        "page_number": 14,
        "section_number": 101,
        "content": "and multidrug-  resistant gonorrhoea in Europe. Eurosurveillance .",
        "metadata": {
            "section_title": "and multidrug-  resistant gonorrhoea in Europe. Eurosurveillance . "
        }
    },
    {
        "page_number": 14,
        "section_number": 102,
        "content": "2014;19:20955.",
        "metadata": {
            "section_title": "2014;19:20955."
        }
    },
    {
        "page_number": 14,
        "section_number": 103,
        "content": "77. Buder S, Dudareva S, Jansen K, et al. Antimicrobial resistance",
        "metadata": {
            "section_title": " 77. Buder S, Dudareva S, Jansen K, et al. Antimicrobial resistance "
        }
    },
    {
        "page_number": 14,
        "section_number": 104,
        "content": "of Neisseria gonorrhoeae in Germany: low levels of cephalospo -",
        "metadata": {
            "section_title": "of Neisseria gonorrhoeae in Germany: low levels of cephalospo -"
        }
    },
    {
        "page_number": 14,
        "section_number": 105,
        "content": "rin resistance, but high azithromycin resistance. BMC Infect Dis .",
        "metadata": {
            "section_title": "rin resistance, but high azithromycin resistance. BMC Infect Dis . "
        }
    },
    {
        "page_number": 14,
        "section_number": 106,
        "content": "2018;18:1-  11.",
        "metadata": {
            "section_title": "2018;18:1-  11."
        }
    },
    {
        "page_number": 14,
        "section_number": 107,
        "content": "78. Wind CM, van der Loeff MFS, van Dam AP, de Vries HJ, van der",
        "metadata": {
            "section_title": " 78. Wind CM, van der Loeff MFS, van Dam AP, de Vries HJ, van der "
        }
    },
    {
        "page_number": 14,
        "section_number": 108,
        "content": "Helm JJ. Trends in antimicrobial susceptibility for azithromycin",
        "metadata": {
            "section_title": "Helm JJ. Trends in antimicrobial susceptibility for azithromycin "
        }
    },
    {
        "page_number": 14,
        "section_number": 109,
        "content": "and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam,",
        "metadata": {
            "section_title": "and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, "
        }
    },
    {
        "page_number": 14,
        "section_number": 110,
        "content": "the Netherlands, between 2012 and 2015. Eurosurveillance .",
        "metadata": {
            "section_title": "the Netherlands, between 2012 and 2015. Eurosurveillance . "
        }
    },
    {
        "page_number": 14,
        "section_number": 111,
        "content": "2017;22:30431.",
        "metadata": {
            "section_title": "2017;22:30431."
        }
    },
    {
        "page_number": 14,
        "section_number": 112,
        "content": "79. Liu Y-  H, Huang Y-  T, Liao C-  H, Hsueh P-  R. Antimicrobial suscepti -",
        "metadata": {
            "section_title": " 79. Liu Y-  H, Huang Y-  T, Liao C-  H, Hsueh P-  R. Antimicrobial suscepti -"
        }
    },
    {
        "page_number": 14,
        "section_number": 113,
        "content": "bilities and molecular typing of Neisseria gonorrhoeae isolates at",
        "metadata": {
            "section_title": "bilities and molecular typing of Neisseria gonorrhoeae isolates at "
        }
    },
    {
        "page_number": 14,
        "section_number": 114,
        "content": "a medical centre in Taiwan, 2001–  2013 with an emphasis on high",
        "metadata": {
            "section_title": "a medical centre in Taiwan, 2001–  2013 with an emphasis on high "
        }
    },
    {
        "page_number": 14,
        "section_number": 115,
        "content": "rate of azithromycin resistance among the isolates. Int J Antimicrob",
        "metadata": {
            "section_title": "rate of azithromycin resistance among the isolates. Int J Antimicrob "
        }
    },
    {
        "page_number": 14,
        "section_number": 116,
        "content": "Agents . 2018;51:768-  774.",
        "metadata": {
            "section_title": "Agents . 2018;51:768-  774."
        }
    },
    {
        "page_number": 14,
        "section_number": 117,
        "content": "80. Latif AS, Gwanzura L, Machiha A, et al. Antimicrobial susceptibility",
        "metadata": {
            "section_title": " 80. Latif AS, Gwanzura L, Machiha A, et al. Antimicrobial susceptibility "
        }
    },
    {
        "page_number": 14,
        "section_number": 118,
        "content": "in Neisseria gonorrhoeae isolates from five sentinel surveillance",
        "metadata": {
            "section_title": "in Neisseria gonorrhoeae isolates from five sentinel surveillance "
        }
    },
    {
        "page_number": 14,
        "section_number": 119,
        "content": "sites in Zimbabwe, 2015–  2016. Sex Transm Infect . 2018;94:62-  66.",
        "metadata": {
            "section_title": "sites in Zimbabwe, 2015–  2016. Sex Transm Infect . 2018;94:62-  66. "
        }
    },
    {
        "page_number": 14,
        "section_number": 120,
        "content": "doi:10.1136/sextr  ans- 2016-  053090",
        "metadata": {
            "section_title": "doi:10.1136/sextr  ans- 2016-  053090"
        }
    },
    {
        "page_number": 14,
        "section_number": 121,
        "content": "81. Lahra MM, Enriquez RP. Australian gonococcal surveillance pro -",
        "metadata": {
            "section_title": " 81. Lahra MM, Enriquez RP. Australian gonococcal surveillance pro -"
        }
    },
    {
        "page_number": 14,
        "section_number": 122,
        "content": "gramme, 1 July to 30 September 2015. Commun Dis Intell Q Rep .",
        "metadata": {
            "section_title": "gramme, 1 July to 30 September 2015. Commun Dis Intell Q Rep . "
        }
    },
    {
        "page_number": 14,
        "section_number": 123,
        "content": "2016;40:E179-  E181.",
        "metadata": {
            "section_title": "2016;40:E179-  E181."
        }
    },
    {
        "page_number": 14,
        "section_number": 124,
        "content": "82. Vandepitte J, Hughes P, Matovu G, Bukenya J, Grosskurth H, Lewis",
        "metadata": {
            "section_title": " 82. Vandepitte J, Hughes P, Matovu G, Bukenya J, Grosskurth H, Lewis "
        }
    },
    {
        "page_number": 14,
        "section_number": 125,
        "content": "DA. High prevalence of ciprofloxacin-  resistant gonorrhea among",
        "metadata": {
            "section_title": "DA. High prevalence of ciprofloxacin-  resistant gonorrhea among "
        }
    },
    {
        "page_number": 14,
        "section_number": 126,
        "content": "female sex workers in Kampala, Uganda (2008–  2009). Sex Transm",
        "metadata": {
            "section_title": "female sex workers in Kampala, Uganda (2008–  2009). Sex Transm "
        }
    },
    {
        "page_number": 14,
        "section_number": 127,
        "content": "Dis. 2014;41:233-  237.",
        "metadata": {
            "section_title": "Dis. 2014;41:233-  237."
        }
    },
    {
        "page_number": 14,
        "section_number": 128,
        "content": "83. Liang J-  Y, Cao W-  L, Li X-  D, et al. Azithromycin-  resistant Neisseria",
        "metadata": {
            "section_title": " 83. Liang J-  Y, Cao W-  L, Li X-  D, et al. Azithromycin-  resistant Neisseria "
        }
    },
    {
        "page_number": 14,
        "section_number": 129,
        "content": "gonorrhoeae isolates in Guangzhou, China (2009–  2013): coevo -",
        "metadata": {
            "section_title": "gonorrhoeae isolates in Guangzhou, China (2009–  2013): coevo -"
        }
    },
    {
        "page_number": 14,
        "section_number": 130,
        "content": "lution with decreased susceptibilities to ceftriaxone and genetic",
        "metadata": {
            "section_title": "lution with decreased susceptibilities to ceftriaxone and genetic "
        }
    },
    {
        "page_number": 14,
        "section_number": 131,
        "content": "characteristics. BMC Infect Dis . 2016;16:1-  8.",
        "metadata": {
            "section_title": "characteristics. BMC Infect Dis . 2016;16:1-  8."
        }
    },
    {
        "page_number": 14,
        "section_number": 132,
        "content": "84. Li W, Zhu BY, Qin SQ, et al. Surveillance of antibiotic susceptibility",
        "metadata": {
            "section_title": " 84. Li W, Zhu BY, Qin SQ, et al. Surveillance of antibiotic susceptibility "
        }
    },
    {
        "page_number": 14,
        "section_number": 133,
        "content": "patterns of Neisseria gonorrhoeae from 2013 to 2015 in Guangxi",
        "metadata": {
            "section_title": "patterns of Neisseria gonorrhoeae from 2013 to 2015 in Guangxi"
        }
    },
    {
        "page_number": 15,
        "section_number": 1,
        "content": "|  15 of 16",
        "metadata": {
            "section_title": "|  15 of 16"
        }
    },
    {
        "page_number": 15,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 15,
        "section_number": 3,
        "content": "Province, China. Jpn J Infect Dis . 2018;71:148-  151. doi: 10.7883/",
        "metadata": {
            "section_title": "Province, China. Jpn J Infect Dis . 2018;71:148-  151. doi: 10.7883/"
        }
    },
    {
        "page_number": 15,
        "section_number": 4,
        "content": "yoken.JJID.2017.169",
        "metadata": {
            "section_title": "yoken.JJID.2017.169"
        }
    },
    {
        "page_number": 15,
        "section_number": 5,
        "content": "85. Jiang F-  X, Lan Q, Le W-  J, Su X-  H. Antimicrobial susceptibility",
        "metadata": {
            "section_title": " 85. Jiang F-  X, Lan Q, Le W-  J, Su X-  H. Antimicrobial susceptibility "
        }
    },
    {
        "page_number": 15,
        "section_number": 6,
        "content": "of Neisseria gonorrhoeae isolates from Hefei (2014-  2015): ge -",
        "metadata": {
            "section_title": "of Neisseria gonorrhoeae isolates from Hefei (2014-  2015): ge -"
        }
    },
    {
        "page_number": 15,
        "section_number": 7,
        "content": "netic characteristics of antimicrobial resistance. BMC Infect Dis .",
        "metadata": {
            "section_title": "netic characteristics of antimicrobial resistance. BMC Infect Dis . "
        }
    },
    {
        "page_number": 15,
        "section_number": 8,
        "content": "2017;17:1-  6.",
        "metadata": {
            "section_title": "2017;17:1-  6."
        }
    },
    {
        "page_number": 15,
        "section_number": 9,
        "content": "86. Yin Y-  P, Han Y, Dai X-  Q, et al. Susceptibility of Neisseria gonor -",
        "metadata": {
            "section_title": " 86. Yin Y-  P, Han Y, Dai X-  Q, et al. Susceptibility of Neisseria gonor -"
        }
    },
    {
        "page_number": 15,
        "section_number": 10,
        "content": "rhoeae to azithromycin and ceftriaxone in China: a retrospective",
        "metadata": {
            "section_title": "rhoeae to azithromycin and ceftriaxone in China: a retrospective "
        }
    },
    {
        "page_number": 15,
        "section_number": 11,
        "content": "study of national surveillance data from 2013 to 2016. PLoS Med .",
        "metadata": {
            "section_title": "study of national surveillance data from 2013 to 2016. PLoS Med . "
        }
    },
    {
        "page_number": 15,
        "section_number": 12,
        "content": "2018;15:e1002499.",
        "metadata": {
            "section_title": "2018;15:e1002499."
        }
    },
    {
        "page_number": 15,
        "section_number": 13,
        "content": "87. Chen X-  S, Yin Y-  P, Wei W-  H, et al. High prevalence of azithromycin",
        "metadata": {
            "section_title": " 87. Chen X-  S, Yin Y-  P, Wei W-  H, et al. High prevalence of azithromycin "
        }
    },
    {
        "page_number": 15,
        "section_number": 14,
        "content": "resistance to Treponema pallidum in geographically different areas",
        "metadata": {
            "section_title": "resistance to Treponema pallidum in geographically different areas "
        }
    },
    {
        "page_number": 15,
        "section_number": 15,
        "content": "in China. Clin Microbiol Infect . 2013;19:975-  979.",
        "metadata": {
            "section_title": "in China. Clin Microbiol Infect . 2013;19:975-  979."
        }
    },
    {
        "page_number": 15,
        "section_number": 16,
        "content": "88. Muldoon EG, Walsh A, Crowley B, Mulcahy F. Treponema pal -",
        "metadata": {
            "section_title": " 88. Muldoon EG, Walsh A, Crowley B, Mulcahy F. Treponema pal -"
        }
    },
    {
        "page_number": 15,
        "section_number": 17,
        "content": "lidum azithromycin resistance in Dublin, Ireland. Sex Transm Dis .",
        "metadata": {
            "section_title": "lidum azithromycin resistance in Dublin, Ireland. Sex Transm Dis . "
        }
    },
    {
        "page_number": 15,
        "section_number": 18,
        "content": "2012;39:784-  786.",
        "metadata": {
            "section_title": "2012;39:784-  786."
        }
    },
    {
        "page_number": 15,
        "section_number": 19,
        "content": "89. Vaez H, Sahebkar A, Pourfarzi F, Yousefi-  Avarvand A, Khademi F.",
        "metadata": {
            "section_title": " 89. Vaez H, Sahebkar A, Pourfarzi F, Yousefi-  Avarvand A, Khademi F. "
        }
    },
    {
        "page_number": 15,
        "section_number": 20,
        "content": "Prevalence of antibiotic resistance of Haemophilus Influenzae in",
        "metadata": {
            "section_title": "Prevalence of antibiotic resistance of Haemophilus Influenzae in "
        }
    },
    {
        "page_number": 15,
        "section_number": 21,
        "content": "Iran- a meta- analysis. Iran J Otorhinolaryngol . 2019;31:349.",
        "metadata": {
            "section_title": "Iran- a meta- analysis. Iran J Otorhinolaryngol . 2019;31:349."
        }
    },
    {
        "page_number": 15,
        "section_number": 22,
        "content": "90. Boroumand M, Irani S, Siadat SD, Bouzari S. Molecular detec -",
        "metadata": {
            "section_title": " 90. Boroumand M, Irani S, Siadat SD, Bouzari S. Molecular detec -"
        }
    },
    {
        "page_number": 15,
        "section_number": 23,
        "content": "tion of genomic islands associated with class 1 and 2 integron in",
        "metadata": {
            "section_title": "tion of genomic islands associated with class 1 and 2 integron in "
        }
    },
    {
        "page_number": 15,
        "section_number": 24,
        "content": "Haemophilus influenzae isolated in Iran. Jundishapur J Microbiol .",
        "metadata": {
            "section_title": "Haemophilus influenzae isolated in Iran. Jundishapur J Microbiol . "
        }
    },
    {
        "page_number": 15,
        "section_number": 25,
        "content": "2015;8:e17249.",
        "metadata": {
            "section_title": "2015;8:e17249."
        }
    },
    {
        "page_number": 15,
        "section_number": 26,
        "content": "91. Jia X, Ren H, Nie X, Li Y, Li J, Qin T. Antibiotic resistance and",
        "metadata": {
            "section_title": " 91. Jia X, Ren H, Nie X, Li Y, Li J, Qin T. Antibiotic resistance and "
        }
    },
    {
        "page_number": 15,
        "section_number": 27,
        "content": "azithromycin resistance mechanism of Legionella pneu -",
        "metadata": {
            "section_title": "azithromycin resistance mechanism of Legionella pneu -"
        }
    },
    {
        "page_number": 15,
        "section_number": 28,
        "content": "mophila serogroup 1 in China. Antimicrob Agents Chemother .",
        "metadata": {
            "section_title": "mophila serogroup 1 in China. Antimicrob Agents Chemother . "
        }
    },
    {
        "page_number": 15,
        "section_number": 29,
        "content": "2019;63:e00768-  19.",
        "metadata": {
            "section_title": "2019;63:e00768-  19."
        }
    },
    {
        "page_number": 15,
        "section_number": 30,
        "content": "92. Rahimi B, Vesal A. Antimicrobial resistance properties of legionella",
        "metadata": {
            "section_title": " 92. Rahimi B, Vesal A. Antimicrobial resistance properties of legionella "
        }
    },
    {
        "page_number": 15,
        "section_number": 31,
        "content": "pneumophila isolated from the cases of lower respiratory tract in -",
        "metadata": {
            "section_title": "pneumophila isolated from the cases of lower respiratory tract in -"
        }
    },
    {
        "page_number": 15,
        "section_number": 32,
        "content": "fections. Biomed Pharmacol J . 2017;10:59-  65.",
        "metadata": {
            "section_title": "fections. Biomed Pharmacol J . 2017;10:59-  65."
        }
    },
    {
        "page_number": 15,
        "section_number": 33,
        "content": "93. Wei B, Kang M. Molecular basis of macrolide resistance in",
        "metadata": {
            "section_title": " 93. Wei B, Kang M. Molecular basis of macrolide resistance in "
        }
    },
    {
        "page_number": 15,
        "section_number": 34,
        "content": "Campylobacter strains isolated from poultry in South Korea.",
        "metadata": {
            "section_title": "Campylobacter strains isolated from poultry in South Korea. "
        }
    },
    {
        "page_number": 15,
        "section_number": 35,
        "content": "BioMed Res Int . 2018;2018:4526576.",
        "metadata": {
            "section_title": "BioMed Res Int . 2018;2018:4526576."
        }
    },
    {
        "page_number": 15,
        "section_number": 36,
        "content": "94. Tang M, Zhou Q, Zhang X, et al. Antibiotic resistance profiles and",
        "metadata": {
            "section_title": " 94. Tang M, Zhou Q, Zhang X, et al. Antibiotic resistance profiles and "
        }
    },
    {
        "page_number": 15,
        "section_number": 37,
        "content": "molecular mechanisms of Campylobacter from chicken and pig in",
        "metadata": {
            "section_title": "molecular mechanisms of Campylobacter from chicken and pig in "
        }
    },
    {
        "page_number": 15,
        "section_number": 38,
        "content": "China. Front Microbiol . 2020;11:2722.",
        "metadata": {
            "section_title": "China. Front Microbiol . 2020;11:2722."
        }
    },
    {
        "page_number": 15,
        "section_number": 39,
        "content": "95. Efimochkina N, Stetsenko V, Sheveleva S. Formation of the resis -",
        "metadata": {
            "section_title": " 95. Efimochkina N, Stetsenko V, Sheveleva S. Formation of the resis -"
        }
    },
    {
        "page_number": 15,
        "section_number": 40,
        "content": "tance of Campylobacter jejuni  to macrolide antibiotics. Bull Exp Biol",
        "metadata": {
            "section_title": "tance of Campylobacter jejuni  to macrolide antibiotics. Bull Exp Biol "
        }
    },
    {
        "page_number": 15,
        "section_number": 41,
        "content": "Med. 2020;169:351-  356.",
        "metadata": {
            "section_title": "Med. 2020;169:351-  356."
        }
    },
    {
        "page_number": 15,
        "section_number": 42,
        "content": "96. Murphy GS Jr, Echeverria P, Jackson LR, Arness MK, LeBron",
        "metadata": {
            "section_title": " 96. Murphy GS Jr, Echeverria P, Jackson LR, Arness MK, LeBron "
        }
    },
    {
        "page_number": 15,
        "section_number": 43,
        "content": "C, Pitarangsi C. Ciprofloxacin-  and azithromycin-  resistant",
        "metadata": {
            "section_title": "C, Pitarangsi C. Ciprofloxacin-  and azithromycin-  resistant "
        }
    },
    {
        "page_number": 15,
        "section_number": 44,
        "content": "Campylobacter causing traveler's diarrhea in US troops deployed",
        "metadata": {
            "section_title": "Campylobacter causing traveler's diarrhea in US troops deployed "
        }
    },
    {
        "page_number": 15,
        "section_number": 45,
        "content": "to Thailand in 1994. Clin Infect Dis . 1996;22:868-  869.",
        "metadata": {
            "section_title": "to Thailand in 1994. Clin Infect Dis . 1996;22:868-  869."
        }
    },
    {
        "page_number": 15,
        "section_number": 46,
        "content": "97. Slater AF. Chloroquine: mechanism of drug action and resistance",
        "metadata": {
            "section_title": " 97. Slater AF. Chloroquine: mechanism of drug action and resistance "
        }
    },
    {
        "page_number": 15,
        "section_number": 47,
        "content": "in Plasmodium falciparum. Pharmacol Ther . 1993;57:203-  235. doi:",
        "metadata": {
            "section_title": "in Plasmodium falciparum. Pharmacol Ther . 1993;57:203-  235. doi:"
        }
    },
    {
        "page_number": 15,
        "section_number": 48,
        "content": "10.1016/0163-  7258(93)90056  - j",
        "metadata": {
            "section_title": "10.1016/0163-  7258(93)90056  - j"
        }
    },
    {
        "page_number": 15,
        "section_number": 49,
        "content": "98. Ohrt C, Willingmyre GD, Lee P, Knirsch C, Milhous W. Assessment",
        "metadata": {
            "section_title": " 98. Ohrt C, Willingmyre GD, Lee P, Knirsch C, Milhous W. Assessment "
        }
    },
    {
        "page_number": 15,
        "section_number": 50,
        "content": "of azithromycin in combination with other antimalarial drugs against",
        "metadata": {
            "section_title": "of azithromycin in combination with other antimalarial drugs against "
        }
    },
    {
        "page_number": 15,
        "section_number": 51,
        "content": "Plasmodium falciparum in vitro. Antimicrob Agents Chemother .",
        "metadata": {
            "section_title": "Plasmodium falciparum in vitro. Antimicrob Agents Chemother . "
        }
    },
    {
        "page_number": 15,
        "section_number": 52,
        "content": "2002;46:2518-  2524. doi: 10.1128/aac.46.8.2518-  2524.2002",
        "metadata": {
            "section_title": "2002;46:2518-  2524. doi: 10.1128/aac.46.8.2518-  2524.2002"
        }
    },
    {
        "page_number": 15,
        "section_number": 53,
        "content": "99. Dunne MW, Singh N, Shukla M, et al. A multicenter study of azith -",
        "metadata": {
            "section_title": " 99. Dunne MW, Singh N, Shukla M, et al. A multicenter study of azith -"
        }
    },
    {
        "page_number": 15,
        "section_number": 54,
        "content": "romycin, alone and in combination with chloroquine, for the treat -",
        "metadata": {
            "section_title": "romycin, alone and in combination with chloroquine, for the treat -"
        }
    },
    {
        "page_number": 15,
        "section_number": 55,
        "content": "ment of acute uncomplicated Plasmodium falciparum malaria in",
        "metadata": {
            "section_title": "ment of acute uncomplicated Plasmodium falciparum malaria in "
        }
    },
    {
        "page_number": 15,
        "section_number": 56,
        "content": "India. J Infect Dis . 2005;191:1582-  1588. doi: 10.1086/429343",
        "metadata": {
            "section_title": "India. J Infect Dis . 2005;191:1582-  1588. doi: 10.1086/429343"
        }
    },
    {
        "page_number": 15,
        "section_number": 57,
        "content": "100. Cook JA, Randinitis EJ, Bramson CR, Wesche DL. Lack of a phar -",
        "metadata": {
            "section_title": " 100. Cook JA, Randinitis EJ, Bramson CR, Wesche DL. Lack of a phar -"
        }
    },
    {
        "page_number": 15,
        "section_number": 58,
        "content": "macokinetic interaction between azithromycin and chloroquine.",
        "metadata": {
            "section_title": "macokinetic interaction between azithromycin and chloroquine. "
        }
    },
    {
        "page_number": 15,
        "section_number": 59,
        "content": "Am J Trop Med Hyg . 2006;74:407-  412.",
        "metadata": {
            "section_title": "Am J Trop Med Hyg . 2006;74:407-  412."
        }
    },
    {
        "page_number": 15,
        "section_number": 60,
        "content": "101. Nakornchai S, Konthiang P. Activity of azithromycin or eryth -",
        "metadata": {
            "section_title": " 101. Nakornchai S, Konthiang P. Activity of azithromycin or eryth -"
        }
    },
    {
        "page_number": 15,
        "section_number": 61,
        "content": "romycin in combination with antimalarial drugs against",
        "metadata": {
            "section_title": "romycin in combination with antimalarial drugs against "
        }
    },
    {
        "page_number": 15,
        "section_number": 62,
        "content": "multidrug-  resistant Plasmodium falciparum in vitro. Acta Trop .",
        "metadata": {
            "section_title": "multidrug-  resistant Plasmodium falciparum in vitro. Acta Trop . "
        }
    },
    {
        "page_number": 15,
        "section_number": 63,
        "content": "2006;100:185-  191. doi: 10.1016/j.actat  ropica.2006.10.008",
        "metadata": {
            "section_title": "2006;100:185-  191. doi: 10.1016/j.actat  ropica.2006.10.008"
        }
    },
    {
        "page_number": 15,
        "section_number": 64,
        "content": "102. Pereira MR, Henrich PP, Sidhu AB, et al. In vivo and in vitro an -",
        "metadata": {
            "section_title": " 102. Pereira MR, Henrich PP, Sidhu AB, et al. In vivo and in vitro an -"
        }
    },
    {
        "page_number": 15,
        "section_number": 65,
        "content": "timalarial properties of azithromycin- chloroquine combina -",
        "metadata": {
            "section_title": "timalarial properties of azithromycin- chloroquine combina -"
        }
    },
    {
        "page_number": 15,
        "section_number": 66,
        "content": "tions that include the resistance reversal agent amlodipine.",
        "metadata": {
            "section_title": "tions that include the resistance reversal agent amlodipine. "
        }
    },
    {
        "page_number": 15,
        "section_number": 67,
        "content": "Antimicrob Agents Chemother . 2011;55:3115-  3124. doi: 10.1128/",
        "metadata": {
            "section_title": "Antimicrob Agents Chemother . 2011;55:3115-  3124. doi: 10.1128/"
        }
    },
    {
        "page_number": 15,
        "section_number": 68,
        "content": "aac.01566  - 10 103. Zhao Q, Tensfeldt TG, Chandra R, Mould DR. Population pharma -",
        "metadata": {
            "section_title": "aac.01566  - 10 103. Zhao Q, Tensfeldt TG, Chandra R, Mould DR. Population pharma -"
        }
    },
    {
        "page_number": 15,
        "section_number": 69,
        "content": "cokinetics of azithromycin and chloroquine in healthy adults and",
        "metadata": {
            "section_title": "cokinetics of azithromycin and chloroquine in healthy adults and "
        }
    },
    {
        "page_number": 15,
        "section_number": 70,
        "content": "paediatric malaria subjects following oral administration of fixed-",
        "metadata": {
            "section_title": "paediatric malaria subjects following oral administration of fixed- "
        }
    },
    {
        "page_number": 15,
        "section_number": 71,
        "content": "dose azithromycin and chloroquine combination tablets. Malar J .",
        "metadata": {
            "section_title": "dose azithromycin and chloroquine combination tablets. Malar J . "
        }
    },
    {
        "page_number": 15,
        "section_number": 72,
        "content": "2014;13:36. doi: 10.1186/1475-  2875-  13- 36",
        "metadata": {
            "section_title": "2014;13:36. doi: 10.1186/1475-  2875-  13- 36"
        }
    },
    {
        "page_number": 15,
        "section_number": 73,
        "content": "104. Phiri K, Kimani J, Mtove GA, et al. Parasitological clearance rates and",
        "metadata": {
            "section_title": " 104. Phiri K, Kimani J, Mtove GA, et al. Parasitological clearance rates and "
        }
    },
    {
        "page_number": 15,
        "section_number": 74,
        "content": "drug concentrations of a fixed dose combination of azithromycin-",
        "metadata": {
            "section_title": "drug concentrations of a fixed dose combination of azithromycin- "
        }
    },
    {
        "page_number": 15,
        "section_number": 75,
        "content": "chloroquine in asymptomatic pregnant women with Plasmodium",
        "metadata": {
            "section_title": "chloroquine in asymptomatic pregnant women with Plasmodium "
        }
    },
    {
        "page_number": 15,
        "section_number": 76,
        "content": "falciparum parasitemia: an open-  label, non-  comparative study in",
        "metadata": {
            "section_title": "falciparum parasitemia: an open-  label, non-  comparative study in "
        }
    },
    {
        "page_number": 15,
        "section_number": 77,
        "content": "Sub-  Saharan Africa. PLoS One . 2016;11:e0165692. doi: 10.1371/",
        "metadata": {
            "section_title": "Sub-  Saharan Africa. PLoS One . 2016;11:e0165692. doi: 10.1371/"
        }
    },
    {
        "page_number": 15,
        "section_number": 78,
        "content": "journ  al.pone.0165692",
        "metadata": {
            "section_title": "journ  al.pone.0165692"
        }
    },
    {
        "page_number": 15,
        "section_number": 79,
        "content": "105. Kshirsagar NA, Gogtay NJ, Moran D, et al. Treatment of adults with",
        "metadata": {
            "section_title": " 105. Kshirsagar NA, Gogtay NJ, Moran D, et al. Treatment of adults with "
        }
    },
    {
        "page_number": 15,
        "section_number": 80,
        "content": "acute uncomplicated malaria with azithromycin and chloroquine in",
        "metadata": {
            "section_title": "acute uncomplicated malaria with azithromycin and chloroquine in "
        }
    },
    {
        "page_number": 15,
        "section_number": 81,
        "content": "India, Colombia, and Suriname. Res Rep Trop Med . 2017;8:85-  104.",
        "metadata": {
            "section_title": "India, Colombia, and Suriname. Res Rep Trop Med . 2017;8:85-  104. "
        }
    },
    {
        "page_number": 15,
        "section_number": 82,
        "content": "doi:10.2147/rrtm.s129741",
        "metadata": {
            "section_title": "doi:10.2147/rrtm.s129741"
        }
    },
    {
        "page_number": 15,
        "section_number": 83,
        "content": "106. Miller RS, Wongsrichanalai C, Buathong N, et al. Effective treat -",
        "metadata": {
            "section_title": " 106. Miller RS, Wongsrichanalai C, Buathong N, et al. Effective treat -"
        }
    },
    {
        "page_number": 15,
        "section_number": 84,
        "content": "ment of uncomplicated Plasmodium falciparum malaria with",
        "metadata": {
            "section_title": "ment of uncomplicated Plasmodium falciparum malaria with "
        }
    },
    {
        "page_number": 15,
        "section_number": 85,
        "content": "azithromycin- quinine combinations: a randomized, dose-  ranging",
        "metadata": {
            "section_title": "azithromycin- quinine combinations: a randomized, dose-  ranging "
        }
    },
    {
        "page_number": 15,
        "section_number": 86,
        "content": "study. Am J Trop Med Hyg . 2006;74:401-  406.",
        "metadata": {
            "section_title": "study. Am J Trop Med Hyg . 2006;74:401-  406."
        }
    },
    {
        "page_number": 15,
        "section_number": 87,
        "content": "107. Noedl H, Krudsood S, Chalermratana K, et al. Azithromycin com -",
        "metadata": {
            "section_title": " 107. Noedl H, Krudsood S, Chalermratana K, et al. Azithromycin com -"
        }
    },
    {
        "page_number": 15,
        "section_number": 88,
        "content": "bination therapy with artesunate or quinine for the treatment of",
        "metadata": {
            "section_title": "bination therapy with artesunate or quinine for the treatment of "
        }
    },
    {
        "page_number": 15,
        "section_number": 89,
        "content": "uncomplicated Plasmodium falciparum malaria in adults: a ran -",
        "metadata": {
            "section_title": "uncomplicated Plasmodium falciparum malaria in adults: a ran -"
        }
    },
    {
        "page_number": 15,
        "section_number": 90,
        "content": "domized, phase 2 clinical trial in Thailand. Clin Infect Dis off Publ",
        "metadata": {
            "section_title": "domized, phase 2 clinical trial in Thailand. Clin Infect Dis off Publ "
        }
    },
    {
        "page_number": 15,
        "section_number": 91,
        "content": "Infect Dis Soc Am . 2006;43:1264-  1271. doi: 10.1086/508175",
        "metadata": {
            "section_title": "Infect Dis Soc Am . 2006;43:1264-  1271. doi: 10.1086/508175"
        }
    },
    {
        "page_number": 15,
        "section_number": 92,
        "content": "108. Noedl H, Krudsood S, Leowattana W, et al. In vitro antimalarial ac -",
        "metadata": {
            "section_title": " 108. Noedl H, Krudsood S, Leowattana W, et al. In vitro antimalarial ac -"
        }
    },
    {
        "page_number": 15,
        "section_number": 93,
        "content": "tivity of azithromycin, artesunate, and quinine in combination and",
        "metadata": {
            "section_title": "tivity of azithromycin, artesunate, and quinine in combination and "
        }
    },
    {
        "page_number": 15,
        "section_number": 94,
        "content": "correlation with clinical outcome. Antimicrob Agents Chemother .",
        "metadata": {
            "section_title": "correlation with clinical outcome. Antimicrob Agents Chemother . "
        }
    },
    {
        "page_number": 15,
        "section_number": 95,
        "content": "2007;51:651-  656. doi: 10.1128/aac.01023  - 06",
        "metadata": {
            "section_title": "2007;51:651-  656. doi: 10.1128/aac.01023  - 06"
        }
    },
    {
        "page_number": 15,
        "section_number": 96,
        "content": "109. Krudsood S, Buchachart K, Chalermrut K, et al. A comparative clin -",
        "metadata": {
            "section_title": " 109. Krudsood S, Buchachart K, Chalermrut K, et al. A comparative clin -"
        }
    },
    {
        "page_number": 15,
        "section_number": 97,
        "content": "ical trial of combinations of dihydroartemisinin plus azithromycin",
        "metadata": {
            "section_title": "ical trial of combinations of dihydroartemisinin plus azithromycin "
        }
    },
    {
        "page_number": 15,
        "section_number": 98,
        "content": "and dihydroartemisinin plus mefloquine for treatment of multidrug",
        "metadata": {
            "section_title": "and dihydroartemisinin plus mefloquine for treatment of multidrug "
        }
    },
    {
        "page_number": 15,
        "section_number": 99,
        "content": "resistant falciparum malaria. Southeast Asian J Trop Med Public",
        "metadata": {
            "section_title": "resistant falciparum malaria. Southeast Asian J Trop Med Public "
        }
    },
    {
        "page_number": 15,
        "section_number": 100,
        "content": "Health . 2002;33:525-  531.",
        "metadata": {
            "section_title": "Health . 2002;33:525-  531."
        }
    },
    {
        "page_number": 15,
        "section_number": 101,
        "content": "110.  Chitasombat MN, Jongkhajornpong P, Lekhanont K, Krajaejun",
        "metadata": {
            "section_title": " 110.  Chitasombat MN, Jongkhajornpong P, Lekhanont K, Krajaejun "
        }
    },
    {
        "page_number": 15,
        "section_number": 102,
        "content": "T. Recent update in diagnosis and treatment of human pythiosis.",
        "metadata": {
            "section_title": "T. Recent update in diagnosis and treatment of human pythiosis. "
        }
    },
    {
        "page_number": 15,
        "section_number": 103,
        "content": "PeerJ . 2020;8:e8555. doi: 10.7717/peerj.8555",
        "metadata": {
            "section_title": "PeerJ . 2020;8:e8555. doi: 10.7717/peerj.8555"
        }
    },
    {
        "page_number": 15,
        "section_number": 104,
        "content": "111. Jesus FP, Ferreiro L, Loreto ÉS, et al. In vitro synergism observed",
        "metadata": {
            "section_title": " 111. Jesus FP, Ferreiro L, Loreto ÉS, et al. In vitro synergism observed "
        }
    },
    {
        "page_number": 15,
        "section_number": 105,
        "content": "with azithromycin, clarithromycin, minocycline, or tigecycline in",
        "metadata": {
            "section_title": "with azithromycin, clarithromycin, minocycline, or tigecycline in "
        }
    },
    {
        "page_number": 15,
        "section_number": 106,
        "content": "association with antifungal agents against Pythium insidiosum.",
        "metadata": {
            "section_title": "association with antifungal agents against Pythium insidiosum. "
        }
    },
    {
        "page_number": 15,
        "section_number": 107,
        "content": "Antimicrob Agents Chemother . 2014;58:5621-  5625. doi: 10.1128/",
        "metadata": {
            "section_title": "Antimicrob Agents Chemother . 2014;58:5621-  5625. doi: 10.1128/"
        }
    },
    {
        "page_number": 15,
        "section_number": 108,
        "content": "aac.02349  - 14",
        "metadata": {
            "section_title": "aac.02349  - 14"
        }
    },
    {
        "page_number": 15,
        "section_number": 109,
        "content": "112. Jesus FP, Ferreiro L, Bizzi KS, et al. In vitro activity of carvacrol",
        "metadata": {
            "section_title": " 112. Jesus FP, Ferreiro L, Bizzi KS, et al. In vitro activity of carvacrol "
        }
    },
    {
        "page_number": 15,
        "section_number": 110,
        "content": "and thymol combined with antifungals or antibacterials against",
        "metadata": {
            "section_title": "and thymol combined with antifungals or antibacterials against "
        }
    },
    {
        "page_number": 15,
        "section_number": 111,
        "content": "Pythium insidiosum. J Mycol Med . 2015;25:e89-  e93. doi: 10.1016/j.",
        "metadata": {
            "section_title": "Pythium insidiosum. J Mycol Med . 2015;25:e89-  e93. doi: 10.1016/j."
        }
    },
    {
        "page_number": 15,
        "section_number": 112,
        "content": "mycmed.2014.10.023",
        "metadata": {
            "section_title": "mycmed.2014.10.023"
        }
    },
    {
        "page_number": 15,
        "section_number": 113,
        "content": "113. Itaqui SR, Verdi CM, Tondolo JS, et al. In vitro synergism be -",
        "metadata": {
            "section_title": " 113. Itaqui SR, Verdi CM, Tondolo JS, et al. In vitro synergism be -"
        }
    },
    {
        "page_number": 15,
        "section_number": 114,
        "content": "tween azithromycin or terbinafine and topical antimicrobial",
        "metadata": {
            "section_title": "tween azithromycin or terbinafine and topical antimicrobial "
        }
    },
    {
        "page_number": 15,
        "section_number": 115,
        "content": "agents against Pythium insidiosum. Antimicrob Agents Chemother .",
        "metadata": {
            "section_title": "agents against Pythium insidiosum. Antimicrob Agents Chemother . "
        }
    },
    {
        "page_number": 15,
        "section_number": 116,
        "content": "2016;60:5023-  5025. doi: 10.1128/aac.00154  - 16",
        "metadata": {
            "section_title": "2016;60:5023-  5025. doi: 10.1128/aac.00154  - 16"
        }
    },
    {
        "page_number": 15,
        "section_number": 117,
        "content": "114. Jesus FP, Loreto ÉS, Ferreiro L, et al. In vitro and in vivo an -",
        "metadata": {
            "section_title": " 114. Jesus FP, Loreto ÉS, Ferreiro L, et al. In vitro and in vivo an -"
        }
    },
    {
        "page_number": 15,
        "section_number": 118,
        "content": "timicrobial activities of minocycline in combination with",
        "metadata": {
            "section_title": "timicrobial activities of minocycline in combination with "
        }
    },
    {
        "page_number": 15,
        "section_number": 119,
        "content": "azithromycin, clarithromycin, or tigecycline against Pythium insid -",
        "metadata": {
            "section_title": "azithromycin, clarithromycin, or tigecycline against Pythium insid -"
        }
    },
    {
        "page_number": 15,
        "section_number": 120,
        "content": "iosum. Antimicrob Agents Chemother . 2016;60:87-  91. doi: 10.1128/",
        "metadata": {
            "section_title": "iosum. Antimicrob Agents Chemother . 2016;60:87-  91. doi: 10.1128/"
        }
    },
    {
        "page_number": 15,
        "section_number": 121,
        "content": "aac.01480  - 15",
        "metadata": {
            "section_title": "aac.01480  - 15"
        }
    },
    {
        "page_number": 15,
        "section_number": 122,
        "content": "115. Warnock DW. Amphotericin B: an introduction. J Antimicrob",
        "metadata": {
            "section_title": " 115. Warnock DW. Amphotericin B: an introduction. J Antimicrob "
        }
    },
    {
        "page_number": 15,
        "section_number": 123,
        "content": "Chemother . 1991;28:27-  38. doi: 10.1093/jac/28.suppl_b.27",
        "metadata": {
            "section_title": "Chemother . 1991;28:27-  38. doi: 10.1093/jac/28.suppl_b.27"
        }
    },
    {
        "page_number": 15,
        "section_number": 124,
        "content": "116. Soltow SM, Brenner GM. Synergistic activities of azithromycin and",
        "metadata": {
            "section_title": " 116. Soltow SM, Brenner GM. Synergistic activities of azithromycin and "
        }
    },
    {
        "page_number": 15,
        "section_number": 125,
        "content": "amphotericin B against Naegleria fowleri in vitro and in a mouse",
        "metadata": {
            "section_title": "amphotericin B against Naegleria fowleri in vitro and in a mouse "
        }
    },
    {
        "page_number": 15,
        "section_number": 126,
        "content": "model of primary amebic meningoencephalitis. Antimicrob Agents",
        "metadata": {
            "section_title": "model of primary amebic meningoencephalitis. Antimicrob Agents "
        }
    },
    {
        "page_number": 15,
        "section_number": 127,
        "content": "Chemother . 2007;51:23-  27. doi: 10.1128/aac.00788  - 06",
        "metadata": {
            "section_title": "Chemother . 2007;51:23-  27. doi: 10.1128/aac.00788  - 06"
        }
    },
    {
        "page_number": 15,
        "section_number": 128,
        "content": "117. Rehman A, Patrick WM, Lamont IL. Mechanisms of ciproflox -",
        "metadata": {
            "section_title": " 117. Rehman A, Patrick WM, Lamont IL. Mechanisms of ciproflox -"
        }
    },
    {
        "page_number": 15,
        "section_number": 129,
        "content": "acin resistance in Pseudomonas aeruginosa : new approaches to",
        "metadata": {
            "section_title": "acin resistance in Pseudomonas aeruginosa : new approaches to "
        }
    },
    {
        "page_number": 15,
        "section_number": 130,
        "content": "an old problem. J Med Microbiol . 2019;68:1-  10. doi: 10.1099/",
        "metadata": {
            "section_title": "an old problem. J Med Microbiol . 2019;68:1-  10. doi: 10.1099/"
        }
    },
    {
        "page_number": 15,
        "section_number": 131,
        "content": "jmm.0.000873",
        "metadata": {
            "section_title": "jmm.0.000873"
        }
    },
    {
        "page_number": 15,
        "section_number": 132,
        "content": "118. Saini H, Chhibber S, Harjai K. Azithromycin and ciprofloxa -",
        "metadata": {
            "section_title": " 118. Saini H, Chhibber S, Harjai K. Azithromycin and ciprofloxa -"
        }
    },
    {
        "page_number": 15,
        "section_number": 133,
        "content": "cin: a possible synergistic combination against Pseudomonas",
        "metadata": {
            "section_title": "cin: a possible synergistic combination against Pseudomonas"
        }
    },
    {
        "page_number": 16,
        "section_number": 1,
        "content": "16 of 16  |",
        "metadata": {
            "section_title": "16 of 16  |    "
        }
    },
    {
        "page_number": 16,
        "section_number": 2,
        "content": "HEIDARY Et Al.",
        "metadata": {
            "section_title": "HEIDARY Et Al."
        }
    },
    {
        "page_number": 16,
        "section_number": 3,
        "content": "aeruginosa biofilm-  associated urinary tract infections. Int",
        "metadata": {
            "section_title": "aeruginosa biofilm-  associated urinary tract infections. Int "
        }
    },
    {
        "page_number": 16,
        "section_number": 4,
        "content": "J Antimicrob Agents . 2015;45:359- 367. doi: 10.1016/j.ijant",
        "metadata": {
            "section_title": "J Antimicrob Agents . 2015;45:359- 367. doi: 10.1016/j.ijant  "
        }
    },
    {
        "page_number": 16,
        "section_number": 5,
        "content": "imicag.2014.11.008",
        "metadata": {
            "section_title": "imicag.2014.11.008"
        }
    },
    {
        "page_number": 16,
        "section_number": 6,
        "content": "119. Saini H, Chhibber S, Harjai K. Antimicrobial and antifouling ef -",
        "metadata": {
            "section_title": " 119. Saini H, Chhibber S, Harjai K. Antimicrobial and antifouling ef -"
        }
    },
    {
        "page_number": 16,
        "section_number": 7,
        "content": "ficacy of urinary catheters impregnated with a combination of",
        "metadata": {
            "section_title": "ficacy of urinary catheters impregnated with a combination of "
        }
    },
    {
        "page_number": 16,
        "section_number": 8,
        "content": "macrolide and fluoroquinolone antibiotics against Pseudomonas",
        "metadata": {
            "section_title": "macrolide and fluoroquinolone antibiotics against Pseudomonas "
        }
    },
    {
        "page_number": 16,
        "section_number": 9,
        "content": "aeruginosa . Biofouling . 2016;32:511-  522. doi: 10.1080/08927",
        "metadata": {
            "section_title": "aeruginosa . Biofouling . 2016;32:511-  522. doi: 10.1080/08927  "
        }
    },
    {
        "page_number": 16,
        "section_number": 10,
        "content": "014.2016.1155564",
        "metadata": {
            "section_title": "014.2016.1155564"
        }
    },
    {
        "page_number": 16,
        "section_number": 11,
        "content": "120. Lim DJ, Skinner D, McLemore J, et al. In-  vitro evaluation of a cipro -",
        "metadata": {
            "section_title": " 120. Lim DJ, Skinner D, McLemore J, et al. In-  vitro evaluation of a cipro -"
        }
    },
    {
        "page_number": 16,
        "section_number": 12,
        "content": "floxacin and azithromycin sinus stent for Pseudomonas aeruginosa",
        "metadata": {
            "section_title": "floxacin and azithromycin sinus stent for Pseudomonas aeruginosa  "
        }
    },
    {
        "page_number": 16,
        "section_number": 13,
        "content": "biofilms. Int Forum Allergy Rhinol . 2020;10:121-  127. doi: 10.1002/",
        "metadata": {
            "section_title": "biofilms. Int Forum Allergy Rhinol . 2020;10:121-  127. doi: 10.1002/"
        }
    },
    {
        "page_number": 16,
        "section_number": 14,
        "content": "alr.22475",
        "metadata": {
            "section_title": "alr.22475"
        }
    },
    {
        "page_number": 16,
        "section_number": 15,
        "content": "121. Lim DJ, Thompson HM, Walz CR, et al. Azithromycin and cipro -",
        "metadata": {
            "section_title": " 121. Lim DJ, Thompson HM, Walz CR, et al. Azithromycin and cipro -"
        }
    },
    {
        "page_number": 16,
        "section_number": 16,
        "content": "floxacin inhibit interleukin-  8 secretion without disrupting human",
        "metadata": {
            "section_title": "floxacin inhibit interleukin-  8 secretion without disrupting human "
        }
    },
    {
        "page_number": 16,
        "section_number": 17,
        "content": "sinonasal epithelial integrity in vitro. Int Forum Allergy Rhinol .",
        "metadata": {
            "section_title": "sinonasal epithelial integrity in vitro. Int Forum Allergy Rhinol . "
        }
    },
    {
        "page_number": 16,
        "section_number": 18,
        "content": "2021;11:136-  143. doi: 10.1002/alr.22656",
        "metadata": {
            "section_title": "2021;11:136-  143. doi: 10.1002/alr.22656"
        }
    },
    {
        "page_number": 16,
        "section_number": 19,
        "content": "122. Raouf M, Essa S, El Achy S, Essawy M, Rafik S, Baddour M.",
        "metadata": {
            "section_title": " 122. Raouf M, Essa S, El Achy S, Essawy M, Rafik S, Baddour M. "
        }
    },
    {
        "page_number": 16,
        "section_number": 20,
        "content": "Evaluation of combined Ciprofloxacin and azithromycin free and",
        "metadata": {
            "section_title": "Evaluation of combined Ciprofloxacin and azithromycin free and "
        }
    },
    {
        "page_number": 16,
        "section_number": 21,
        "content": "nano formulations to control biofilm producing Pseudomonas",
        "metadata": {
            "section_title": "nano formulations to control biofilm producing Pseudomonas "
        }
    },
    {
        "page_number": 16,
        "section_number": 22,
        "content": "aeruginosa isolated from burn wounds. Indian J Med Microbiol .",
        "metadata": {
            "section_title": "aeruginosa isolated from burn wounds. Indian J Med Microbiol . "
        }
    },
    {
        "page_number": 16,
        "section_number": 23,
        "content": "2021;39:81-  87. doi: 10.1016/j.ijmmb.2021.01.004",
        "metadata": {
            "section_title": "2021;39:81-  87. doi: 10.1016/j.ijmmb.2021.01.004"
        }
    },
    {
        "page_number": 16,
        "section_number": 24,
        "content": "123. Grégoire N, Aranzana-  Climent V, Magréault S, Marchand S, Couet",
        "metadata": {
            "section_title": " 123. Grégoire N, Aranzana-  Climent V, Magréault S, Marchand S, Couet "
        }
    },
    {
        "page_number": 16,
        "section_number": 25,
        "content": "W. Clinical pharmacokinetics and pharmacodynamics of Colistin.",
        "metadata": {
            "section_title": "W. Clinical pharmacokinetics and pharmacodynamics of Colistin. "
        }
    },
    {
        "page_number": 16,
        "section_number": 26,
        "content": "Clin Pharmacokinet . 2017;56:1441-  1460. doi: 10.1007/s4026",
        "metadata": {
            "section_title": "Clin Pharmacokinet . 2017;56:1441-  1460. doi: 10.1007/s4026  "
        }
    },
    {
        "page_number": 16,
        "section_number": 27,
        "content": "2- 017- 0561-  1",
        "metadata": {
            "section_title": "2- 017- 0561-  1"
        }
    },
    {
        "page_number": 16,
        "section_number": 28,
        "content": "124. Li Y, Lin X, Yao X, et al. Synergistic antimicrobial activity of",
        "metadata": {
            "section_title": " 124. Li Y, Lin X, Yao X, et al. Synergistic antimicrobial activity of "
        }
    },
    {
        "page_number": 16,
        "section_number": 29,
        "content": "Colistin in combination with rifampin and azithromycin against",
        "metadata": {
            "section_title": "Colistin in combination with rifampin and azithromycin against "
        }
    },
    {
        "page_number": 16,
        "section_number": 30,
        "content": "Escherichia coli  producing MCR-  1. Antimicrob Agents Chemother .",
        "metadata": {
            "section_title": "Escherichia coli  producing MCR-  1. Antimicrob Agents Chemother . "
        }
    },
    {
        "page_number": 16,
        "section_number": 31,
        "content": "2018;62:e01631-  18. doi: 10.1128/aac.01631  - 18",
        "metadata": {
            "section_title": "2018;62:e01631-  18. doi: 10.1128/aac.01631  - 18"
        }
    },
    {
        "page_number": 16,
        "section_number": 32,
        "content": "125. WHO Guidelines Approved by the Guidelines Review Committee.",
        "metadata": {
            "section_title": " 125. WHO Guidelines Approved by the Guidelines Review Committee. "
        }
    },
    {
        "page_number": 16,
        "section_number": 33,
        "content": "WHO Guidelines for the Treatment of Neisseria Gonorrhoeae . World",
        "metadata": {
            "section_title": "WHO Guidelines for the Treatment of Neisseria Gonorrhoeae . World "
        }
    },
    {
        "page_number": 16,
        "section_number": 34,
        "content": "Health Organization©. 2016.",
        "metadata": {
            "section_title": "Health Organization©. 2016."
        }
    },
    {
        "page_number": 16,
        "section_number": 35,
        "content": "126. Furuya R, Nakayama H, Kanayama A, et al. In vitro synergistic",
        "metadata": {
            "section_title": " 126. Furuya R, Nakayama H, Kanayama A, et al. In vitro synergistic "
        }
    },
    {
        "page_number": 16,
        "section_number": 36,
        "content": "effects of double combinations of beta-  lactams and azithromy -",
        "metadata": {
            "section_title": "effects of double combinations of beta-  lactams and azithromy -"
        }
    },
    {
        "page_number": 16,
        "section_number": 37,
        "content": "cin against clinical isolates of Neisseria gonorrhoeae. J Infect",
        "metadata": {
            "section_title": "cin against clinical isolates of Neisseria gonorrhoeae. J Infect "
        }
    },
    {
        "page_number": 16,
        "section_number": 38,
        "content": "Chemother off J Jpn Soc Chemother . 2006;12:172-  176. doi: 10.1007/",
        "metadata": {
            "section_title": "Chemother off J Jpn Soc Chemother . 2006;12:172-  176. doi: 10.1007/"
        }
    },
    {
        "page_number": 16,
        "section_number": 39,
        "content": "s1015  6- 006-  0445-  z",
        "metadata": {
            "section_title": "s1015  6- 006-  0445-  z"
        }
    },
    {
        "page_number": 16,
        "section_number": 40,
        "content": "127. Onodera S, Kiyota H, Endo K, et al. Enhancement of antimicro -",
        "metadata": {
            "section_title": " 127. Onodera S, Kiyota H, Endo K, et al. Enhancement of antimicro -"
        }
    },
    {
        "page_number": 16,
        "section_number": 41,
        "content": "bial activities of cefteram or clavulanic acid/amoxicillin against",
        "metadata": {
            "section_title": "bial activities of cefteram or clavulanic acid/amoxicillin against "
        }
    },
    {
        "page_number": 16,
        "section_number": 42,
        "content": "cefixime-  resistant Neisseria gonorrhoeae in the presence of",
        "metadata": {
            "section_title": "cefixime-  resistant Neisseria gonorrhoeae in the presence of "
        }
    },
    {
        "page_number": 16,
        "section_number": 43,
        "content": "clarithromycin or azithromycin. J Infect Chemother off J Jpn Soc",
        "metadata": {
            "section_title": "clarithromycin or azithromycin. J Infect Chemother off J Jpn Soc "
        }
    },
    {
        "page_number": 16,
        "section_number": 44,
        "content": "Chemother . 2006;12:207-  209. doi: 10.1007/s1015  6- 006-  0447-  x",
        "metadata": {
            "section_title": "Chemother . 2006;12:207-  209. doi: 10.1007/s1015  6- 006-  0447-  x"
        }
    },
    {
        "page_number": 16,
        "section_number": 45,
        "content": "128. Singh V, Bala M, Bhargava A, Kakran M, Bhatnagar R. In vitro",
        "metadata": {
            "section_title": " 128. Singh V, Bala M, Bhargava A, Kakran M, Bhatnagar R. In vitro "
        }
    },
    {
        "page_number": 16,
        "section_number": 46,
        "content": "efficacy of 21 dual antimicrobial combinations comprising novel",
        "metadata": {
            "section_title": "efficacy of 21 dual antimicrobial combinations comprising novel "
        }
    },
    {
        "page_number": 16,
        "section_number": 47,
        "content": "and currently recommended combinations for treatment of drug",
        "metadata": {
            "section_title": "and currently recommended combinations for treatment of drug "
        }
    },
    {
        "page_number": 16,
        "section_number": 48,
        "content": "resistant gonorrhoea in future era. PLoS One . 2018;13:e0193678.",
        "metadata": {
            "section_title": "resistant gonorrhoea in future era. PLoS One . 2018;13:e0193678. "
        }
    },
    {
        "page_number": 16,
        "section_number": 49,
        "content": "doi:10.1371/journ  al.pone.0193678",
        "metadata": {
            "section_title": "doi:10.1371/journ  al.pone.0193678"
        }
    },
    {
        "page_number": 16,
        "section_number": 50,
        "content": "129. Fricker M, Gibson PG. Macrophage dysfunction in the pathogene -",
        "metadata": {
            "section_title": " 129. Fricker M, Gibson PG. Macrophage dysfunction in the pathogene -"
        }
    },
    {
        "page_number": 16,
        "section_number": 51,
        "content": "sis and treatment of asthma. Eur Respir J . 2017;50:1700196.",
        "metadata": {
            "section_title": "sis and treatment of asthma. Eur Respir J . 2017;50:1700196."
        }
    },
    {
        "page_number": 16,
        "section_number": 52,
        "content": "130. Gibson PG, Yang IA, Upham JW, et al. Effect of azithromycin on",
        "metadata": {
            "section_title": " 130. Gibson PG, Yang IA, Upham JW, et al. Effect of azithromycin on "
        }
    },
    {
        "page_number": 16,
        "section_number": 53,
        "content": "asthma exacerbations and quality of life in adults with persistent",
        "metadata": {
            "section_title": "asthma exacerbations and quality of life in adults with persistent "
        }
    },
    {
        "page_number": 16,
        "section_number": 54,
        "content": "uncontrolled asthma (AMAZES): a randomised, double-  blind,",
        "metadata": {
            "section_title": "uncontrolled asthma (AMAZES): a randomised, double-  blind, "
        }
    },
    {
        "page_number": 16,
        "section_number": 55,
        "content": "placebo-  controlled trial. Lancet . 2017;390:659-  668.",
        "metadata": {
            "section_title": "placebo-  controlled trial. Lancet . 2017;390:659-  668."
        }
    },
    {
        "page_number": 16,
        "section_number": 56,
        "content": "131. Douglas LC, Choi J, Esteban-  Cruciani N. Azithromycin treatment",
        "metadata": {
            "section_title": " 131. Douglas LC, Choi J, Esteban-  Cruciani N. Azithromycin treatment "
        }
    },
    {
        "page_number": 16,
        "section_number": 57,
        "content": "in children hospitalized with asthma: a retrospective cohort study.",
        "metadata": {
            "section_title": "in children hospitalized with asthma: a retrospective cohort study. "
        }
    },
    {
        "page_number": 16,
        "section_number": 58,
        "content": "J Asthma . 2020;57:525-  531.",
        "metadata": {
            "section_title": "J Asthma . 2020;57:525-  531."
        }
    },
    {
        "page_number": 16,
        "section_number": 59,
        "content": "132. Schögler A, Kopf BS, Edwards MR, et al. Novel antiviral properties",
        "metadata": {
            "section_title": " 132. Schögler A, Kopf BS, Edwards MR, et al. Novel antiviral properties "
        }
    },
    {
        "page_number": 16,
        "section_number": 60,
        "content": "of azithromycin in cystic fibrosis airway epithelial cells. Eur Respir",
        "metadata": {
            "section_title": "of azithromycin in cystic fibrosis airway epithelial cells. Eur Respir "
        }
    },
    {
        "page_number": 16,
        "section_number": 61,
        "content": "J. 2015;45:428-  439.",
        "metadata": {
            "section_title": "J. 2015;45:428-  439."
        }
    },
    {
        "page_number": 16,
        "section_number": 62,
        "content": "133. Luisi F, Roza CA, Silveira VdA, et al. Azithromycin administered for",
        "metadata": {
            "section_title": " 133. Luisi F, Roza CA, Silveira VdA, et al. Azithromycin administered for "
        }
    },
    {
        "page_number": 16,
        "section_number": 63,
        "content": "acute bronchiolitis may have a protective effect on subsequent",
        "metadata": {
            "section_title": "acute bronchiolitis may have a protective effect on subsequent "
        }
    },
    {
        "page_number": 16,
        "section_number": 64,
        "content": "wheezing. J Bras De Pneumol . 2020;46:e20180376. 134. Che S-  Y, He H, Deng Y, Liu E-  M. Clinical effect of azithromycin ad -",
        "metadata": {
            "section_title": "wheezing. J Bras De Pneumol . 2020;46:e20180376. 134. Che S-  Y, He H, Deng Y, Liu E-  M. Clinical effect of azithromycin ad -"
        }
    },
    {
        "page_number": 16,
        "section_number": 65,
        "content": "juvant therapy in children with bronchiolitis: a systematic review",
        "metadata": {
            "section_title": "juvant therapy in children with bronchiolitis: a systematic review "
        }
    },
    {
        "page_number": 16,
        "section_number": 66,
        "content": "and Meta analysis. Chin J Contemp Pediatrics . 2019;21:812-  819.",
        "metadata": {
            "section_title": "and Meta analysis. Chin J Contemp Pediatrics . 2019;21:812-  819."
        }
    },
    {
        "page_number": 16,
        "section_number": 67,
        "content": "135. Huckle AW, Fairclough LC, Todd I. Prophylactic antibiotic use in",
        "metadata": {
            "section_title": " 135. Huckle AW, Fairclough LC, Todd I. Prophylactic antibiotic use in "
        }
    },
    {
        "page_number": 16,
        "section_number": 68,
        "content": "COPD and the potential anti- inflammatory activities of antibiotics.",
        "metadata": {
            "section_title": "COPD and the potential anti- inflammatory activities of antibiotics. "
        }
    },
    {
        "page_number": 16,
        "section_number": 69,
        "content": "Respir Care . 2018;63:609-  619.",
        "metadata": {
            "section_title": "Respir Care . 2018;63:609-  619."
        }
    },
    {
        "page_number": 16,
        "section_number": 70,
        "content": "136. Naderi N, Assayag D, Kaddaha Z, et al. Long-  term azithromy -",
        "metadata": {
            "section_title": " 136. Naderi N, Assayag D, Kaddaha Z, et al. Long-  term azithromy -"
        }
    },
    {
        "page_number": 16,
        "section_number": 71,
        "content": "cin therapy to reduce acute exacerbations in patients with",
        "metadata": {
            "section_title": "cin therapy to reduce acute exacerbations in patients with "
        }
    },
    {
        "page_number": 16,
        "section_number": 72,
        "content": "severe chronic obstructive pulmonary disease. Respir Med .",
        "metadata": {
            "section_title": "severe chronic obstructive pulmonary disease. Respir Med . "
        }
    },
    {
        "page_number": 16,
        "section_number": 73,
        "content": "2018;138:129-  136.",
        "metadata": {
            "section_title": "2018;138:129-  136."
        }
    },
    {
        "page_number": 16,
        "section_number": 74,
        "content": "137. Han MK, Tayob N, Murray S, et al. Predictors of chronic ob -",
        "metadata": {
            "section_title": " 137. Han MK, Tayob N, Murray S, et al. Predictors of chronic ob -"
        }
    },
    {
        "page_number": 16,
        "section_number": 75,
        "content": "structive pulmonary disease exacerbation reduction in re -",
        "metadata": {
            "section_title": "structive pulmonary disease exacerbation reduction in re -"
        }
    },
    {
        "page_number": 16,
        "section_number": 76,
        "content": "sponse to daily azithromycin therapy. Am J Respir Crit Care Med .",
        "metadata": {
            "section_title": "sponse to daily azithromycin therapy. Am J Respir Crit Care Med . "
        }
    },
    {
        "page_number": 16,
        "section_number": 77,
        "content": "2014;189:1503-  1508.",
        "metadata": {
            "section_title": "2014;189:1503-  1508."
        }
    },
    {
        "page_number": 16,
        "section_number": 78,
        "content": "138. Uzun S, Djamin RS, Kluytmans JA, et al. Azithromycin mainte -",
        "metadata": {
            "section_title": " 138. Uzun S, Djamin RS, Kluytmans JA, et al. Azithromycin mainte -"
        }
    },
    {
        "page_number": 16,
        "section_number": 79,
        "content": "nance treatment in patients with frequent exacerbations of",
        "metadata": {
            "section_title": "nance treatment in patients with frequent exacerbations of "
        }
    },
    {
        "page_number": 16,
        "section_number": 80,
        "content": "chronic obstructive pulmonary disease (COLUMBUS): a ran -",
        "metadata": {
            "section_title": "chronic obstructive pulmonary disease (COLUMBUS): a ran -"
        }
    },
    {
        "page_number": 16,
        "section_number": 81,
        "content": "domised, double-  blind, placebo-  controlled trial. Lancet Respir",
        "metadata": {
            "section_title": "domised, double-  blind, placebo-  controlled trial. Lancet Respir "
        }
    },
    {
        "page_number": 16,
        "section_number": 82,
        "content": "Med . 2014;2:361-  368.",
        "metadata": {
            "section_title": "Med . 2014;2:361-  368."
        }
    },
    {
        "page_number": 16,
        "section_number": 83,
        "content": "139. Clement A, Tamalet A, Leroux E, Ravilly S, Fauroux B, Jais J-  P. Long",
        "metadata": {
            "section_title": " 139. Clement A, Tamalet A, Leroux E, Ravilly S, Fauroux B, Jais J-  P. Long "
        }
    },
    {
        "page_number": 16,
        "section_number": 84,
        "content": "term effects of azithromycin in patients with cystic fibrosis: a dou -",
        "metadata": {
            "section_title": "term effects of azithromycin in patients with cystic fibrosis: a dou -"
        }
    },
    {
        "page_number": 16,
        "section_number": 85,
        "content": "ble blind, placebo controlled trial. Thorax . 2006;61:895-  902.",
        "metadata": {
            "section_title": "ble blind, placebo controlled trial. Thorax . 2006;61:895-  902."
        }
    },
    {
        "page_number": 16,
        "section_number": 86,
        "content": "140. Aggarwal A, Ghosh A, Gomber S, Mitra M, Parikh A. Efficacy and",
        "metadata": {
            "section_title": " 140. Aggarwal A, Ghosh A, Gomber S, Mitra M, Parikh A. Efficacy and "
        }
    },
    {
        "page_number": 16,
        "section_number": 87,
        "content": "safety of azithromycin for uncomplicated typhoid fever: an open",
        "metadata": {
            "section_title": "safety of azithromycin for uncomplicated typhoid fever: an open "
        }
    },
    {
        "page_number": 16,
        "section_number": 88,
        "content": "label non-  comparative study. Indian Pediatr . 2011;48:553-  556.",
        "metadata": {
            "section_title": "label non-  comparative study. Indian Pediatr . 2011;48:553-  556."
        }
    },
    {
        "page_number": 16,
        "section_number": 89,
        "content": "141. Frenck RW Jr, Mansour A, Nakhla I, et al. Short-  course azithromy -",
        "metadata": {
            "section_title": " 141. Frenck RW Jr, Mansour A, Nakhla I, et al. Short-  course azithromy -"
        }
    },
    {
        "page_number": 16,
        "section_number": 90,
        "content": "cin for the treatment of uncomplicated typhoid fever in children",
        "metadata": {
            "section_title": "cin for the treatment of uncomplicated typhoid fever in children "
        }
    },
    {
        "page_number": 16,
        "section_number": 91,
        "content": "and adolescents. Clin Infect Dis . 2004;38:951-  957.",
        "metadata": {
            "section_title": "and adolescents. Clin Infect Dis . 2004;38:951-  957."
        }
    },
    {
        "page_number": 16,
        "section_number": 92,
        "content": "142. Parry CM, Ho VA, Bay PVB, et al. Randomized controlled com -",
        "metadata": {
            "section_title": " 142. Parry CM, Ho VA, Bay PVB, et al. Randomized controlled com -"
        }
    },
    {
        "page_number": 16,
        "section_number": 93,
        "content": "parison of ofloxacin, azithromycin, and an ofloxacin-  azithromycin",
        "metadata": {
            "section_title": "parison of ofloxacin, azithromycin, and an ofloxacin-  azithromycin "
        }
    },
    {
        "page_number": 16,
        "section_number": 94,
        "content": "combination for treatment of multidrug-  resistant and nali -",
        "metadata": {
            "section_title": "combination for treatment of multidrug-  resistant and nali -"
        }
    },
    {
        "page_number": 16,
        "section_number": 95,
        "content": "dixic acid-  resistant typhoid fever. Antimicrob Agents Chemother .",
        "metadata": {
            "section_title": "dixic acid-  resistant typhoid fever. Antimicrob Agents Chemother . "
        }
    },
    {
        "page_number": 16,
        "section_number": 96,
        "content": "2007;51:819-  825.",
        "metadata": {
            "section_title": "2007;51:819-  825."
        }
    },
    {
        "page_number": 16,
        "section_number": 97,
        "content": "143. Vukelic D, Trkulja V, Salkovic-  Petrisic M. Single oral dose of azi -",
        "metadata": {
            "section_title": " 143. Vukelic D, Trkulja V, Salkovic-  Petrisic M. Single oral dose of azi -"
        }
    },
    {
        "page_number": 16,
        "section_number": 98,
        "content": "thromycin versus 5 days of oral erythromycin or no antibiotic in",
        "metadata": {
            "section_title": "thromycin versus 5 days of oral erythromycin or no antibiotic in "
        }
    },
    {
        "page_number": 16,
        "section_number": 99,
        "content": "treatment of campylobacter enterocolitis in children: a prospec -",
        "metadata": {
            "section_title": "treatment of campylobacter enterocolitis in children: a prospec -"
        }
    },
    {
        "page_number": 16,
        "section_number": 100,
        "content": "tive randomized assessor-  blind study. J Pediatric Gastroenterol",
        "metadata": {
            "section_title": "tive randomized assessor-  blind study. J Pediatric Gastroenterol "
        }
    },
    {
        "page_number": 16,
        "section_number": 101,
        "content": "Nutr. 2010;50:404-  410.",
        "metadata": {
            "section_title": "Nutr. 2010;50:404-  410."
        }
    },
    {
        "page_number": 16,
        "section_number": 102,
        "content": "144. Rustomjee R, Kharsany A, Connolly C, Karim SA. A randomized",
        "metadata": {
            "section_title": " 144. Rustomjee R, Kharsany A, Connolly C, Karim SA. A randomized "
        }
    },
    {
        "page_number": 16,
        "section_number": 103,
        "content": "controlled trial of azithromycin versus doxycycline/ciproflox -",
        "metadata": {
            "section_title": "controlled trial of azithromycin versus doxycycline/ciproflox -"
        }
    },
    {
        "page_number": 16,
        "section_number": 104,
        "content": "acin for the syndromic management of sexually transmitted",
        "metadata": {
            "section_title": "acin for the syndromic management of sexually transmitted "
        }
    },
    {
        "page_number": 16,
        "section_number": 105,
        "content": "infections in a resource-  poor setting. J Antimicrob Chemother .",
        "metadata": {
            "section_title": "infections in a resource-  poor setting. J Antimicrob Chemother . "
        }
    },
    {
        "page_number": 16,
        "section_number": 106,
        "content": "2002;49:875-  878.",
        "metadata": {
            "section_title": "2002;49:875-  878."
        }
    },
    {
        "page_number": 16,
        "section_number": 107,
        "content": "145. Macaux L, Zemali N, Jaubert J, et al. Single dose of azithromycin",
        "metadata": {
            "section_title": " 145. Macaux L, Zemali N, Jaubert J, et al. Single dose of azithromycin "
        }
    },
    {
        "page_number": 16,
        "section_number": 108,
        "content": "for treatment of patients with asymptomatic rectal chlamydia tra -",
        "metadata": {
            "section_title": "for treatment of patients with asymptomatic rectal chlamydia tra -"
        }
    },
    {
        "page_number": 16,
        "section_number": 109,
        "content": "chomatis. Acta Derm Venereol . 2020;100:adv00313.",
        "metadata": {
            "section_title": "chomatis. Acta Derm Venereol . 2020;100:adv00313."
        }
    },
    {
        "page_number": 16,
        "section_number": 110,
        "content": "146.  Sinha S, Adhikari K, Shankarbabu T, Sinha KT. Azithromycin–  the un -",
        "metadata": {
            "section_title": " 146.  Sinha S, Adhikari K, Shankarbabu T, Sinha KT. Azithromycin–  the un -"
        }
    },
    {
        "page_number": 16,
        "section_number": 111,
        "content": "sung hero in periodontics. IP Int J Periodontol Implantol . 2017;2:1-  4.",
        "metadata": {
            "section_title": "sung hero in periodontics. IP Int J Periodontol Implantol . 2017;2:1-  4."
        }
    },
    {
        "page_number": 16,
        "section_number": 112,
        "content": "147. Mascarenhas P, Gapski R, Al-  Shammari K, et al. Clinical response",
        "metadata": {
            "section_title": " 147. Mascarenhas P, Gapski R, Al-  Shammari K, et al. Clinical response "
        }
    },
    {
        "page_number": 16,
        "section_number": 113,
        "content": "of azithromycin as an adjunct to non-  surgical periodontal therapy",
        "metadata": {
            "section_title": "of azithromycin as an adjunct to non-  surgical periodontal therapy "
        }
    },
    {
        "page_number": 16,
        "section_number": 114,
        "content": "in smokers. J Periodontol . 2005;76:426-  436.",
        "metadata": {
            "section_title": "in smokers. J Periodontol . 2005;76:426-  436."
        }
    },
    {
        "page_number": 16,
        "section_number": 115,
        "content": "How to cite this article: Heidary M, Ebrahimi Samangani A,",
        "metadata": {
            "section_title": "How to cite this article: Heidary M, Ebrahimi Samangani A, "
        }
    },
    {
        "page_number": 16,
        "section_number": 116,
        "content": "Kargari A, et al. Mechanism of action, resistance, synergism,",
        "metadata": {
            "section_title": "Kargari A, et al. Mechanism of action, resistance, synergism, "
        }
    },
    {
        "page_number": 16,
        "section_number": 117,
        "content": "and clinical implications of azithromycin. J Clin Lab Anal.",
        "metadata": {
            "section_title": "and clinical implications of azithromycin. J Clin Lab Anal. "
        }
    },
    {
        "page_number": 16,
        "section_number": 118,
        "content": "2022;36:e24427. doi: 10.1002/jcla.24427",
        "metadata": {
            "section_title": "2022;36:e24427. doi: 10.1002/jcla.24427"
        }
    }
]